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 “If you expect to see the final result of your work, 
you simply have not asked a big enough question” 
-I.F. Stone 
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OSBP-related proteins (ORPs) are lipid binding and transport proteins expressed 
ubiquitously in eukaryotic cells. ORPs localize at specific organelle interfaces 
designated membrane contact sites (MCSs). They possess a characteristic ligand-
binding domain with specificity for oxysterols, cholesterol and phospholipids. Some 
ORPs have the capacity to mediate bi-directional transfer and exchange of two 
different lipids over MCSs. However, a number of findings suggest that a majority of 
the ORP family members act as lipid sensors with cell signalling properties rather 
than actual lipid transporters. ORP2 localizes on the surface of cellular lipid droplets. 
Earlier finding suggests that ORP2 contributes in triglyceride (TAG) and cholesterol 
homeostasis but the comprehensive knowledge of the cellular function of ORP2 is 
deficient. 
 
In my thesis I investigated the sterol regulation of the subcellular localization ORP–
VAP complexes and the role of ORP2 in cellular physiology by generating a stable 
ORP2 knock out (KO) cell line in HuH7 hepatocytes. I demonstrated that the 
subcellular distribution of OSBP–, ORP4L– and ORP2–VAP-A complexes at MCSs 
are regulated by ORP oxysterol liganding and by the cellular cholesterol status. 
Moreover, ORP2-KO impaired a diversity of cellular functions. The ORP2-KO 
affected mRNAs of >2000 genes, including TAG and glucose processing metabolic 
enzymes, components of several cell signalling processes and actin cytoskeleton 
regulators. 
 
Analysis of ORP2 interaction partners revealed novel connections of ORP2 with 
PI3K/Akt and RhoA signalling, important regulators of cell metabolic processes and 
the actin cytoskeleton. Consistently, the ORP2-KO impaired the hepatocellular energy 
metabolism by inhibiting the synthesis of TAGs and glycogen, and by reducing the 
rates of glucose uptake and glycolysis, suggesting an extensive contribution of ORP2 
to cellular bioenergetics. 
 
In addition, I present novel clues of ORP2 function beyond the lipid and energy 
metabolism. In migrating cells, ORP2 was found to localize to lamellipodial cell 
surface protrusions, and the ORP2-KO, on the other hand, was found to impair the 
lamellipodia formation. Moreover, ORP2-KO resulted in an inhibition of cell 
adhesion, migration and proliferation, important cell physiological processes 
involving function of the actin cytoskeleton. 
 
The results point at a novel function of ORP2 as a lipid-sensing regulator of the actin 
cytoskeleton, which importantly involves the integration of cellular metabolism with 






ACC acetyl-CoA carboxylase 
ACL ATP citrate lyase 
ADP adenosine diphosphate 
AMP adenosine monophosphate 
Arhgap12 Rho GTPase activating protein 12 
Arp2/3 actin related protein 2/3 
ATP adenosine triphosphate 
BiFC bimolecular fluorescence complementation technique 
CERT ceramide transporter 
ChREBP carbohydrate response element binding protein 
CPT carnitine palmitoyltransferase 
DAG diacylglycerol 
DGAT diacylglycerol acyltransferase 
DHPR dihydropyridine receptor 
DIAPH1 diaphanous-1 (gene) 
DRP1 dynamin-related protein 1 
ER endoplasmic reticulum 
ERK extracellular signal-regulated kinase 
ERM ezrin/radixin/moesin family 
ERMES ER-mitochondria encounter structure 
E-Syt extended synaptotagmin 
FAS fatty acid synthase 
FFAT two phenylalanines in an acidic tract motif 
GK glucokinase 
GKRP glucokinase regulatory protein 
GLUT glucose transporter 
GPAT glycerol-3-phosphate acyltransferase 
gRNA guide RNA 
GSK-3 glycogen synthase kinase-3 
GST glutathione S-transferase 
GYS glycogen synthase 
G-6-P glucose 6-phosphate 
G6Pase glucose-6-phosphatase 
HA hemagglutinin 
HOPS homoptypic fusion and vacuole protein sorting 
HSL hormone sensitive lipase 
Hsp90 heat shock protein 90 
HUVEC human umbilical vein endothelial cells 
IQGAP1 Ras GTPase-activating-like protein 
IPA Ingenuity pathway analysis software 
IP3R inositol triphosphate receptor 
-KC ketocholesterol 
KO knock out 
LD lipid droplet 
LDL low-density lipoprotein 
LE late endosome 
LPA lysophosphatic acid 
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LTP lipid transfer protein 
LXR liver X receptor 
MAPK mitogen-activated protein kinase 
MCS membrane contact site 
MCU mitochondrial Ca2+ uniporter 
mDia1 diaphanous-1 
MFN mitofusin 
MLC myosin light chain 
mTOR mammalian target of rapamycin 
MVB multivesicular body 
NPC Niemann-Pick C 
-OHC hydroxycholesterol 
ORD OSBP-related domain 
ORP OSBP-related protein 
OSBP oxysterol-binding protein 






PDK protein kinase D 
PE phosphatidylethanolamine 
PEPCK phophoenolpuruvate carboxykinase 
PFK-1 phosphofructokinase 
PFKFB 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 
PHD pleckstrin homology domain 
PI phosphatidylinositol 
PIP phosphatidylinositol phosphate 
PI3K phosphoinositide 3-kinase 
PI4P5K phosphatidylinositol-4-phosphate 5-kinase 
PK pyruvate kinase 
PS phosphatidylserine 
PTPIP51 protein tyrosine phosphatase-interacting protein 51 
PYGL glycogen phosphorylase 
ROCK Rho-associated kinase 
RyR ryanodine receptor 
SCD1 stearoyl-CoA desaturase-1 
SM sphingomyelin 
SOCE store-operated Ca2+ entry 
SREBP sterol regulatory element binding protein 
STARD3 StAR-related lipid transfer domain protein 3 
STIM1 stromal interaction molecule-1 
SR sarcoplasmic reticulum 
TAG triacylglycerol 
TCA tricarboxylic acid 
TGN trans-Golgi network 
VAP VAMP-associated protein 
VDAC voltage-dependent anion channel 
VLDL very-low-density lipoprotein 





Oxysterol-binding protein (OSBP) was initially discovered by A. Kandutsch and co-
workers in the turn of 1980s, from a cytosolic protein fraction containing 25-
hydroxycholesterol (Kandutsch et al., 1977; Kandutsch and Thompson, 1980). 
Around the turn of the millennium and also by the efforts of our group, additional 11 
mammalian OSBP-related proteins (ORPs) were characterized (Jaworski et al., 2001; 
Laitinen et al., 1999; Lehto et al., 2001). The OSBP/ORP protein family is found to 
be present in all studied eukaryotes. In addition to 12 mammalian proteins, Danio 
rerio has 14 OSBP/ORP encoding genes (Zhou et al., 2014), Drosophila 
melanogaster and Caenorhabditis elegans four genes (Alphey et al., 1998; Ma et al., 
2010; Sugawara et al., 2001), Arabidopsis thaliana 12 genes (Skirpan et al., 2006) 
and Saccharomyces cerevisiae has seven ORP orthologs (Beh et al., 2001).  
 
A few decades of dedicated research on OSBP/ORPs have shed light on their ligand 
binding properties: They are currently known to bind various different types of lipids, 
not only oxysterols to which their name refers, but also cholesterol and 
glycerophospholipids including phosphoinositides (Olkkonen, 2013). However, there 
is no unambiguous perception of their cellular functions, as researches struggle to 
understand the relation between their function in intracellular lipid transport and in 
lipid sensing through which they apparently impact a broad spectrum of cell 
signalling events (Vihervaara et al., 2011a). Nevertheless, their ubiquitous expression 
profile and their existence in all eukaryotes implicate a fundamental role for 
OSBP/ORPs in the cell physiology. This is supported by an early finding by Beh et al. 
(2001), describing that simultaneous deletion of all seven yeast proteins is lethal 
implying an essential role for ORPs in cell viability. 
 
The general interest on OSBP/ORPs among researchers’ have increased considerably 
in the recent years as the understanding of the role of organelle contacts sites in the 
intracellular communication has begun to emerge. Currently these specialized 
membrane structures are accepted as important mediators of a number of cellular 
processes, including the transmission of calcium signals and lipid trafficking (Helle et 
al., 2013; Prinz, 2014). ORP family of proteins are implicated as prominent effectors 
in the communication of endoplasmic reticulum (ER) with other membranous 
organelles, such as Golgi apparatus, mitochondria, plasma membrane, endosomes and 
lipid droplets, due to their capacity to localize to distinct organelle contacts. In 
principle, ORP family have a potential capacity to bridge ER with almost all cellular 
membrane compartments, making them highly intriguing subjects in the research field 
of inter-organelle communication over membrane contact sites. 
 
In the present series of studies I have mainly focused on ORP2. I have established a 
complete ORP2 knock out cell line by means of CRISPR-Cas9 mediated genome 
editing, in order to comprehensively study the effects of ORP2 depletion on cell 
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physiology. The cellular function of ORP2 was in previous studies linked to the 
metabolism of neutral lipids (Hynynen et al., 2009; Weber-Boyvat et al., 2015b), but 
the detailed mechanism of its action remained poorly understood. The present studies 
elucidate novel connections of ORP2 with the cell metabolic processes, not only in 
the regulation of cellular lipid storage, but also in cellular glucose homeostasis and in 
the signalling processes which ultimately control the cellular bioenergetics. 
Furthermore, these studies provide novel information of the involvement of ORP2 in 
cytoskeletal functions, including cell migration and proliferation. Such a 
comprehensive involvement of ORP2 in these cellular metabolic and cytoskeletal 
functions is not previously reported, for which reason the basic scientific knowledge 
of these cellular processes is summarized in the literature review. These studies also 
focused on to elucidating the role of ORP high-affinity sterol liganding on their 
targeting to membrane contact sites. The study employed the Bimolecular 
Fluorescence Complementation (BiFC) technique, which enabled me to limit the 
analysis to ORPs in interaction with their ER anchor protein VAP-A. The present 
studies imply the importance of ORP2 in the coordination of different cell 





2 REVIEW OF THE LITERATURE 
 
2.1 Mammalian oxysterol binding proteins 
 
2.1.1 Structural features of ORPs 
 
Twelve OSBP genes encode a conserved family of mammalian proteins termed 
oxysterol-binding protein-related proteins (ORPs; Figure 1) (Anniss et al., 2002; 
Jaworski et al., 2001; Lehto et al., 2001; Levanon et al., 1990), named after the 
discovery of their ability to bind oxysterols as their ligands (Taylor et al., 1984). 
OSBP/ORPs are, apart from ORP5 and ORP8, cytosolic proteins, but also localize to 
distinct cellular membranes via lipid or protein interactions enabled by their specific 
structural features. The unifying feature of all ORPs is a conserved carboxy-terminal 
OSBP-related domain (ORD) with a signature motif EQVSHHPP, which has been 
used for identifying the ORP family members (Jaworski et al., 2001; Laitinen et al., 
1999). The domain itself includes a hydrophobic ligand-binding cavity and a mobile 
lid, which encloses the OSBP/ORP lipid ligand within the pocket and shields the 
hydrophobic lipid from the hydrophilic environment of cytosol by blocking the cavity 
entrance. 
 
The detailed structures of mammalian ORPs have not been determined, but erudite 
deductions of ORPs structural characteristics have been made by exploiting structural 
information from S. cerevisiae OSBP/ORP orthologs termed Osh. Crystallographic 
characterization of Osh4 by Im. et al. (2005) led to a fundamental proposition that the 
ligand binding is important for determining the conformation of ORPs. The study 
concluded that the ligand binding immobilizes the otherwise instable lid region 
resulting in a more soluble protein conformation. 
 
With the exception of ORP2, OSBP/ORPs contain an amino-terminal pleckstrin 
homology (PH) domain, which binds phosphatidylinositol phosphates (PIPs) at the 
surface of cellular membranes, which have an important role in subcellular targeting 
of the ORPs (Lagace et al., 1997; Lehto et al., 2005; Levine and Munro, 1998; Levine 
and Munro, 2002; Musacchio et al., 1993; Ngo and Ridgway, 2009; Ridgway et al., 
1992). ORP1, ORP4 and ORP9 are expressed as two variants, long (L) and short (S), 
encoded by transcripts derived from different promoters, and the short variant 
similarly to ORP2 lacks this membrane-targeting PH-domain (Jaworski et al., 2001). 
Moreover, the subcellular targeting of ORP1L is not mediated by a PH-domain but 
via protein interactions enabled by an additional ankyrin motif (Johansson et al., 
2005). 
 
Furthermore, eight out of twelve ORPs contain a two phenylalanines in an acidic tract 
(FFAT) motif, which interacts with type-2 ER trans-membrane proteins VAMP-
associated proteins (VAPs), thus attaching ORPs to a close association with the ER 
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(Kaiser et al., 2005; Loewen et al., 2003). On the other hand, ORP5 and ORP8 
contain an ER trans-membrane domain, which docks these proteins predominantly to 
the ER (Du et al., 2011; Yan et al., 2008). Hence, ORP10 and ORP11 are the only 
family members, which are not shown to interact with the ER. 
 
Figure 1. Schematic figure of the structural features of human ORP family. The roman numerals 
designates to different protein subfamilies defined by their sequence homology. Shown are ORP 
signature motif EQVSHHPP, OSBP-related domain (ORD), two phenylalanines in an acidic tract motif 
(FFAT), plecstrin homology domain (PHD), Ankyrin motif and transmembrane domain (TM). Letter 
‘L’ indicates for long protein variant and ‘S’ for short. 
  
 
2.1.2 Ligands of the ORPs 
 
Oxysterol-binding proteins were named after their first identified ligands, oxysterols, 
which are oxygenated derivatives of cholesterol – generated by cholesterol 
autoxidation or by enzymatic processing – with a number of reported cell signalling 
and cholesterol homeostatic properties (Olkkonen et al., 2012; Schroepfer, 2000). 
Later ORPs were found to bind also cholesterol (usually with lower affinity) and 
glycerophospholipids. The currently characterized lipid ligands of the mammalian 
ORPs’ ORD are summarized in the Table 1. ORPs binds lipids with a 1:1 
stoichiometry and most likely the hydrophobic surface of the lid domain accessible in 
the open conformation helps to extract the lipid from membranes (Wang et al., 
2008a). The Osh4 structure revealed that the bound sterol is oriented in the ligand-
binding pocket with the 3β-hydroxyl group facing to the bottom and the side chains 
interact with the lid at its inner hydrophobic surface. Importantly, the structure 
showed no direct interaction between hydroxyl-groups of the sterol and the protein 
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suggesting that Osh4 can bind a variety of different sterols with a low degree of 
ligand specificity. (Im et al., 2005) 
 
The ORPs’ PH domain binds PIPs at organelle membranes, but later discoveries 
indicated that the ORD is capable of binding PIPs as well (de Saint-Jean et al., 2011). 
In fact, the structure of Osh3 suggested that its ligand binding cavity is too narrow for 
sterols but binds PI(4)P instead (Tong et al., 2013). In fact, it is suggested that PI(4)P 
binding is a unifying feature for the ORDs of all Osh/ORPs, recognized by highly 
conserved amino acid residues, and the sterol binding is an additional feature of only 
some of the family members (de Saint-Jean et al., 2011; Tong et al., 2013). 
 
 LIGANDS REFERENCES 
OSBP 25OHC (Kd 10 nM), cholesterol (Kd 173 
nM), 20OHC, 7KC, PI(4)P 
 
(Dawson et al., 1989; Mesmin et al., 2013; 
Ridgway et al., 1992; Wang et al., 2005; Wang 
et al., 2008a) 
ORP1 24(S)OHC, 22(R)OHC, 25OHC (Kd 97 nM), 
7KC, cholesterol, PA, PS, PG, cardiolipin, 
PI(3)P, PI(4)P, PI(5)P, PI(3,4)P2, PI(3,5)P2, 
PI(4,5)P2, PI(3,4,5)P3 
 
(Fairn and McMaster, 2005a; Suchanek et al., 
2007; Vihervaara et al., 2011b; Xu et al., 2001; 
Yan et al., 2007) 
ORP2 22(R)OHC (Kd 14 nM), 25OHC (Kd 3.9 μM), 
7KC (Kd 140 nM), cholesterol, PA, 
cardiolipin, PI(3)P, PI(3,4)P2, PIP(3,5)2, 
PI(3,4,5)P3 
 
(Hynynen et al., 2005; Hynynen et al., 2009; 




ORP4 25OHC (Kd 10 nM), 7KC, 20OHC, 
22(R)OHC, 22(S)OHC, 7OHC, cholesterol, 
PI(4)P  
 
(Charman et al., 2014; Wang et al., 2002; Wyles 
et al., 2007) 
ORP5 PS, dehydroerhosterol, PI(3)P (Kd 9 μM), 
PI(4)P (Kd 6.7 μM), PI(5)P (Kd 26.8 μM), 
PI(3,4)P2 (Kd 0.8 μM), PI(3,5)P2 (Kd 5.9 μM), 
PI(4,5)P2 (Kd 6.7 μM), PIP3 (Kd 1.1 μM) 
 








ORP8 PS?,cholesterol, 25OHC, PI(3)P (Kd 1.7 
μM), PI(4)P (Kd 2.3 μM), PI(5)P (Kd 5.9 μM), 
PI(3,4)P2 (Kd 2.5 μM), PI(3,5)P2 (Kd 3.6 μM), 
PI(4,5)P2 (Kd 5.3 μM), PIP3 (Kd 6 μM) 
 
(Ghai et al., 2017; Yan et al., 2008; Zhou et al., 
2011) 
ORP9 cholesterol, PI(4)P, PI(5)P, PI(3)P,PI(3,5)P2, 
PI(4,5)P2 
 
(Fairn and McMaster, 2005b; Liu and Ridgway, 
2014; Ngo and Ridgway, 2009) 
ORP10 PS, cholesterol, PI(3)P 
 
(Fairn and McMaster, 2005b; Maeda et al., 
2013; Nissila et al., 2012) 
ORP11 ?  
 
Table 1. Identified mammalian OSBP/ORPs ORD ligands with known dissociation constants (Kd) 
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2.1.3 ORPs in intracellular lipid transport 
 
OSBP/ORPs are suggested to function in inter-organelle lipid transport or in lipid 
sensing with regulatory functions (D'Angelo et al., 2008). Lipid trafficking is 
essential for constructing and maintaining the composition of organelle lipid 
membrane bilayers. The inter-organelle lipid transport occurs by vesicular or by non-
vesicular mechanisms, but non-vesicular lipid trafficking is suggested to be more 
dominant (Lev, 2010). The non-vesicular transport upholds lateral diffusion of lipids 
and lipid transport by carrier proteins, of which the latter enables lipid movement 
across greater distances, as the lipid-enclosing proteins shield the hydrophobic lipids 
from the aqueous cytosol (D'Angelo et al., 2008; Lev, 2010). 
 
The most revealing evidences for OSBP/ORPs lipid transporter functions are derived 
from in vitro studies by using purified recombinant proteins. Actual lipid transfer 
activity in vitro has been shown for OSBP, ORP5, ORP8 and ORP9L (Chung et al., 
2015; Du et al., 2011; Mesmin et al., 2013; Ngo and Ridgway, 2009), but 
manipulation of the cellular levels of ORP1S/ORP2 was shown to affect the transport 
of exogenously administered cholesterol between plasma membrane (PM) and ER or 
lipid droplets (LDs) (Jansen et al., 2011). Intriguingly, Mesmin et al. (2013) showed 
by using liposomes mimicking the ER and trans-Golgi membranes, that OSBP is 
capable of transporting cholesterol from ER to Golgi and exchanging it to PI(4)P 
which is then transported in opposite  – from Golgi to ER – direction. After reaching 
ER, PI(4)P is dephosphorylated to phosphatidylinositol (PI) by the PI-phosphatase 
Sac1, and the energy consumed is utilised by OSBP for the continuum of cholesterol 
transport against its chemical gradient. On the other hand, the transport of PI from the 
ER back to the Golgi is suggested to occur via the PI-transporter Nir2, which is 
shown to restore Golgi PI(4)P levels and to support OSBP PHD Golgi targeting, 
presumably via PI phosphorylation by Golgi-localized PI4-kinases (Peretti et al., 
2008). The study by Mesmin et al. also pinpointed the importance of OSBP’s 
structural features for this transporter function: In order to transport and exchange 
cholesterol for PI(4)P, OSBP needs both the FFAT motif and PHD to connectedly 
bind to ER and sense PI(4)P at Golgi membranes (Mesmin et al., 2013). Furthermore, 
25OHC binding to OSBP was shown to inhibit this bi-directional lipid transportation 
(Mesmin et al., 2013). 
 
The OSBP/ORP4L antagonist OSW-1, a drug that binds to the same ligand-binding 
cavity of OSBP as sterols, was established to inhibit OSBP function and promote its 
protein degradation (Burgett et al., 2011). In line with reduction of OSBP-mediated 
cholesterol transport by 25OHC liganding, the same group later showed that 
inhibition of the endogenous OSBP by OSW-1 impaired cholesterol transport from 
ER to other membranes, including trans-Golgi network (TGN), resulting in 
cholesterol accumulation in the ER (Mesmin et al., 2017). Moreover, OSW-1 
treatment increased the cellular levels of PI(4)P and also its amount in TGN (Mesmin 
et al., 2017). The studies of OSBP counter-transport function refers that cholesterol 
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transport against its chemical gradient is enabled by the energy provided by the 
retrograde transport and subsequent hydrolysis of PI(4)P, which is in line with the 
observed increment of PI(4)P as a result of OSBP inhibition (Mesmin et al., 2017). 
This model could also serve as a plausible explanation for an earlier report observing 
that the knock down of Sac1 causes a disorganization of the Golgi membranes by an 
unknown mechanism (Liu et al., 2008). 
 
Similarly, the group of De Camilli and co-workers (2015) showed that ORP5 and 
ORP8 also exploit PI(4)P hydrolysis derived energy by Sac1 to counter-transport 
PI(4)P and phosphatidylserine (PS) between the ER and the PM, thus sustaining 
sufficient PM PS levels (Chung et al., 2015). Importantly, a recent study by Ghai et 
al. (2017) demonstrated that the PHDs/ORDs of ORP5 and ORP8 do not exclusively 
bind PI(4)P but are able to bind all PIPs with a similar affinity, and moreover, the 
PM–ER PS counter-transport activity was shown to be even higher with PI(4,5)P2 
than with PI(4)P. In addition, ORP5/8 double knock down was shown to decrease the 
PM PS levels and increase the PI(4,5)P2, further supporting a function of ORP5/8 in 
bi-directional transport of PS and PI(4,5)P2 (Ghai et al., 2017). 
 
It is still unclear whether the lipid cargo transport by PIP counter-exchange is a 
universal function for ORP family members, but studies with yeast Osh proteins also 
support the role of a number of Osh’s in bi-directional lipid/PIP transport (de Saint-
Jean et al., 2011; Maeda et al., 2013; Moser von Filseck et al., 2015). In addition, the 
above finding that PIPs other than PI(4)P could also serve as counter-transport 




2.1.4 ORPs in cell signalling  
 
In addition to the above described findings of ORPs in lipid transport, various studies 
implicate OSBP/ORPs in cellular processes in which the role of their lipid transport 
activity is unknown. Hence various studies suggest that ORPs could in addition 
function as lipid sensors or receptors regulating cell signalling via effector proteins. 
 
 
O S B P 
 
OSBP – the archetype of oxysterol-binding proteins – is suggested to act as a sterol 
sensor regulating sphingomyelin (SM) synthesis at ER–trans-Golgi interfaces via 
protein kinase signalling. Cellular cholesterol depletion or external 25OHC treatment 
is shown to promote OSBP trans-Golgi localization (Mohammadi et al., 2001; 
Ridgway et al., 1992; Ridgway et al., 1998; Storey et al., 1998), mediated by the 
interaction of its PHD with PI(4)P and with ADP-ribosylation factor (Arf1) (Godi et 
al., 2004; Levine and Munro, 1998; Levine and Munro, 2002; Mesmin et al., 2013). 
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The 25OHC liganding by OSBP was found to inhibit the cholesterol–PI(4)P counter-
transport activity as described above, apparently by occupying the OSBP ORD. In 
turn, in the presence of 25OHC, OSBP was shown to facilitate association of a 
ceramide transporter CERT with trans-Golgi, required for the transport of ceramides 
from ER to Golgi apparatus for SM synthesis (Banerji et al., 2010; Hanada et al., 
2003; Perry and Ridgway, 2006). This process is additionally regulated 
phosphorylation of OSBP at Ser240 by protein kinase D (PDK). OSBP 
phosphorylation inhibits its localization to Golgi in response to 25OHC or cholesterol 
depletion, which consequently reduces the ceramide transport by impairing the Golgi 
localization of CERT and promotes Golgi fragmentation (Nhek et al., 2010). 
 
On the other hand, when bound with cholesterol instead of 25OHC, OSBP was found 
to form a complex with active form of PP2A and HePTP phosphatases (Wang et al., 
2005; Wang et al., 2008a), which regulate the activity of extracellular signal-
regulated kinases ERK1/2, important factors in the mitogen-activated protein kinase 
(MAPK) signalling pathway. Increment of 25OHC or cholesterol depletion was found 
to dissociate OSBP from the complex and disrupt the complex assembly resulting in 
the phosphorylation of ERK1/2. OSBP is also reported to mediate a 7-ketocholesterol 
(7KC) induced up-regulation of the actin binding protein Profilin-1 via a JAK-
2/STAT3 signalling pathway (Romeo and Kazlauskas, 2008). However, the affinity of 
OSBP for 7KC is only moderate (Dawson et al., 1989), thus it is possible that other 
unidentified factors participate in this process. 
 
Regardless, it is evident that OSBP executes its cell signalling functions in a sterol-
dependent manner, showing different modes of action in the presence of 25OHC or 
cholesterol, supporting the idea that OSBP is a multifunctional sterol 




O R P 3 
 
Unlike OSBP, the ORP3 ORD is unlikely to accommodate sterols but presumably 
binds PI(4)P (Zhou et al., 2014), and the PHD is shown to interact with PI(3,4)P2 and 
PI(3,4,5)P3 at the PM (Lehto et al., 2005). ORP3 also interacts with VAPs at the ER, 
the affinity of which was shown to be regulated by ORP3 phosphorylation status 
(Weber-Boyvat et al., 2015a). ORP3 interacts with a small GTPase R-Ras, and 
manipulation of ORP3 controls various R-Ras downstream signalling processes 
including cell adhesion and migration, organization of the actin cytoskeleton, Akt 
phosphorylation and β1-integrin activity (Lehto et al., 2008; Weber-Boyvat et al., 
2015a). Moreover, R-Ras signalling was suggested to originate at ER–PM membrane 
contact sites (MCS), as the activation of R-Ras by ORP3 was found to be dependent 
on ORP3 targeting to both the ER and the PM (Weber-Boyvat et al., 2015a). 
 
18
O R P 9 
 
ORP9 is also suggested to regulate Akt activity, thus potentially controlling a variety 
of functions subjected to regulation by PI3K/Akt signalling. ORP9S/L was identified 
as a substrate for phosphoinositide-dependent kinase-2 (PDK-2) at Ser287 (Lessmann 
et al., 2007), which also phosphorylates Akt at Ser473 (Kawakami et al., 2004). 
Phosphorylation of ORP9 by PDK-2 was found to depend on protein kinase Cβ or 
mammalian target of rapamycin (mTOR), and negatively regulate Akt 
phosphorylation at Ser473 (Lessmann et al., 2007). 
 
 
O R P 5 
 
A recent study by Du et al. (2018) suggested that the cellular function of ORP5 is not 
limited to PS transport at ER–PM MCSs, but it regulates mTORC1 signalling. The 
study suggested, that dependent on its lipid-binding pocket, ORP5 interacts with 
mTORC1. Moreover, ORP5 overexpression was found to induce mTORC1 signalling 
activity, and to enhance cell migration and proliferation of HeLa cells, also dependent 
on ORP5 ability for ligand binding. ORP5 silencing, on the other hand, was found to 
inhibit mTORC1 and disrupt mTOR localization to lysosomes. (Du et al., 2018) This 
further suggests that the lipid transporting is nonexclusive function of ORPs, but in 
addition they are lipid sensors contributing to cell signalling processes, which direct 
connection to the lipid transporting is rather undecipherable. 
 
 
O R P 2 
 
Similar to OSBP, sterol binding was also shown to regulate the subcellular targeting 
of ORP2. ORP2 is a cytosolic protein which also targets the ER via VAP-binding and 
is also found on the surface of the intracellular LDs, a targeting which is abolished by 
an external 22(R)OHC treatment (Hynynen et al., 2009). The co-expression of ORP2 
and VAP-A was observed to enhance the LD targeting of ORP2, and a sterol-binding 
deficient mutant of ORP2 also displayed enhanced LD association (Hynynen et al., 
2009; Weber-Boyvat et al., 2015b). It is however unclear what physiological function 
of ORP2 this sterol liganding regulates. 
 
The manipulations of ORP2 cellular levels correlate with the homeostatic regulation 
of trigacylglycerols (TAGs) (Hynynen et al., 2009; Weber-Boyvat et al., 2015b), 
which together with cholesterol esters constitute the lipophilic core of LDs. In 
addition, ORP2 promotes transport of newly synthesized cholesterol to the PM as well 
as cholesterol efflux (Hynynen et al., 2005; Jansen et al., 2011; Laitinen et al., 2002). 
Consistently, co-suppression of ORP2 and ORP1S expression was found to inhibit 
cholesterol transport from the PM to the ER and LD (Jansen et al., 2011). In 
adrenocortical cells, ORP2 was suggested to be important for LXR nuclear 
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localization and ORP2 silencing was shown to increase the levels of cellular 
cholesterol while decreasing 22(R)OHC and 7KC (Escajadillo et al., 2016). 
Furthermore, adrenocortical cells have an important physiological role in the 
production of steroid hormones, and ORP2 was shown to be physically involved in a 
protein complex, which regulates cortisol synthesis (Li et al., 2013). Consistently, 
silencing of ORP2 in adrenocortical cells was shown to reduce expression of proteins 
involved in cortisol synthesis as well as the amounts of several steroid metabolites, 
and increase the concentrations of androgens and estrogens (Escajadillo et al., 2016). 
 
In addition, ORP2 interacts with diaphanous-1 (mDia1) (Li et al., 2013), an important 
molecular component in RhoA signalling. mDia1/RhoA also regulate the steroid 
hormone production of adrenocortical cells but additionally have a pivotal role in the 
actin cytoskeleton and microtubule organization (Geneste et al., 2002; Li et al., 2013; 
Nakano et al., 1999; Palazzo et al., 2001). Mutations in mDia1 are connected with 
autosomal dominant hearing loss (Kang et al., 2017; Neuhaus et al., 2017; Stritt et al., 
2016), where it is suggested to play a role in actin polymerization in inner ear hair 
cells (Stritt et al., 2016). Intriguingly, ORP2 was also found to be expressed in inner 
and outer hair cell stereocilia, and a frameshift mutation in the ORP2 encoding gene 
was suggested to cause a form of autosomal dominant hearing loss (Thoenes et al., 




2.2 Membrane contact sites in mammals 
 
2.2.1 Biology of membrane contact sites 
 
Eukaryotic cells are compartmentalized into intracellular organelles specialized in 
different biological processes encompassing organelle specific proteins and other 
components necessary for their function. These organelles are usually membrane 
enclosed regions separated from the cytosol in order to have their own optimal 
physical and chemical micro-environments. However, for a cell to operate as a 
functional integrity and sustain life, all cellular compartments need to be connected 
and co-operated optimally. One of the mechanisms how organelles are able to 
communicate with each other is over membrane contact sites, which are described as 
close appositions (10–30 nm) between membranes of two organelles without 
involving membrane fusion (Helle et al., 2013; Prinz, 2014). The existence of these 
sites has been known for decades (Copeland and Dalton, 1959; Porter and Palade, 
1957; Robertson, 1960), yet the knowledge of the function of these membrane 
domains is still more or less insufficient. Currently there is no comprehensive 
information explaining the molecular machineries responsible for MCS biogenesis or 
the mechanisms of MCS regulation and function. MCSs are, however, found to be 
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universal architectures present in yeast, mammalian and plant cells, and similar 
structures are also found to exist in prokaryotes. 
 
Most MCS are sites between ER and a second membranous organelle, such as Golgi 
apparatus, mitochondria, endosomes or plasma membrane. However, MCS also exist 
between non-ER organelles, such as lysosomes and peroxisomes, and between LD 
and mitochondria (Chu et al., 2015; Jagerstrom et al., 2009). The two membranes are 
kept in close proximity by tethering components allowing steady but temporally 
regulated connections. Up to this point, there is no indisputable evidence, which 
defines proteins involved in the MCS formation. The first intrinsic MCS tethers were 
identified by Kornmann et al. (2009) in yeast S. cerevisiae ER–mitochondria 
encounter structure (ERMES), in which a protein complex composed of four subunits 
[maintenance of mitochondrial morphology protein 1 (Mmm1) and mitochondrial 
distribution and morphology protein 10/12/34 (Mdm10/Mdm12/Mdm34)] tethering 
between the ER and mitochondria, was suggested to play a role in phospholipid 
synthesis and Ca2+signalling. An additional groundbreaking achievement was made 
by the group of S. Emr by managing to abolish MCS between ER and PM in yeast by 
deleting six individual genes (Manford et al., 2012). This study implicated that the 
proteins required for the existence of PM–ER contact sites in yeast are cortical ER 
protein Ist2 (related to mammalian anoctamin/TMEM16), tricalbin 1–3, and ER trans-
membrane proteins Scs2/22. Of those Scs2, which is homologous to mammalian 
VAPs, was suggested to be the most essential (Manford et al., 2012). Importantly, the 
study emphasised that MCSs are not necessarily formed by a single factor but by 
multiple determinants. 
 
In mammalian cells the involvement of tricalbin homologues termed extended 
synaptotagmins (E-Syts) have been shown to play a role in the formation of MCSs 
between PM and ER (Chang et al., 2013; Giordano et al., 2013). E-Syts, like many 
other MCS tethering factors, have domains targeting both membranes, and the 
localization of E-Syts at PM–ER junctions are regulated by calcium and binding to 
PI(4,5)P2 (Chang et al., 2013; Giordano et al., 2013; Idevall-Hagren et al., 2015; Min 
et al., 2007). Another family of established mammalian MCS promoters are 
junctophilins. Also junctophilins have structural features enabling them to bind two 
membranes simultaneously, and they are found to be responsible for the formation of 
contact sites between PM and sarcoplasmic reticulum (SR) in muscle cells (Garbino 
et al., 2009; Takeshima et al., 2000). The deletion of junctophilins does not, however, 
completely prevent the SR–PM contact site formation, which implies that also in 
myocytes the MCSs are rather formed by groups of proteins or protein complexes 
(Hirata et al., 2006; Ito et al., 2001). 
 
To this day, dozens of proteins are found to localize and function at MCSs, and some 
of them presumably stabilize already formed contacts. However, the role of those 
tethering factors in the de novo MCSs formation is either unclear or for some of them 
even unlikely. The proteins found to localize at MCS and later discussed in this 
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chapter are listed in Table 2. Of note, MCSs can also form between compartments in 
the same organelle or inside organelles, for example between cis-, medial-, and trans-
Golgi cisternae or between the inner and outer mitochondria membrane (Harner et al., 
2011; Schorr and van der Laan, 2018; Wollweber et al., 2017; Xiang and Wang, 





PM–ER MCS PM ER  References 
  junctophilins Section 2.2.1 (Garbino et al., 2009; 
Takeshima et al., 2000) 
  E- Syts Section 2.2.1 (Chang et al., 2013; 
Giordano et al., 2013) 
 DHPRs RyRs Section 2.2.2 (Rebbeck et al., 2011) 
 Orai1 STIM1 Section 2.2.2 (Korzeniowski et al., 2009; 
Maleth et al., 2014; Park et 
al., 2009; Wu et al., 2006) 
  ORP5, ORP8 Section 2.2.3 (Chung et al., 2015; Ghai et 
al., 2017) 
 Nir2 VAPs Section 2.2.3 (Chang et al., 2013; Chang 
and Liou, 2015; Kim et al., 
2015) 
Mitochondria– Mitochondria ER   
ER MCS MFN2/MFN1 MFN2 Section 2.2.4 (de Brito and Scorrano, 2008) 
 PTPIP51 VAP-B Section 2.2.2 (De Vos et al., 2012) 
 PTPIP51 ORP5/8 Section 2.2.3 (Galmes et al., 2016) 
 VDAC1 IP3R Section 2.2.2 (Csordas et al., 2010; De 
Stefani et al., 2016; 
Szabadkai et al., 2006) 
  DRP1  Section 2.2.4 (Friedman et al., 2011) 
Golgi–ER MCS Golgi ER   
 OSBP VAPs Section 2.2.3 (Mesmin et al., 2013; Mesmin 
et al., 2017) 
 CERT VAPs Section 2.2.3 (Hanada et al., 2003; Perry 
and Ridgway, 2006) 
LE–ER MCS Endosome ER   
 ORP1L VAPs Section 2.2.4 (Johansson et al., 2007; 
Rocha et al., 2009; van der 
Kant et al., 2013) 
 NPC1 ORP5 Section 2.2.3 (Du et al., 2011) 
 STARD3 VAPs Section 2.2.3 (Alpy et al., 2013; Wilhelm et 
al., 2017) 
 Annexin A1 S100A1 Section 2.2.4 (Eden et al., 2016) 
 Protrudin VAPs Section 2.2.4 (Raiborg et al., 2015) 
 








2.2.2 Cellular calcium homeostasis at organelle contacts 
 
One of the best known roles for MCSs is in the regulation of cellular calcium 
homeostasis. Ca2+ is an important second messenger that, if uncontrolled, causes cell 
toxicity, and hence it needs to be conducted impeccably to its action site. MCSs 
provide solid pipelines for calcium crossover between membranes. One important site 
for calcium signalling is at the ER–PM MCSs, especially in muscle cells, where Ca2+ 
has a crucial role in triggering muscle contractions. In dormant state the cytoplasmic 
Ca2+ concentration is relatively low, but to activate muscle contraction, the Ca2+ 
quickly flows into the cytosol from the sarcoplasmic reticulum and from the 
extracellular space through the PM, which allows myosin – an actin motor protein – 
to manoeuver along actin filaments in the sarcomeres.  This process is enabled by PM 
Ca2+ channels, dihydropyridine receptors (DHPRs), and ER Ca2+ channels, ryanodine 
receptors (RyRs), which form a coupled gating at SR–PM contacts and in strict 
cooperation regulate the cytosolic Ca2+ increase (Bannister, 2007; Bannister, 2016; 
Rebbeck et al., 2011). The modulation of DHPR and RyR1 levels have no effect on 
the quantity of SR–PM contacts, suggesting only a functional role at these sites 
(Franzini-Armstrong et al., 1991; Ikemoto et al., 1997; Takekura et al., 1995a; 
Takekura et al., 1995b). 
 
Ca2+ homeostasis is also regulated at PM–ER contacts sites in non-contractile cells. 
ER is the storage compartment for cellular Ca2+ and many cellular calcium-dependent 
processes takes place at this site. ER has a mechanism to preserve adequate levels of 
luminal calcium without significantly elevating cytosolic Ca2+ via a process called 
store-operated Ca2+ entry (SOCE): When the ER calcium levels reduce, the integral 
ER calcium sensor stromal interaction molecule-1 (STIM1) oligomerizes and 
undergoes a conformational change which allows it to bind PI(4,5)P2 at PM and 
interact and activate the PM calcium channel Orai1, which mediates the calcium 
transmission into the ER lumen (Korzeniowski et al., 2009; Liou et al., 2005; Liou et 
al., 2007; Luik et al., 2008; Maleth et al., 2014; Park et al., 2009; Stathopulos et al., 
2008; Walsh et al., 2009; Wang et al., 2009; Wu et al., 2006). The direct interaction 
between STIM1 and Orai1 at membrane contacts allows straight calcium influx into 
the ER (Jousset et al., 2007). 
 
Ca2+ is important also for mitochondrial function. Mitochondria contain enzymes with 
important functions in cellular respiration which are activated by Ca2+ (Denton, 
2009). Ca2+ is pumped from ER to mitochondria via channels which are interacting at 
ER–mitochondria MCSs (Rizzuto and Pozzan, 2006). The ER inositol triphosphate 
receptor (IP3R) and outer mitochondria voltage-dependent anion channel (VDAC1) 
are found to bridge ER–mitochondria membranes with the cytosolic chaperone 
glucose-regulated protein 75 (GRP75) and mitochondrial Ca2+ uniporter (MCU) 
complex to induce the Ca2+ exchange (Csordas et al., 2010; De Stefani et al., 2016; 
Szabadkai et al., 2006). In addition, ER resident VAP-B is found to interact with the 
mitochondrial membrane protein tyrosine phosphatase-interacting protein 51 
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(PTPIP51) and similarly regulate the Ca2+ uptake at ER–mitochondria contacts (De 
Vos et al., 2012). 
 
 
2.2.3 Role of MCSs in lipid biosynthesis and transport 
 
Lipids are the major compounds of cellular membranes and different organelles have 
their own characteristic lipid composition affiliated with their function. The 
maintenance of the adequate lipid concentration of membranes requires lipid 
trafficking from their synthesis site, most commonly from the ER, to their 
destinations. However, due to their hydrophobic nature, maverick diffusion of lipids 
is limited and therefore lipids are transported intracellularly via non-vesicular or 
vesicular pathways. The non-vesicular lipid transfer is suggested to cover the major 
proportion of the cellular lipid transportation (Lev, 2010) in which they are often 
transported via carrier proteins enclosed with a hydrophobic ligand-binding pocket 
characteristic of these proteins. 
 
Lipid transfer protein (LTP) is a generic name covering multiple protein families 
functioning in the intracellular lipid transport: PITP/Nir, START, GLTP, SEC14, 
SCP2, Ups/PRELI, TULIP, LAM and OSBP/ORP (Alva and Lupas, 2016; Burgardt 
et al., 2017; D'Angelo et al., 2008; Hsuan and Cockcroft, 2001; Lev, 2010; Wong et 
al., 2017). Although LTPs carry lipids by moving within the cell between donor and 
acceptor membranes, there is emerging evidence implicating that a proportion of the 
lipid transfer occurs at closely apposed membranes that LTPs are bridging (Helle et 
al., 2013). In fact, various LTPs from different protein families are found to tether at 
MCSs, in example PITP/Nir, START and OSBP/ORP (Alpy et al., 2013; Chang and 
Liou, 2015; Chung et al., 2015; Mesmin et al., 2013; Peretti et al., 2008). The studies 
of OSBP at trans-Golgi–ER interfaces and ORP5/ORP8 at ER–PM contacts have 
provided novel information of the mechanism of lipid transport over MCSs. These 
proteins are found to bi-directionally transport PI(4)P to ER for its hydrolysis and 
exploit the from the PI(4)P hydrolysis for the transport of counter lipid against its 
chemical gradient (Chung et al., 2015; Ghai et al., 2017; Mesmin et al., 2013). The 
more detailed description of this bi-directional lipid transport as well as the role of 
OSBP/CERT in the synthesis of SM at trans-Golgi–ER contacts are described in 
chapters 2.1.3 and 2.1.4, respectively. These findings, however, illustrate examples of 
how MCSs orchestrate the maintenance of lipid compositions of cellular membranes. 
 
Furthermore, ER–PM MCSs are suggested to regulate the PI(4,5)P2 levels of the PM. 
PI(4,5)P2 is an important signalling molecule that controls various cellular functions. 
The activation of G-coupled receptors at PM reduces the PI(4,5)P2 which causes a 
disruption of E-Syt2 mediated ER–PM contacts and also reduces the interaction of 
phosphoinositide phosphatase Sac1 with the PM. The impaired association of Sac1 
with the PM increases the PI(4)P precursor pool resulting in PI(4,5)P2 elevation. The 
opposite effect is caused by activation of SOCE after ER luminal Ca2+ depletion, in 
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which the Sac1 enhances its interaction with the PM at the E-Syt2 mediated ER–PM 
contacts, resulting to depletion of the PM PI(4)P. (Dickson et al., 2016) On the other 
hand, the PM PI(4)P is generated from PI, which itself is produced at ER from 
phosphatidic acid (PA). For the sequential generation of PI(4,5)P2, PI needs to be 
transported from the ER to the PM. The reduction of PM PI(4,5)P2 via its hydrolysis 
to inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) is found to induce Nir2 
translocation to E-Syt1 mediated ER–PM contacts for the enhancement of PI transport 
to the PM via exchange for PA (Chang et al., 2013; Chang and Liou, 2015). The 
localization of Nir2 to the PM is mediated via binding to PA, which is generated from 
DAG after the hydrolysis of PI(4,5)P2, and at the ER–PM contacts, Nir2 exchanges 
the ER PI for the PM PA and counter transports PA to the ER (Figure 2) (Chang and 
Liou, 2015; Kim et al., 2015).  
 
The synthesis of phosphatidylethanolamine (PE) and phosphatidycholine (PC) are 
also suggested to occur via MCSs (Dimmer and Rapaport, 2017; Flis and Daum, 
2013; Osman et al., 2011). PS is the precursor for PE and PC, and is synthetized in 
the ER from the PA, which is then passed to inner membranes of mitochondria for PS 
decarboxylase to convert it to PE (Emoto et al., 1999; Osman et al., 2011). In 
addition, in hepatocytes the synthesis of PC takes place at the ER, hence, the 
precursor PE needs to be transferred back to the ER from the mitochondria for 
methylation via N-methyltransferase to generate PC (Figure 2). This phospholipid 
exchange between ER and mitochondrial membranes is suggested to occur through 
ER–mitochondria contacts (Daum and Vance, 1997; Dennis and Kennedy, 1972; Flis 
and Daum, 2013; Osman et al., 2011; Rusinol et al., 1994; Vance, 1990; Vance, 2014; 
Voelker, 1989; Wu and Voelker, 2004). A study by Galmes et al. (2016) suggested 
that in addition to localization of ORP5/8 to ER–PM MCSs, these PS transporting 
proteins also found at the ER–mitochondria contacts by interaction with the 
mitochondrial PTPIP51. The study reported that the localization of ORP5/8 to ER–
mitochondria MCSs was dependent on the ORD, but direct PS transport of ORP5/8 
from ER to mitochondria was not addressed in the study (Galmes et al., 2016). The 
study, however, did not exclude the possibility that the PS transport from ER to 
mitochondria could also be mediated by ORP5/8. In fact, the finding that the PS 
transport over ER–PM MCS was shown to be higher with PI(4,5)P2 counter-transport 
rather than with PI(4)P is further supporting the possibility (Ghai et al., 2017), since 
PI(4,5)P2 but not PI(4)P is found from the outer mitochondrial membrane (Rosivatz 





Figure 2. Schematic model of phospholipid transfer over ER–PM and ER–mitochondria MCSs. 
PI(4,5)P2 is generated at PM by phosphorylation of PI to PI(4)P and then to PI(4,5)P2. The hydrolysis 
of PI(4,5)P2 generates IP3 and DAG, from which the DAG is converted to PA. The PA at PM is 
exchanged for PI at ER via Nir2. At the ER, the PA is used for the synthesis of PS and PI. The PS is 
counter transported to PM via ORP5/ORP8, and the PI(4)P is transported in opposite direction. 
Alternatively, the PS is transported to mitochondria for the synthesis of PE.  The newly formed PE is 
then transferred to the ER for the synthesis of PC. 
 
 
Finally, the cholesterol transfer from the late endosome (LE)/lysosome to the ER is 
also suggested to occur directly through MCSs between ER and LE. Luminal 
endosomal cholesterol egress factor Niemann-Pick C2 (NPC2) transfers LDL-derived 
cholesterol to the LE limiting membrane cholesterol transporter NPC1, which 
subsequently transfers cholesterol to the ER (Infante et al., 2008; Kwon et al., 2009). 
This transfer is suggested to occur via interaction of NPC1 with ORP5 at ER (Du et 
al., 2011), and via ORP1L–VAP mediated LE association with ER (Zhao and 
Ridgway, 2017). This is supported by findings that silencing of NPC1 or ORP5, or 
ORP1L knock out, results in cholesterol accumulation at LE and inhibition of its 
esterification, which occurs in the ER (Du et al., 2011; Zhao and Ridgway, 2017). An 
other LTP found to transport cholesterol between ER–LE contacts is STARD3, which 
localizes to LEs, and similar to ORP1L, interacts with VAPs at the ER (Alpy et al., 
2013; Wilhelm et al., 2017). Wilhelm et al. (2017) found that STARD3 transports 
cholesterol to opposite direction compared to NPCs, from the ER to the LE, and 
STARD3 overexpression was found to increase cholesterol accumulation in 
endosomes by routing its transport from the ER to LE and concomitantly decreasing 






2.2.4 Role of MCSs in organelle dynamics 
 
Endosomes traffic along microtubules during their maturation, which allows them to 
distribute endocytic cargo to different cellular compartments. Trafficking of 
endosomes is also associated with ER contacts, which at least in the case of endocytic 
transport of cholesterol is associated with endosome motility. Via its ankyrin motif, 
the cholesterol sensor ORP1L interacts with the LE GTPase Rab7 and Rab-interacting 
lysosomal protein (RILP). Upon high cholesterol conditions, this LE protein complex 
recruits dynein-dynactin motor complex and homotypic fusion and vacuole protein 
sorting (HOPS) on LE, which promotes LE trafficking towards the cell centre where 
it fuses with lysosome (Johansson et al., 2007; Rocha et al., 2009; van der Kant et al., 
2013). Conversely, when endosomal cholesterol is depleted, ORP1L is suggested to 
undergo enhanced interaction with ER-bound VAP increasing its association with 
ER–LE contacts. This results in the dissociation of dynein–dynactin motor complexes 
from LE and hence restricts the dynein-mediated LE mobility (Rocha et al., 2009). 
 
The formation and regulation of ER–LE contacts is suggested to occur via 
interactions of the endosome-localized Annexin A1 and its ER resident ligand 
S100A1 (Eden et al., 2016). When the endosomal cholesterol depletes and the LE 
motility is restricted, Annexin A1 regulates the transfer of ER cholesterol to 
multivesicular endosome/bodies (MVBs) through the ER–LE contacts, which also 
requires the ORP1L–VAP interaction (Eden et al., 2016). However, enhancement in 
ER–LE contacts does not necessarily implicate reduced LE motility. In fact, Friedman 
et al. (2013) showed that the ER–LE contacts are enhanced during LE maturation. 
Moreover, the above studies puzzlingly suggested roles of ORP1L the transport of 
cholesterol both from LE to ER and in the opposite direction. Of note, Vihervaara et 
al. (2011) showed that ORP1L knock down inhibited the efflux of endocytosed 
cholesterol from macrophages, supporting a function of the protein in the egress of 
cholesterol from LE. Future study is warranted to reach a full understanding of the 
function of ORP1L in intracellular cholesterol trafficking. 
 
LE trafficking is also linked to ER–LE MCSs upon neurite outgrowth via the ER 
trans-membrane protein protrudin. Protrudin interacts on LE with Rab7 and PI(3)P, 
and with VAPs in the ER. In association with LEs, protrudin recruits kinesin-1 which 
promotes LE trafficking towards cell periphery resulting in endosome fusion with the 
PM, and overexpression or down-regulation of protrudin are found to result LE 
accumulation on cell periphery or in cell centre, respectively (Raiborg et al., 2015). 
Finally, ER–LE contacts are also found as key components in the determination of the 
time and position of endosome fission (Rowland et al., 2014). 
 
 
Similarly, also the mitochondrial fission is associated with ER contacts. 
Mitochondrial fission is dependent on dynamin-related protein 1 (DRP1), which 
localizes to mitochondria–ER junctions before initiating the mitochondrial division 
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(Friedman et al., 2011). In yeast the mitochondrial fission is mediated by the ERMES, 
the counterpart of which has not been found in mammals (Kornmann et al., 2009; 
Murley et al., 2013). Moreover, dynamin-like GTPase mitofusin 2 (MFN2) has been 
suggested tether between mitochondria and the ER, and at the ER, it homo- or 
heterodimerizes with mitochondrial MFN2 or MFN1, respectively (de Brito and 
Scorrano, 2008). Mitofusins are known to be involved in mitochondrial fusion (Chen 
et al., 2003), but it is however unclear whether MFN2 at ER–mitochondria contacts 
promotes this fusion. Finally, ER-mitochondria contacts are also found to play an 
important role in the formation of autophagosomes (Hamasaki et al., 2013). 
 
 
2.3 Hepatic energy metabolism 
 
2.3.1 Glucose uptake into hepatocytes 
 
Liver is an essential metabolic organ that for provides energetic substrates for other 
tissues such as skeletal muscle and adipose tissue. Hepatic energy metabolism is 
tightly controlled by neuronal, hormonal and nutrient signals, and the dysfunction of 
liver metabolic processes predisposes to various metabolic disorders such as type 2 
diabetes and non-alcoholic fatty liver disease (NAFLD). One of the most essential 
nutrient is glucose since it can serve as a precursor for amino acids and lipids, or for 
the energy production. Glucose uptake from the bloodstream into the hepatocytes 
occurs largely via the GLUT2 plasma membrane glucose transporter (Nordlie et al., 
1999). After entering the hepatocytes, the glucose is rapidly phosphorylated to 
glucose 6-phosphate (G-6-P) by a glucokinase (GK) to prevent its exit back into the 
bloodstream, but in fasted state it can also be dephosphorylated back to glucose. G-6-
P is a precursor for pyruvate and glycogen, which are discussed later in this chapter. 
 
In non-hepatic insulin sensitive cells glucose uptake occurs largely via the GLUT4 
glucose transporter, the translocation of which from intracellular vesicles to the PM is 
regulated by insulin (Watson et al., 2004). In hepatocytes the insulin does not regulate 
the glucose uptake by mobilizing glucose transporters, but it stimulates GK 
expression and counteracts glucose absorption via an indirect mechanism (Kim et al., 
2004): The conversion of glucose to G-6-P reduces the concentration of intracellular 
glucose which promotes the glucose uptake by generation of a concentration gradient. 
 
 
2.3.2 Glycogenesis and glycogenolysis 
 
Glucose cannot be stored within hepatocytes in long term, hence, it is processed and 
stored as the polysaccharide glycogen for its later demand. Glycogen is the main 
source of liver glucose during short-term fasting. In the synthesis of glycogen, G-6-P 
is first converted to glucose 1-phosphate and then activated by an addition of uridine 
28
nucleotide to form UDP-glucose. Multiple UDP-glucoses are then chained by 
glycogenin and fully polymerized by glycogen synthase (GYS) (Adeva-Andany et al., 
2016). The reverse catabolic reaction is called glycogenolysis, in which the glycogen 
chain is degraded back to free glucose subunits by a glycogen phosphorylase (PYGL) 
(Agius, 2015). 
 
G-6-P acts as an allosteric activator for GYS and allosteric inhibitor for PYGL 
(Agius, 2008), but the activity of GYS and PYGL are primarily regulated by kinases 
and phosphatases, as phosphorylation of GYS inhibits its activity and activates 
PYGL. GYS is a downstream target of phosphatidylinositol 3-kinase (PI3K)/Akt 
signal transduction pathway which is regulated by insulin and other growth factors. 
Active Akt phosphorylates and inactivates the GYS phosphorylating kinase glycogen 
synthase kinase 3 (GSK-3), thus increasing glycogen synthesis via GYS as a 
downstream effect of insulin (Cross et al., 1995). In the fasted state the levels of 
glucose and insulin are depleted, and glucagon increases, resulting in the activation of 





The hepatic glucose in not only stored as glycogen, but it is also metabolized in a 
process termed glycolysis, which importantly provides both energy fuel and various 
building blocks for hepatocytes. In the glycolysis glucose is metabolized through 
various enzymatic steps finally to pyruvate. The rate limiting steps in this multiphase 
process are glucose phosphorylation to G-6-P by GK, fructose 6-phosphate 
phosphorylation to fructose 1,6-bisphosphate by phosphofructokinase (PFK-1), and 
phosphoenolpyruvate conversion to pyruvate by liver pyruvate kinase (L-PK), 
processes which are induced in the fed state by glucose and insulin and conversely 
inhibited during fasting. (Rui, 2014) In addition to glycolysis, the G-6-P can be 
alternatively catabolized in a parallel process termed pentose phosphate pathway, 
which generates NADPH required for lipogenesis. 
 
The expression level of GK is markedly elevated after ingestion of carbohydrates. The 
transcription factor sterol regulatory element binding protein 1c (SREBP-1c) induces 
the gene expression of GK as a consequence of activated insulin/Akt signalling 
(Fleischmann and Iynedjian, 2000; Foretz et al., 1999a; Kim et al., 2004; Ribaux and 
Iynedjian, 2003). The GK is also regulated by glucokinase regulatory protein 
(GKRP): Under low cellular glucose conditions glycolysis is unwarranted causing GK 
to interact with GKRP, leading to the nuclear localization of this protein complex and 
preventing the cytosolic function of GK (Brouwers et al., 2015). When the level of 
glucose is elevated, GK is enabled to dissociate from GKRP permitting its release 
from the nucleus to the cytosol. 
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PFK-1 primarily admits glucose to glycolysis in order to create more ATP, hence 
PFK-1 is allosterically activated by high concentrations of AMP and conversely 
inactivated by ATP. The final rate limiting enzyme regulating the levels of glycolysis 
is L-PK. L-PK converts phosphoenolpyruvate to pyruvate, which can be then passed 
to mitochondria. The expression of L-PK is also nutritionally regulated – glucose 
activates the transcription factor Carbohydrate response element binding protein 
(ChREBP), which binds to the L-PK promoter and permits its expression (Dentin et 
al., 2004; Iizuka et al., 2004; Kawaguchi et al., 2001; Yamashita et al., 2001). In 
addition, L-PK is subjected to allosteric regulation by fructose-1,6-bisphosphate. 
Fructose-1,6-bisphosphate binds to L-PK resulting in a conformational change, which 
activates L-PK (Jurica et al., 1998). L-PK transcription is repressed by glucagon, 
which acts through its second messenger cyclic AMP (cAMP) (Vaulont et al., 1984). 
cAMP also inactivates ChREBP by phosphorylation thus preventing its nuclear 
function (Denechaud et al., 2008; Dentin et al., 2012). 
 
The cytosolic pyruvate formed as an end product of glycolysis enters mitochondria 
where it is decarboxylated by the key mitochondrial enzyme complex, pyruvate 
decarboxylase (PDC), to acetyl-CoA. The mitochondrial acetyl-CoA is then either 
completely oxidized in tricarboxylic acid (TCA) cycle and oxidative phosphorylation 
to generate high energetic ATP molecules, or alternatively, the acetyl-CoA is 
removed from the TCA cycle and carried back into the cytosol to be used for fatty 
acid synthesis. (Rui, 2014) In addition to pyruvate, the glycolysis provides also other 
important intermediates, which can be used for the synthesis of different metabolic 
compounds such as glycerol, which is required for fatty acid esterification. Moreover, 





De novo glucose synthesis or gluconeogenesis is the main source of glucose after the 
depletion of stored glycogen during long term fasting or starvation. Liver is able to 
synthetize glucose from lactate, pyruvate, glycerol and amino acids. Lactate and 
pyruvate are converted to oxaloacetate in mitochondria, and then to 
phophoenolpuruvate by cytoplasmic phophoenolpuruvate carboxykinase (PEPCK). 
Phophoenolpuruvate is further converted to G-6-P and finally to glucose by glucose-
6-phosphatase (G6Pase) through enzymatic steps reverse to those of glycolysis. 
Amino acids, on the other hand, are first converted to α-ketoacids, which can be then 
converted to gluconeogenic substrates such as pyruvate and oxaloacetate. Glycerol 
can be used for glucose synthesis by conversion to glycol-3-phosphate by glycerol 
kinase, which is a gluconeogenic intermediate. (Rui, 2014) 
 
The regulation of gluconeogenesis depends on the metabolic state and the availability 
of gluconeogenic substrates, affecting the expression of gluconeogenic enzymes. 
Insulin suppresses gluconeogenesis and glucagon stimulates the expression of the rate 
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limiting enzymes PEPCK and G6Pase (Hatting et al., 2018; Oh et al., 2013; 
Sutherland et al., 1996). 
 
 
2.3.5 De novo lipogenesis 
 
Another important metabolic function of the liver is to convert absorbed 
carbohydrates into fatty acids. When carbohydrates are abundant, only part of the 
absorbed carbohydrates are stored as hepatic glycogen and the excess is used for de 
novo lipogenesis. Lipogenesis requires release of the acetyl-CoA from glucose 
through glycolysis and mitochondrial pyruvate decarboxylation, after which it enters 
the TCA cycle. Fatty acid synthesis occurs in the cytosol, but mitochondrial acetyl-
CoA cannot directly switch over back to the cytosol from the mitochondrial TCA 
cycle, therefore it is first converted to citrate before transfer into the cytosol, after 
which it is converted back to acetyl-CoA by ATP citrate lyase (ACL). In the first 
enzymatic reactions of the lipogenesis, the cytosolic acetyl-CoA is carboxylated to 
malonyl-CoA via acetyl-CoA carboxylase (ACC), and the malonyl-CoA is then 
converted to palmitic acid by fatty acid synthase (FAS), which is the precursor 
molecule for the synthesis of the other phospholipid species and TAG. In the 
synthesis of TAGs, the other intermediate fatty acids are then produced by palmitic 
acid elongation and desaturation, which involves stearoyl-CoA desaturase-1 (SCD1). 
In the final stage, the fatty acids are esterified with glycerol-3-phosphate by glycerol-
3-phosphate acyltransferase (GPAT) to lysophosphatic acid (LPA). LPA is used for 
the synthesis of DAG followed by the synthesis of TAG by diacylglycerol 
acyltransferase (DGAT). The TAGs produced in lipogenesis are either stored within 
hepatic LDs or secreted into bloodstream as very-low-density lipoprotein (VLDL) 
particles for the usage of the extrahepatic tissues. (Rui, 2014) 
 
Dietary carbohydrates promote the lipogenesis since the rate of lipogenesis is highly 
reliant of the availability of lipogenic precursors (Figure 3). Hence it is not surprising 
that the de novo lipogenesis is principally regulated by the same two transcription 
factors as the glycolysis – SREBP-1c and ChREBP (Dentin et al., 2004; Dentin et al., 
2005; Foretz et al., 1999a). SREBP-1c and ChREBP themselves are subject to 
regulation by insulin and glucose, respectively, ensuring coordination between 
glucose and fatty acid metabolism. Together SREBP-1c and ChREBP regulate the 
expression of all pivotal lipogenic enzymes: ACL, ACC, FAS, SCD1, GPAT and 
DGAT (Berwick et al., 2002; Dentin et al., 2004; Dentin et al., 2006; Foretz et al., 
1999a; Foufelle and Ferre, 2002; Horton, 2002; Iizuka et al., 2004; Ishii et al., 2004; 
Magana and Osborne, 1996). Conversely, the rate of lipogenesis is inhibited by 
dietary fats, polyunsaturated fatty acids in particular, which suppress the production 





2.3.6 Lipolysis and fatty acid β-oxidation 
  
In the fasted state the acquisition of necessary energy from nutrients diminishes, 
hence the metabolic fuel needs to be released from the intracellular energy reservoirs. 
Lipolysis is a catabolic process which breaks down store stored TAGs from LDs by 
hydrolase enzymes termed lipases. Lipolysis occurs primarily in adipocytes, but also 
in other high-energy demanding cells such as muscle cells and hepatocytes. Adipose 
triglyceride lipase (ATGL), monoacylglycerol lipase (MGL) and hormone sensitive 
lipase (HSL) hydrolyse TAGs, DAGs and monoacylglycerols to release non-esterified 
fatty acids and glycerol (Zechner et al., 2009). Those can then be exploited as 
precursors for membrane lipid synthesis or to be used for energy production via fatty 
acid oxidation. 
 
For the mitochondrial fatty acid oxidation, fatty acids are esterified by fatty acyl-CoA 
synthase to create long-chain acyl-CoAs. Long-chain fatty acyl-CoAs are, however, 
unable to pass the mitochondrial membrane, thus carnitine palmitoyltransferase-1 
(CPT1) converts long-chain acyl-CoA to long-chain acylcarnitine, which can be 
substituted with intra-mitochondrial carnitine. In mitochondria, long-chain 
acylcarnitine is transported across the inner mitochondrial membrane via carnitine 
translocase, after which it is converted back to long-chain acyl-CoA by carnitine 
palmitoyltransferase-2 (CPT2) for its complete oxidation. Four main enzymatic steps 
are required for β-oxidation in which long-chain acyl-CoAs are catalysed to acyl- and 
acetyl-CoAs, which can then be passed on to the TCA cycle and oxidative 
phosphorylation. (Rui, 2014) The main oxidative enzymes are acyl-CoA 
dehydrogenase, enoyl-CoA hydratase, hydroxyl acyl-CoA dehydrogenase and 
ketoacyl-CoA thiolase, of which the activity of the last three can be covered by 
mitochondrial trifunctional enzyme. Instead of the complete oxidation, the formed 
acyl- and acetyl-CoA molecules can also be used for the formation of ketone bodies 
through ketogenesis, which liver releases into the bloodstream for the use of other 
organs such as brain, heart and skeletal muscle. 
 
Similar to gluconeogenesis, lipolysis and fatty acid β-oxidation are enhanced by 
glucagon and inhibited by insulin (Longuet et al., 2008; Sidossis and Wolfe, 1996). 
Fasting also suppresses ChREBP and activates the nuclear receptor Peroxisome 
proliferator-activated receptor α (PPARα), which induces genes involved in β-
oxidation and ketogenesis (Dentin et al., 2006; Kersten et al., 1999; Kersten, 2014). It 
is vital that the rates of catabolic and anabolic processes are tightly co-regulated by 
the availability of external nutrients for the liver to ensure constant but efficient 







Figure 3. Schematic figure of glucose conversion into fatty acids in hepatocytes. Glucose enters to 
hepatocytes via plasma membrane GLUT2 transporter, after which glucose is either subjected to 
glycogens synthesis or glycolysis to generate pyruvate. The pyruvate is channelled into TCA cycle and 
completely oxidized in oxidative phosphorylation to create ATP, or the pyruvate is converted to citrate 
for the synthesis of fatty acids (FA). The lipogenesis involves FA desaturation and elongation, and in 
the final stage in the formation of triglycerides (TAG) FA is esterified with glycerol-3-phosphate, an 
intermediate of glycolysis or absorbed from plasma via aquaporin-9. TAGs are stored within 





2.3.7 PI3K/Akt-signalling in metabolic regulation 
 
As described already in the previous chapters, PI3K/Akt signalling is a signal 
transduction pathway regulating a variety of cellular functions, including glucose and 
fatty acid metabolism, in order to maintain cellular growth and survival. The 
signalling cascade is triggered by an external insulin-like growth factor stimuli, which 
leads to phosphoinositide 3-kinase (PI3K) activation via cell surface receptors. 
Activated PI3K phosphorylates plasma membrane PI(4,5)P2 to PI(3,4,5)P3, which 
leads to PM recruitment of certain PH-domain containing proteins (Lietzke et al., 
2000). Particularly, this attracts Akt and 3-phosphoinositide-dependent kinase 
(PDK1) to re-localize and bind PI(3,4,5)P3 at PM, where PDK1 phosphorylates Akt at 
residue Thr308 (Alessi et al., 1997; Franke et al., 1995). The full activation of Akt-
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kinase requires phosphorylation at second residue (Ser473) by mammalian target of 
rapamycin (mTOR) (Sarbassov et al., 2005). The activation of Akt consequently 
results to phosphorylation of dozens of Akt downstream targets leading to activation 
or inactivation of signalling cascades regulating various distinct functions including 
protein synthesis, cell cycle, apoptosis and metabolism. 
 
The regulation of cellular glucose and fatty acid metabolism by PI3K/Akt signalling 
are mainly triggered by the anabolic signals of insulin. By communicating through 
PI3K/Akt signalling pathway insulin is able to promote the expression of glycolytic 
and lipogenic genes required for the complete glucose utilization (Berwick et al., 
2002; Deprez et al., 1997; Gottlob et al., 2001; Semenza et al., 1996). This is 
primarily mediated via transcription factor SREBP-1c, which synthesis and nuclear 
localization Akt induces (Bauer et al., 2005; Berwick et al., 2002; Fleischmann and 
Iynedjian, 2000; Porstmann et al., 2005; Porstmann et al., 2008; Ribaux and 
Iynedjian, 2003; Yecies et al., 2011). Conversely, PI3K/Akt inhibits catabolic 
processes including the production and release of glucose by down-regulating the 
expression of pivotal enzymes of gluconeogenesis, glycogenolysis and also lipolysis 
(Barthel et al., 2001; Li et al., 2007; Nakae et al., 2001; Sutherland et al., 1996). 
 
PI3K/Akt also regulates carbohydrate metabolism by non-transcriptional means, as it 
increases glucose uptake by stimulating the PM translocation of GLUT4 and GLUT1 
(Barthel et al., 1999; Kohn et al., 1996; Rathmell et al., 2003), and furthermore, 
PI3K/Akt signalling also promotes glucose storage by GSK-3 phosphorylation (Cross 
et al., 1995). The activation of PI3K/Akt signalling as a downstream response of 
extracellular insulin is essential for cells to be able to adapt their metabolism and 
growth to correspond to the availability of external energetic substrates. Thus it is not 
surprising that dysfunctional PI3K/Akt signalling is associated with various different 
types of human diseases (Follo et al., 2015; Jha et al., 2015; Matsuda et al., 2013; 
Patel and Mohan, 2005). 
 
 
2.4 The actin cytoskeleton 
 
2.4.1 Actin architecture and dynamics 
 
Actin is one of the most abundant proteins in all cell types having a fundamental role 
in the organization of the cellular cytoskeleton. Actin networks provide mechanical 
strength, motility and internal communication routes for the cell. Actin is largely 
accompanied with actin-binding proteins, which for example, orchestrate actin 
assembly from actin monomers to polymeric filamentous actin (F-actin). Among the 
most important actin regulators are Rho GTPases, which in regard, play a pivotal role 
in the regulation of actin transitions between its mono- and polymeric states as a 
response to extracellular signals. External plasma membrane receptors transmit 
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signals to intracellular Rho GTPases, which distribute the messenger information via 
signalling cascades throughout the cell finally to actin effectors (Hall, 1994; Ridley, 
2001). 
 
In the generation of filamentous actin through polymerization of actin monomers, an 
important actin effector is Arp2/3 complex (Higgs and Pollard, 1999; Machesky and 
Gould, 1999; Pollard and Borisy, 2003). The actin filament nucleation is an 
energetically unfavourable process hence restricted from spontaneous occurrence. The 
Arp2/3 complex acts as a nucleation factor to join free actin monomers to initiate 
filament growth (Pollard, 2007). The actin monomers are asymmetric and bind to 
each other in the filament in the same orientation, making the two ends of the filament 
structurally different. The slower growing terminus of the filament is termed a pointed 
end and the faster growing side a barbed end. The elongation of actin polymers 
requires the actin-binding protein profilin, which recruits monomeric actin to bind to 
the barbed end of the growing filament and inhibits monomer association with the 
pointed end (Goldschmidt-Clermont et al., 1991). In addition, each actin monomer is 
an ATPase which hydrolyses ATP. When the concentration of free actin subunits are 
optimal and the barbed end is in ATP-bound state and the pointed end is in ADP-
bound state, the filament adopts a property termed actin filament treadmilling, in 
which new monomeric actin is added to the barbed end at the same rate as the pointed 
end looses its subunits, dependent on the energy consumption from the constant 
hydrolysis of ATP (Wegner, 1976). The shrinkage of the pointed end is often 
mediated by actin-depolymerizing factor (ADF)/cofilin, which binds the ADP-bound 
actin at the filament pointed end and causes a depolymerization (Carlier et al., 1997; 
Carlier et al., 1999; Ichetovkin et al., 2000; Lappalainen et al., 1998). Together with 
profilin, the detached actin monomers can be recycled back into filaments after being 
re-energized through exchange of bound ADP to ATP (Pollard et al., 2000). 
 
Via the regulation by actin effectors, the filamentous actin together with actin-binding 
proteins organizes to different higher-order architectures with different biochemical 
and mechanical properties. Multiple actin filaments form close parallel or antiparallel 
alignments termed bundles and more loosely orthogonally oriented branched 
networks, which define the cell shape by supporting the plasma membrane. Actin also 
provides contractile force for the cell via cross-linking of actin bundles with myosin 
II. Myosin binds to ATP-bound actin and uses the energy of ATP hydrolysis to move 
towards the barbed end of the actin filament, regulated by the myosin light chain 
phosphorylation. These contractile structures present in most cells are termed stress 
fibers, which also participates in connecting the cell to the extracellular matrix. Actin 
also assembles into transient structures such as lamellipodia, filopodia and focal 
adhesions – important elements in the cell physiology that permit cell contacts, 
movement, cell to cell signalling and sensing of cell environment. The important 
property of actin filament is its dynamicity, as it can rapidly undergo disassembly, 
reassembly or depolymerisation based on the cell’s demands to adapt to the 
fluctuating changes of its external environment. (Lee and Dominguez, 2010) 
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2.4.2 Cell migration 
 
Cell migration plays an important role during development in embryonic 
morphogenesis, but cells also migrate in fully developed organisms during the normal 
life cycle (e.g. the migration of immune cells) and in diseases (e.g. by promoting 
cancer cell invasion and metastasis). During migration, cells forms a polarized leading 
edge and membrane protrusions, as well as new cell adhesions, which all involve 
cytoskeletal reorganization via effector proteins. (Svitkina, 2018) 
 
Cell migration is commonly driven by actin-rich plasma membrane extensions called 
lamellipodia composed of branched actin networks, which pushes the leading edge by 
extensive actin polymerization at the front (Abercrombie et al., 1971; Abercrombie et 
al., 1972; Pollard and Borisy, 2003). The leading edge then forms new adhesions to 
the substratum, termed focal adhesions, and to move forward, the lamellipodium fills 
with cytosol and the membrane at the trailing edge de-adheres and retracts towards 
the cell body, executed by a pulling force of actin stress fibers. (Lauffenburger and 
Horwitz, 1996; Medalia and Geiger, 2010; Mitchison and Cramer, 1996; Palecek et 
al., 1998; Ridley and Hall, 1992) 
 
Another important structure mediating cell migration is a fingerlike protrusion of 
actin bundles termed filopodium. Filopodia are organized at the leading edge 
lamellipodium, and they project out of the cell body and mediate the sensing of the 
extracellular matrix (Mattila and Lappalainen, 2008). Compared to lamellipodia, the 
protrusion forces generated by filopodia are much weaker, but some cells lacking 
lamellipodia can predominantly migrate via filopodia (Suraneni et al., 2012; Wu et 
al., 2012). 
 
A less common mechanism of cell migration is via cell surface protrusions termed 
blebs. Blebs are formed when actin cortex is locally detached from the plasma 
membrane (Charras et al., 2008). The intracellular hydrostatic pressure forces the 
non-actin bound parts of the plasma membrane to push out as a hernia (Charras et al., 
2005; Charras et al., 2006). After their extension, cell surface blebs are filled with 
filamentous actin and myosin to form new actin cortex (Charras et al., 2006). 
Lamellipodia or bleb-based cell motility are not necessary exclusive, but instead can 
occur concurrently or in certain conditions some cells can switch between these two 
modes of action (Bergert et al., 2012; Wolf et al., 2003). 
 
 
2.4.3 Actin in cell proliferation 
 
Cell division requires extensive re-organization of the cytoskeleton. The most notable 
process is the re-organization of microtubules into mitotic spindle, which orchestrates 
chromosome segregation into daughter nuclei, but the cell cycle progression also 
involves contribution of the actin network. During mitosis, cell migration is arrested 
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and the actin cytoskeleton is reorganized to give the cells the characteristic round 
shape with reduced cell-matrix adhesions (Cramer and Mitchison, 1997; Dao et al., 
2009). Actin also contributes to the cell cycle control and centrosome separation, 
evident by drugs inhibiting actin polymerization, which result in delayed progression 
of mitosis or unseparated centrosomes (Lee and Song, 2007; Uzbekov et al., 2002). 
This is associated with an actin binding protein cortactin, which is found to connect 
the actin filaments to centrosomes to drive the centrosome separation (Wang et al., 
2008b). 
 
The rounding of the cell is achieved by cross-linking actin beneath the plasma 
membrane to form an actomyosin cortex, which increases cell rigidity (Bray and 
White, 1988; Dao et al., 2009). The actin cross-linking is mediated by 
ezrin/radixin/moesin (ERM) family of actin-binding proteins, which have the ability 
to interact with trans-membrane proteins and PI(4,5)P2 of the PM hence stabilizing 
the cortical actin network (Fehon et al., 2010; Hao et al., 2009; Niggli and Rossy, 
2008; Wang et al., 2008a). In the end of mitosis, actin–myosin bundles play a role in 
the formation of a contractile ring pivotal for cytokinesis by producing the force to 
divide the cell into two (Mabuchi, 1986). After the complete cell division, the two 
daughter cells re-establish their actin networks in order to migrate apart and re-adhere 
with the substratum. 
 
 
2.4.4 Rho GTPases in actin cytoskeleton regulation 
 
Actin is involved in the dynamic regulation of various cellular functions, which is 
enabled by co-operation of a multitude of actin regulators and cell signalling 
processes. Rho GTPases are designated as the most pivotal factors in actin 
cytoskeleton regulation, in particular RhoA, Rac1 and Cdc42, which are the most 
studied members of the Rho GTPase family and highly conserved across eukaryotes 
(Boureux et al., 2007; Hall, 1994). Here I describe the central properties of RhoA, 
Rac1 and Cdc42, principally their role in the assembly of actin cytoskeleton during 
cell locomotion. These proteins are active when bound to GTP promoted by guanine 
nucleotide exchange factors (GEFs) and are inactivated by the hydrolysis of bound 
GTP to GDP (Rossman et al., 2005). The key function of the active RhoA, Rac1 and 
Cdc42 signalling pathways is to distribute external messenger information to 
downstream effectors, which consequently orchestrate the actin organization into 
higher-order structures important for cell locomotion: Rac1 is mainly responsible for 
the formation of lamellipodia at the leading edge and the activation of Cdc42 triggers 
the formation of filopodia organized by bundled actin (Gupton and Gertler, 2007; 
McCarty et al., 2005), while RhoA permits the cross-linking of actin bundles with 









Figure 4. Schematic figure of actin cytoskeleton regulation via RhoA, Cdc42 and Rac1 signalling, 
which are responsible for stress fiber, filopodia and lamellipodia formation, respectively. RhoA 
activates Rho-associated kinase (ROCK), which phosphorylates myocin light chain (MLC), thus 
increasing actomyosin contractility. RhoA polymerisizes actin via mDia1. Cdc42 also increases actin 
polymerization via mDia1, Ena/VASP, WASP and IQGAP1, which activates Arp2/3 complex. Rac1 
involves actin polymerization via IQGAP1 and WAVE. Rac1 and ROCK also activate LIM-kinase, 
which inactivates cofilin by phosphorylation. 
 
 
The lamellipodia formation is mainly enabled by actin nucleation and polymerization 
via the Arp2/3 complex, which is activated by a WAVE complex – downstream of 
Rac1 (Chen et al., 2017; Chen et al., 2010; Miki et al., 1998). Rac1 also inhibits 
cofilin-mediated actin depolymerization by stimulating the cofilin phosphorylating 
LIM-kinase (Nishita et al., 2005; Stanyon and Bernard, 1999). Rac1 also interacts 
with Ras GTPase-activating-like protein (IQGAP1) scaffold, which stabilizes Rac1 
(Briggs and Sacks, 2003). Similarly, the extension of filopodia requires extensive 
actin nucleation and polymerization. Cdc42 activates the formin family member 
diaphanous-1 (mDia1) and Wiskott-Aldrich syndrome proteins (WASP, N-WASP), 
which consequently activates the Arp2/3 complex supported by IQGAP1 (Ismail et 
al., 2009; Le Clainche et al., 2007; Peng et al., 2003; Peng et al., 2003; Rohatgi et al., 
1999; Symons et al., 1996). Cdc42 also mediates actin filament elongation through 
Ena/VASP family of proteins, which are able to bind to the barbed end of bundled 
actin filaments and catalyse their growth (Disanza et al., 2013; Sechi and Wehland, 
2004). 
 
Similar to Cdc42, also RhoA activates the formin mDia1, which is important for the 
polymerization of unbranched actin filaments and formation of actin bundles 
(Narumiya et al., 2009; Pollard, 2007; Watanabe et al., 1999). RhoA also activates the 
Rho-associated kinase (ROCK), which increases myosin light chain phosphorylation 
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enabling myosin motor protein binding to actin bundles, hence stimulating the 
actomyosin contractility (Kimura et al., 1996; Narumiya et al., 2009). Furthermore, 
ROCK inhibits cofilin via the LIM-kinase to stabilize actin filaments (Maekawa et al., 
1999). The induced actin polymerization and actomyosin tension are important for 
stress fiber contraction that mediates the retraction of the rear end of the cell during 
the cell migration. Furthermore, ROCK also promotes the ERM family proteins to 
induce association of the actin cortex with PM via PIP5K (Lacalle et al., 2007; 
Lokuta et al., 2007; Niggli and Rossy, 2008; Yamazaki et al., 2002). High levels of 
RhoA/ROCK activity are associated with the inhibition of lamellipodia and observed 




1. To determine sterol regulation of ORP–VAP-A complexes at MCSs 
2. To shed light to ORP2 intracellular function and role in cell pysiology 




4 MATERIALS AND METHODS 
 
4.1 List of used methods 
 
The methods explained here are the ones that I have personally used for my thesis. 
The complete description of all used methods can be found from the original 







Antibodies I, II, III 
Anti-HA co-immunoprecipitation II, III 
Bligh and Dyer lipid extraction I, III 
Cell culture and transfections I, II, III 
Cellular sterol manipulation I, III 
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The following primary antibodies were used in the experiments: 
 
Antibody Source Type Manufacturer 
anti-Akt rabbit polyclonal Cell Signaling 
anti-Akt(Ser473) rabbit polyclonal Cell Signaling 
anti-β-actin rabbit polyclonal Millipore-Sigma 
anti-Cdc37 rabbit polyclonal Cell Signaling 
anti-Cdc37 mouse monoclonal Thermo Scientific 
anti-cortactin mouse monoclonal Millipore-Sigma 
anti-GFP rabbit polyclonal BD Bioscience 
anti-GM130  mouse monoclonal BD Bioscience 
anti-GSK-3β rabbit polyclonal Cell Signaling 
anti-GSK-3β(Ser9) rabbit polyclonal Cell Signaling 
anti-Hsp90 rabbit polyclonal Cell Signaling 
anti-IQGAP1 mouse monoclonal BD Biosciences 
anti-ORP2 rabbit polyclonal (Laitinen et al., 2002) 
anti-PDI mouse monoclonal Enzo Life Sciences 
anti-vimentin  mouse monoclonal Millipore-Sigma 
 
Cell Signaling (Danvers, MA); Millipore-Sigma (Billerica, MA); Thermo Scientific (Waltham, MA); 





Cells transiently overexpressing HA-ORP2 or ORP2 cultured in 10 cm were lysed in 
lysis buffer [10 mM HEPES (pH 7.6), 150 mM NaCl, 0.5 mM MgCl2, 10% glycerol, 
0.5% Triton X-100, 0.5% Saponin, Protease inhibitor cocktail] and the unbroken cells 
were removed by centrifugation at 20 000 x g for 10 min. To reduce the unspecific 
binding to the beads, the obtained lysates were first incubated with 30 µl of Protein G 
Magnetic Beads (Pierce/Thermo Scientific) for 30 min at 4 °C, before adding the 
magnetic anti-hemagglutinin (HA) beads (Pierce/Thermo Scientific) and incubated 
for 1.5 h on rotation at 4 °C. The beads were washed three times with lysis buffer and 
two times with deionized H2O. Bound proteins were eluted with 100 µl of 0.1 M 
glycine (pH 2.0) for 30 min at room temperature and the alkaline elution was 
neutralized with 8 µl of 1 M Tris base (pH 9.0). The eluted proteins were identified by 
mass spectrometry [Meilahti Clinical Proteomic Core Facility (University of Helsinki, 
Finland)]. The non-spesific interactions identified in the ORP2 sample lacking a HA 
epitope tag were subtracted from the proteins identified in the anti-HA-precipitated 
HA-ORP2 sample. 
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Bligh and Dyer lipid extraction 
 
To extract cellular cholesterol and triglycerides, cells were scraped in 2% NaCl and 
collected by centrifugation at 700 x g in 4 °C. 2:1 methanol-chloroform was added to 
the cells, followed by separation of insoluble material by centrifugation. For the 
extraction of hydrophilic lipids, 1:1 chloroform-H2O was added, followed by 
centrifugation and collection of the hydrophobic phase. The solvent was evaporated 




Cell culture and transfection 
 
Human hepatoma cell line (HuH7) was cultured in Eagle’s minimal essential medium 
with Earle’s salts (AQmedia™, Millipore-Sigma) supplemented with 10% heat 
inactivated fetal bovine serum (Millipore-Sigma), 4 mM L-Glutamine (pH 7.35)  
(Millipore-Sigma), 100 μg/ml streptomycin and 100 U/ml penicillin (Millipore-
Sigma). Cells were transfected with Lipofectamine® 2000 (Invitrogen, Carlsbad, CA) 
using manufacturer’s instruction for 24 h in non-antibiotic containing media. 
 
 
Cellular sterol manipulation 
 
Cellular cholesterol was depleted from HuH7 cells by culturing the cells in AQmedia 
depleted from fetal bovine serum but containing 5% lipoprotein-deficient serum 
instead (LPDS, from Matti Jauhiainen, THL, Helsinki) for 96 h. Alternatively 5 µM 
Mevastatin (Millipore-Sigma) supplement was included at the end for 24 h. To 
increase the cellular cholesterol, 20–50 µg/ml human low-density lipoprotein [LDL; 
as total protein, from Matti Jauhiainen, THL, Helsinki) was added at the end for 24 h. 
For the oxysterol treatment, the cultured cells were loaded with 6 µM 22(R)OHC, 
25OHC or 7KC or vehicle for 24 h.  
 
 
Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technique 
 
The endogenous ORP2 was stably knocked out (KO) from HuH7 using RNA-guided 
CRISPR-Cas9 genome editing with double nicking. The OSBPL2 targeted guide 
RNAs (gRNAs) were designed using optimized CRISPR design tool 
(http://crispr.mit.edu/) with Nickase analysis. The gRNA primers were cloned into 
pGL3-puro-sgRNA vector (obtained from Dr. Shiqian Li, Department of Anatomy, 
University of Helsinki, Finland) and the acquired plasmids were verified by 
sequencing. Cells transfected with gRNA plasmids and Cas9 (pcDNA4-Cas9n-2A-
GFP, obtained from Dr. Shiqian Li), or only Cas9 for the generation of control cells, 
were collected as single cells using fluorescence-activated cell sorting (FACSAriaII, 
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BD Biosciences, Franklin Lakes, NJ) at the Biomedicum Flow Cytometry Core 
Facility, Helsinki, Finland. Single cell clones were expanded for 3 weeks in cell 
culture to generate stable cell lines. The complete deletion of ORP2 from the HuH7 
cells was ensured by western blotting with anti-ORP2 antibody and by sequencing of 





HuH7 cells were transfected with ORP2-V5 and GFP-MLC12 or GFP-MLC12 alone 
as a negative control. Cells were lysed in lysis buffer [10 mM HEPES pH 7.6, 150 
mM NaCl, 0.5 mM MgCl2, 10% glycerol, 0.5% Triton X-100, 0.5% Na-deoxycholate, 
Protease inhibitor cocktail (Roche Diagnostics)] and the intact cells were removed by 
centrifugation at 20 000 x g. Lysates were incubated with 15 µl anti-HA Magnetic 
Beads (Pierce/Thermo Scientific) to reduce the unspecific binding for 30 min at 4 °C. 
The unbound proteins were incubated with 40 µl anti-V5 Magnetic Beads (MBL, 
Woburn, MA) overnight at 4 °C. The beads were washed four times with lysis buffer, 
resuspended in 30 µl Laemmli sample buffer and boiled for 5 min. 
 
 
Co-precipitation using recombinant protein 
 
HuH7 cells were transfected with GFP-SEPT9 or GFP-ARHGAP12 plasmid or 
alternatively left untrasfected for the pull-down of endogenous proteins, and lysed in 
lysis buffer [10 mM HEPES pH 7.6, 150 mM NaCl, 0.5 mM MgCl2, 10% glycerol, 
0.5% Triton X-100, 0.5% Na-deoxycholate, Protease inhibitor cocktail (Roche 
Diagnostics)] and the intact cells were removed by centrifugation at 20 000 x g. The 
obtained lysates were mixed with 300 µmol GST-ORP2 or plain GST (produced in 
insect cells by the BioMediTech Protein Technologies core facility) and 20 µl 
Glutathione-Sepharose 4B (GE Healthcare, Buckinghamshire, UK) for 2 h at 4 °C. 
The beads were the washed thoroughly and resuspended in 30 µl Laemmli sample 





Fluorescence signals were visualized with a Zeiss Axio Observer Z1 microscope with 
an ECPInN 40x/0.75 DICII or PInApo x63/1.40 oil DICII objectives and a Colibri 
laser (Zeiss, Oberkochen, Germany). Images were recorded with Axio Visio Rel. 
4.8.1 or Zen 2 v.2.0.0 softwares (Carl Zeiss Imaging Solutions GmbH, Oberkochen, 
Germany). For image processing Adobe Photoshop 7 (San Jose, CA) and Image J 




Glucose and fatty acid uptake 
 
The cells were initially starved for 3 h in glucose and serum free media [Dulbecco’s 
modified Eagle medium (DMEM) Gibco, Grand Island, NY]. To measure the fatty 
acid uptake, the cells were pulse labeled with a mixture of 20 mM glucose, 5 nM oleic 
acid-BSA and 1 µCi [3H]-oleic acid for 15 min. In turn to measure the glucose uptake, 
the cells were pulse labelled with 10 µM [3H]-2-deoxy-D-glucose (100 mCi/mmol) 
(PerkinElmer, Waltham, MA) supplemented with 10 µM 2-Deoxy-D-glucose 
(Millipore-Sigma) for 15 min. To determine the rate of non-specific glucose uptake, 
the control cells were treated with 40 µM Cytochalasin B (Millipore-Sigma) for 45 
min prior the pulse labelling. After the pulse labelling, the cells were washed 
thoroughly with PBS and lysed in 0.03% SDS. The radioactivity was measured using 
liquid scintillation counting in Optiphase HiSafe 3 scintillation cocktail (PerkinElmer) 
and normalized to total cellular protein (BCA assay, Thermo Scientific). To determine 
the intrinsic glucose uptake, the rate of non-specific glucose uptake was subtracted 





The cells were starved for 2 h in glucose and serum free media (DMEM, Gibco), 
followed by a pulse labeling with 0.18 µCi/µmol D-[U-14C]-glucose (PerkinElmer) 
for 1 h. After the pulse labelling, the cells were washed thoroughly with PBS, lysed in 
0.03% SDS, and the cellular glycogen was precipitated with a 1 mg of carrier 
glycogen (Millipore-Sigma) by 30 min boiling followed by addition of ethanol. The 
glycogen precipitate was washed with 70% ethanol, centrifuged at 20,000 x g for 15 
min and dried from the excess ethanol. The radioactivity was measured using liquid 
scintillation counting in Optiphase HiSafe 3 scintillation cocktail (PerkinElmer) and 





The cells were cultured on Seahorse XF96 cell culture microplates in basal growth 
medium (Agilent Tecnologies, Santa Clara, CA) for 24 h. One hour prior the 
measurements the medium was changed to Seahorse XF base medium with 2 mM L-
glutamine and the cells were incubated at 37 °C without CO2. Extracellular 
acidification rate (ECAR) was measured in real time 3 x 3 min cycles with Seahorse 
XFe Analyzer (Agilent Technologies) with addition of following compounds prior 
single measurement cycle: 10 mM glucose (Millipore-Sigma), 1 μM Oligomycin 
(Millipore-Sigma) and finally 50 mM 2-Deoxy-D-glucose (Millipore-Sigma). ECAR 
values were normalised to the corresponding total protein concentrations (BCA assay, 
Thermo Scientific) and the glycolysis was calculated by subtracting the non-




Cells were fixed with 4% paraformaldehyde, additionally combined with 0.02% 
glutaraldehyde, for 20 min. Aldehyde groups were blocked with 50 mM NH4Cl for 10 
min and the cells were permeabilized with 0.1% Triton X-100 for 5 min. Unspecific 
binding of antibodies were blocked with 10% fetal bovine serum for 45 min at 37 °C, 
followed by incubation with the primary antibody in 5% fetal bovine serum for 1 h 
and the secondary antibodies [fAlexa Fluor-568 goat anti-rabbit (Molecular 
Probes/Invitrogen, Carlsbad, CA), [fAlexa Fluor-594 goat anti-mouse (Thermo 
Scientific)], Cy5® goat anti-mouse [Life Technologies, Eugene, OR] or Oregon green 
488 phalloidin (Molecular Probes, Eugene, OR) in the same conditions. The cells 
were mounted in Mowiol (Calbiochem, LA Jolla, CA)/1,4-Diazabicyclo-[2.2.2] 




Lipid droplet staining 
 
Cellular lipid droplets were labelled with 5 nM Bodipy-C12 (Molecular Probes) in 
serum-free medium at 37 °C for 1 h, followed by 4 h chase in basal growth medium 
and cell fixation. 
 
 
Thin layer chromatography (TLC) 
 
TAGs and cholesterol esters were analysed by thin layer chromatography (TLC). 
After the Bligh and Dyer lipid extraction described above, the radioactively labelled 
lipids were applied to analytical silica gel glass plates (Merck, Kenilworth, NJ) and 
separated in glass chamber in solvent containing 80% of hexane, 18% of diethylether, 
0.01% of acetic acid and 0.003% of H2O. The segregated lipids were visualized with 
iodine and scraped in Optiphase HiSafe 3 scintillation cocktail (PerkinElmer). The 
radioactivity was measured using liquid scintillation counting and the count of lipids 





The cells pulse labelled with 3.5 μCi [3H]oleic acid (PerkinElmer) in ethanol for 3h, 
after which they were washed thoroughly and scraped into 2% NaCl. The TGs were 








Cells were lysed in lysis buffer [10 mM HEPES pH 7.6, 150 mM NaCl, 0.5 mM 
MgCl2, 10% glycerol, 0.5% Triton X-100, 0.5% Na-deoxycholate, Protease inhinbitor 
cocktail (Roche Diagnostics, Mannheim, DE)], mixed thoroughly by vortexing and 
incubated on ice for 10 min. Intact cells were removed by centrifugation at 20 000 x g 
for 10 min. Total cellular proteins were measured with BCA assay (Thermo 
Scientific) and lysates containing 10–20 µg of total cellular proteins were boiled with 
Laemmli sample buffer for 5 min. After boiling, the lysates were subjected to SDS-
PAGE followed by transfer to membranes [Hybond-C Extra nitrocellulose (GE 
Healthcare) or Trans-Blot Turbo LF PVDF, Bio-Rad (Hercules, CA)]. Unspecific 
binding was blocked with 5% fat-free milk in TBS containing 0.01% Tween-20 at 
room temperature for 1 h, followed by primary antibody treatment in the same 
blocking buffer at 4°C over night. HRP-conjugated secondary antibodies were 
incubated in the same blocking buffer at room temperature for 1 h. Bound antibodies 
were detected with enhanced chemiluminescence system ECL (Thermo Scientific). 
 
 
Wound healing assay 
 
HuH7 cells were grown in the basal growth medium and the confluent cell 
monolayers were wounded with a small pipet tip. The cells were washed extensively 
with PBS to remove the detached cells, and the wound was marked at the bottom of 
the dish. The wound closure was monitored for 22 h with by using the bright-field 
Evos XL Cell Imaging Systerm (AMG, Thermo Scientific). 
 
 
xCelligence Real-Time Cell Analysis 
 
xCELLigence® Real-Time Cell Analysis system with DP instrument (ACEA 
Bioscience, San Diego, CA) was employed to analyse the cell adhesion to substratum, 
proliferation and cell migration. For the analysis of adhesion and proliferation, cells 
were seeded at 8 x 103 cells per well on electronic microtiter plates with noninvasive 
gold microelectrode biosensors (E-plate® 16, ACEA Bioscience) and electrical 
impedance was monitored in real-time with RTCA Software 1.2 (ACEA Bioscience) 
for 85 h. For the analysis of migration cells were seeded at 3 x 104 cells per chamber 
in upper chambers in medium depleted of fetal bovine serum (CIM-plate® 16, ACEA 
Bioscience) and the lower electronically integrated Boyden chambers contained basal 
growt medium. Cell movement from the upper to the lower chamber was monitored 
in real-time by electrical impedance with the RTCA Software 1.2 for 24 h. 
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5 RESULTS AND DISCUSSION 
 
5.1 The localization of ORP–VAP complexes is regulated by cellular 
sterol content 
 
5.1.1 Subcellular targeting of ORP–VAP-A complexes alters upon cellular sterol 
manipulations (I) 
 
Several studies indicate that OSBP/ORPs sterol liganding regulates their intracellular 
localization (Hynynen et al., 2009; Mesmin et al., 2013; Nhek et al., 2010; Ridgway 
et al., 1992; Storey et al., 1998). However, the impacts of sterol liganding have not 
been carried out as a systematic screen among the ORP family, and moreover, the 
sterol effects on the localization of ORPs in a complex with VAPs, integral trans-
membrane proteins of the ER, are not comprehensively described. In this study we 
screened the sterol manipulation effects on the ORP–VAP complexes, limiting the 
analysis to ORPs which i) are known to bind sterols and ii) contain the VAP-
interacting FFAT-motif. The ORPs included in the study were OSBP, ORP1L, ORP2, 
ORP4L and ORP9L. 
 
To focus the analysis to ORP–VAP interactions, we employed the Bimolecular 
Fluorescence Complementation technique (BiFC), which enables fluorescent 
microscopy visualization of protein interactions in live cells. BiFC is based on a 
formation of a fluorescent complex when two truncated non-fluorescent fluorophore 
fragments are organized in close association with each other (Kerppola, 2008). To 
visualize protein–protein interactions in live cells, the interaction candidates are fused 
with the non-fluorescent fragments and the formed protein interactions permit the 
association between the two fragments, which then generate a fluorescent complex 
(Kerppola, 2008). The specificity of the BiFC signal is reasonably good but not 
absolute, requiring verification of the positive interaction and exclusion of putative 
false positive signals (Kerppola, 2008). In our study we used ORP8 as a negative 
control for ORP–VAP interaction, since ORP8 lacks FFAT-motif and is incapable of 
binding to VAPs. In addition, the abolishment of BiFC signal by using ORP 
constructs with FFAT-motifs inactivated by mutations is established previously 
(Weber-Boyvat et al., 2015b). 
 
Moreover, when using the BiFC technique, it is important to take into account that the 
BiFC complex formation is irreversible in vitro (Shyu and Hu, 2008), and this 
irreversible nature of the BiFC requires careful evaluation because BiFC is able to 
trap transient and strengthen weak interactions, which sets limitations to the analysis 
of dynamic interactions (Kerppola, 2008; Kodama and Hu, 2012). Here, however, we 
did not employ the BiFC to study the ORP–VAP interaction dynamics, and the 
cellular sterol manipulations were carried out before the generation of the BiFC 
interactions. 
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To study the sterol manipulation effects on ORP–VAP BiFC distribution, HuH7 
hepatocytes were treated for 24 h with 6 μM oxysterols [25OHC, 22(R)OHC or 7KC], 
or alternatively, the cellular cholesterol level was manipulated by 96 h lipoprotein 
starvation, with an additional 5 μM Mevastatin or 50 μg/ml human LDL treatment for 
24 h.  
 
The studied BiFC complexes were OSBP–, ORP1L–, ORP2–, ORP4L– and ORP9–
VAP-A, from which three were found to be sensitive to the sterol manipulations 
(OSBP–, ORP2– and ORP4L–VAP-A), while no effects were observed in ORP1L– or 
ORP9–VAP-A BiFC complexes upon any of the cellular sterol manipulations (I: Fig. 
1A & 2A). Moreover, no detectable BiFC signal was observed upon ORP8–VAP-A 
expression, indicating specificity of the observed ORP–VAP BiFC signals. 
 
The observation that none of the above described sterol manipulations affected the 
ORP1L– or ORP9L–VAPA-A BiFC distributions is to some extent conflicting, as it 
has previously suggested that the sterol binding deficient mutants of ORP1L 
[ORP1L(ΔELSK)] and ORP9L [ORP9L(ΔDLTK)] alter the subcellular targeting of 
these proteins in complex with VAP-A (Weber-Boyvat et al., 2015b). The wild type 
ORP1L–VAP-A was found to localize to ring-like structures surrounding the LEs, but 
overexpression of ORP1L(ΔELSK)–VAP-A was suggested to narrow down the 
diameters of the LE-surrounding ring-like BiFC-positive structures (Weber-Boyvat et 
al., 2015b). Furthermore, the wild type ORP9L–VAP-A BiFC expressed as dots, 
blobs and perinuclear lines, but the ORP9L(ΔDLTK)–VAP-A displayed an altered 
distribution  co-localizing with a Golgi marker, which was not observed with the wild 
type ORP9L (Weber-Boyvat et al., 2015b). It is, however, possible, that ORP1L and 
ORP9L are subjective to regulation by other ligands not included in this study (PIPs 
for example), or alternatively, the altered localization of sterol binding mutants can be 
a result of structural alterations or improper folding, putatively resulting in unnatural 
properties of these mutated proteins. 
 
 
5.1.2 Sterol manipulation effects on cholesterol and TAG content (I) 
 
To analyse the above described sterol manipulation effects on the concentration of 
cellular lipids, the content of free and esterified cholesterol and TAGs were measured 
by thin-layer chromatography. The lipoprotein starvation reduced the cellular content 
of cholesterol esters by 35% and the Mevastatin treatment by 50%, and conversely, 
the LDL loading increased cholesterol esters by 29% (I, Supplementary Figure S1 A). 
However, the Mevastatin treatment did not reduce the amount of free cholesterol 
compared to basal control, and the lipoprotein starvation in fact increased the free 
cholesterol by 17% (I, Supplementary Figure S1 C). Also the LDL treatment 
increased the free cholesterol compared to basal control by 35%, but the increment of 
free cholesterol was not significant as compared to the lipoprotein starvation (I, 
Supplementary Figure S1 C). 
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The analysis clearly indicated that the cellular cholesterol depletion with lipoprotein 
starvation and additional Mevastatin treatment diminished the level of total cellular 
cholesterol by an efficient reduction of cholesterol esters, but the level of free 
cholesterol was not reduced and during the lipoprotein starvation the level of free 
cholesterol was even moderately increased. We have to assume that the lipoprotein 
starvation resulted in an activation of compensatory mechanisms to elevate the 
cellular cholesterol levels, thus increasing the levels of free cholesterol. This is 
supported by the finding that the elevation in the free cholesterol was abolished by the 
additional Mevastatin treatment, which effectively down-regulates the hepatic de 
novo cholesterol synthesis. 
 
Moreover, all these cholesterol manipulations increased the cellular levels of TAGs (I, 
Supplementary Figure S1 B), but on the contrary, the oxysterol treatments 
[22(R)OHC and 25OHC] decreased the TAG content (I, Supplementary Figure S2 B). 
The oxysterols also reduced the level of free cholesterol by 27–55% (I, 
Supplementary Figure S2 C), but the levels of cholesterol esters, on the other hand, 
were increased with 25OHC by 20% (I, Supplementary Figure S2 A). The modulation 
of cellular cholesterol content by the 25OHC or 22(R)OHC increment is probably due 
to their cholesterol homeostatic properties. 25OHC is able to reduce cholesterol 
synthesis, and its formation is implicated as a feed-back control mechanism to inhibit 
excess cholesterol synthesis, but 25OHC is also found to increase cholesterol 
esterification, putatively explaining the observed effects of 25OHC treatment on the 
levels of free and esterified cholesterol (Du et al., 2004; Kandutsch and Chen, 1975; 
Lange et al., 1999). Moreover, 22(R)OHC is also suggested to reduce the cellular 
cholesterol content by suppressing cholesterol synthesis via LXR and by enhancing 
cholesterol efflux via increased expression of ATP-binding cassette transporter A1 
(ABCA1) (Janowski et al., 1996; Koldamova et al., 2003; Lehmann et al., 1997; 
Wang et al., 2008b). 
 
 
5.1.3 Sterol liganding regulates OSBP–VAP-A Golgi localization (I) 
 
The effects of the cellular sterol manipulations on the cellular distribution of OSBP–
VAP-A BiFC were investigated. In the basal control cells, the OSBP–VAP-A 
complex displayed a scattered perinuclear localization, which partly co-localized with 
the trans-Golgi/TGN marker GalT1(1-81) and only weakly with cis-Golgi visualized 
by GM130 staining (I, Figure 3A,B). Upon 25OHC loading – which is a high-affinity 
oxysterol ligand of OSBP – in 80% of the cells the OSBP–VAP-A BiFC was 
clustered at one pole of the nucleus, significantly distinct compared to the diffuse 
BiFC signal observed in the control cells (I, Figure 1A). By the mCherry-GalT1(1-81) 
overexpression or by GM130 staining, the clustered OSBP–VAP-A BiFC was found 
to co-localize completely with the condensed Golgi apparatus (I, Figure 3A,B), 
indicating enhanced Golgi localization of OSBP–VAP-A complexes. Importantly, the 
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25OHC treatment did not only affect the distribution of OSBP–VAP-A but also the 
organization of the Golgi apparatus, by clustering the cis-/trans-Golgi at a 
juxtanuclear position. On the other hand, the low-affinity oxysterol ligands of OSBP – 
22(R)OHC and 7KC – had no significant effects on the OSBP–VAP-A BiFC 
localization compared to control cells. 
 
The cellular cholesterol depletion resulted in a similar clustering of OSBP–VAP-A 
BiFC at cis/trans-Golgi as that observed with 25OHC (I, Figure 3A,B). To be precise, 
the lipoprotein starvation induced the clustering in 36% of the cells and Mevastatin in 
49% (I, Figure 2A), indicating that cellular cholesterol depletion enhances the OSBP–
VAP-A Golgi targeting similar to 25OHC. The LDL loading, however, did not affect 
the OSBP–VAP-A BiFC localization compared to control cell: In both conditions the 
OSBP–VAP-A clustering was observed only in ≈10% of the cells (I, Figure 1A, 2A). 
 
To verify that the 25OHC effect on the OSBP–VAP-A BiFC distribution is a result of 
OSBP ligand binding, effects on a sterol-binding deficient mutant (ΔELSK) of OSBP 
were investigated upon 25OHC treatment. Interestingly, the 25OHC treatment 
condensed the Golgi markers close to the nucleus, but OSBP(ΔELSK)–VAP-A BiFC 
was unaffected by the 25OHC treatment, displaying a scattered perinuclear 
localization similar to the basal control. As a result, OSBP(ΔELSK)–VAP-A BiFC 
showed no co-localization with Golgi markers (I, Figure 3A,B). The result indicates 
that 25OHC regulates the subcellular localization of OSBP–VAP-A by directly 
binding to OSBP, but overexpression of the OSBP–VAP-A complex is not required 
for the Golgi clustering. Consistently, the 25OHC treatment induced the GM130 and 
GalT1(1-81) clustering also in the absence of OSBP–VAP-A BiFC overexpression (I, 
Supplementary Figure S3). 
 
However, Nhek and co-workers previously indicated that LDL treatment resulted in a 
scattered distribution of the trans-Golgi marker TGN46, and as a result, they implied 
that the inefficient localization of the OSBP to the Golgi in response to the LDL 
treatment promoted the Golgi fragmentation (Nhek et al., 2010). The HuH7 cells’ 
Golgi is naturally highly fragmented and thus unaffected by the LDL treatment, but is 
condensed upon 25OHC treatment or cholesterol depletion. We observed clustering of 
the cis- and trans-Golgi upon 25OHC also in the untransfected cells. However, we 
have to take into account that the cells contained endogenous OSBP and VAP-A, thus 
the involvement of OSBP in the Golgi clustering cannot be reliably excluded based on 
our observation. 
 
Also the ligand binding dependency of the OSBP Golgi localization has been 
previously investigated, and several studies support our findings that the OSBP Golgi 
targeting is promoted by 25OHC or cholesterol depletion, or by altered plasma 
membrane cholesterol trafficking, and conversely, cholesterol increment reduces the 
OSBP Golgi localization (Nhek et al., 2010; Ridgway et al., 1992; Storey et al., 
1998). In addition, Storey et al. (1998) indicated that the Golgi localization of OSBP, 
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in response to 25OHC, increased the Golgi SM synthesis, which was conversely 
inhibited by cholesterol. Mesmin et al. (2013) suggested that the 25OHC treatment 
additionally modifies the localization of VAP-A when co-expressed with OSBP. The 
study reported that in the basal conditions, VAP-A was evenly distributed along the 
ER membrane, but upon the 25OHC treatment, it co-localized with OSBP at the 
perinuclear Golgi structures. Hence, it was suggested that the 25OHC treatment 
promotes the VAP-A translocation towards the Golgi via the OSBP interaction. The 
study also showed that mutation of the PHD of OSBP shifted the OSBP localization 
to the ER, and the FFAT mutation towards the Golgi, implicating an important role 
for PHD PIP-binding in the OSBP Golgi targeting and VAP-binding in the ER 
association. (Mesmin et al., 2013) Later it was also shown that OSW-1 treatment, 
which blocks the OSBP ligand binding, also induced OSBP translocation to the Golgi 
accompanied with VAP-A (Mesmin et al., 2017). 
 
The observed BiFC signals in our experiments implicate that the interaction of OSBP 
with VAP-A is not compromised upon any of the cellular sterol manipulations, but 
the localization of the OSBP–VAP-A interaction is altered depending on the cellular 
cholesterol or 25OHC levels. One could criticise, that the cellular oxysterol treatments 
using micromolar concentrations represent an unnaturally high dose compared to the 
levels of endogenously produced oxysterols, the concentrations of which in the 
plasma are in nanomolar range. However, our unpublished observations suggest that 
oxysterols rapidly precipitate in aqueous solutions, i.e. when added to the culture 




5.1.4 Sterol manipulations regulate ORP4L–VAP-A localization to vimentin filaments 
(I) 
 
ORP4L is the closest homologue of OSBP and similarly found to bind 25OHC with 
high-affinity (Wang et al., 2002). In addition, both OSBP and ORP4L contain a 
dimerization motif enabling the formation of OSBP–ORP4L heterodimers (Wyles et 
al., 2007). ORP4 was previously shown to localize to vimentin intermediate filaments 
and to regulate the vimentin filament organization (Wyles et al., 2007). Here in the 
basal conditions, the ORP4L–VAP-A BiFC complexes showed localization to 
vimentin but also to a lesser extent at the PM (I, Figure 1A). At the PM, the ORP4L–
VAP-A BiFC signals co-localized with the ER–PM MCS marker E-syt2 (I, Figure 
4A). The 25OHC treatment, but not 22(R)OHC or 7KC, caused a re-localization of 
ORP4L–VAP-A to punctate cytosolic-like structures in 62% of the treated cells (I, 
Figure 1B), which did not co-localize with the vimentin (I, Figure 4B). Also the 
cholesterol depletion through lipoprotein starvation or Mevastatin resulted in similar 
punctate elements in 40% and 50% of the cells, respectively (I, Figure 2B). 
Furthermore, upon the LDL treatment, the ORP4L–VAP-A BiFC was found at the 
PM and did not display vimentin-associated structures (I, Figure 2B). 
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The sterol-binding deficient mutant of ORP4L displayed enhanced PM targeting 
compared to wild-type ORP4L–VAP-A BiFC, as the co-localization of 
ORP4L(ΔELSR)–VAP-A with the vimentin filaments was abolished (I, Figure 4A,B). 
The punctate elements induced by 25OHC or sterol depletion, which co-localized 
with the ER marker protein disulphide isomerase (PDI) (I, Figure 4C), were also 
observed with ORP4L(ΔELSR)–VAP-A after the 25OHC treatment (I, Figure 4A,B), 
suggesting that the localization of ORP4L–VAP-A complexes to the condensed ER 
elements is not a result of direct binding of 25OHC to ORP4L. It is possible that the 
25OHC elevation regulates the ORP4L–VAP-A localization via an indirect 
mechanism, or that the ORP4L(ΔELSR) mutant does not completely prevent the 
25OHC binding to ORP4L. 
 
ORP4L was previously shown to localize to vimentin, and a leucine repeat motif of 
ORP4L was suggested to be important for the native organization of the vimentin 
filaments, since the overexpression of ORP4S or ORP4L mutant, with a leucine 
repeat deletion, aggregates the vimentin filaments close to the nucleus (Wang et al., 
2002; Wyles et al., 2007). On the other hand, another study implicated that the PHD 
of ORP4L is important for the impact of ORP4L on vimentin organization, since the 
overexpression of mutant ORP4L lacking the PHD strongly induced vimentin 
aggregation (Charman et al., 2014). 
 
In controversy with our observation, the study by Wyles et al. (2007) indicated that 
the 25OHC or cholesterol binding does not affect the ORP4L localization to vimentin. 
In our observations the 25OHC and the cholesterol depletions accumulated ORP4L–
VAP-A BiFC to condensed ER elements, and the LDL treatment induced PM 
targeting of the ORP4L–VAP-A complexes. However, the conclusion of the study 
was acquired by using a very different approach to ours: In the earlier study the 
affinity of recombinant wild type and a sterol binding deficient mutant ORP4L(Δ501-
505) proteins for vimentin binding was analysed using a pull-down assay, combined 
with 25OHC and cholesterol treatments. The pull-downs showed similar affinity of 
wild type ORP4L and ORP4L(Δ501-505) for the vimentin binding, and furthermore, 
no difference was observed for the vimentin binding of ORP4L with the sterols 
compared to the non-sterol containing controls, resulting to a hypothesis that the 
vimentin targeting of ORP4L is not regulated by sterols (Wyles et al., 2007). 
 
However, consistent with our observations, in live cell imaging the sterol binding 
deficient mutant (Δ501-505) of ORP4L was not observed to co-localize with vimentin 
(Wyles et al., 2007), and in our studies the ORP4L(ΔELSR)–VAP-A BiFC signal 
localized at the PM instead. It is possible that, despite the affinity of sterol binding 
mutants of ORP4L for vimentin, in live cells other cellular mechanisms are reducing 
its vimentin targeting. Our observation suggests that the sterol binding domain is 
important for the ORP4L vimentin targeting, but is not however necessarily due to its 
sterol binding capacity, as the ORP4L(ΔELSR) was not completely immune to the 
25OHC treatment.  Possibly the 4-aa deletion mutation caused a conformational 
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change, which permitted more efficient targeting to the PM. On the other hand, the 
discrepancy with the earlier study addressing ORP4L vimentin targeting (Wyles et al., 
2007) could also be a result of the sterol manipulations affecting specifically the 
interaction site in the ORP4L–VAP-A complex but not in ORP4L alone. 
 
Here we did not analyse the putative effect of ORP4L–VAP-A BiFC on the vimentin 
filament organization. Our result, however, provides a novel clue implicating that the 
ORP4L function is not limited to the interaction with vimentin, but instead ORP4L 
also plays a role at the ER–PM MCSs. In fact, ORP4 silencing causes a growth arrest 
and proliferation defect, that were suggested to be independent of the ORP4L 
vimentin targeting (Charman et al., 2014). In addition, in T-cell acute lymphoblastic 
leukemia cells ORP4L is shown co-localize and activate phospholipase C β3 
(PLCβ3) at the PM by scaffolding PLCβ3 with CD3ɛ and Gαq/11 into a signalling 




5.1.5 ORP2–VAP-A targeting to LDs is inhibited by 22(R)OHC (I) 
 
In basal HuH7 cells, the ORP2–VAP-A BiFC displayed a blob-like perinuclear 
localization, which was found to associate with ER–LD contacts visualized with 
Bodipy-C12 and the ER marker PDI (I, Figure 5A,B). In a previous study ORP2 was 
suggested to localize on the surface of the LDs (Hynynen et al., 2009), but here the 
ORP2–VAPA BiFC was often observed in enlarged ER patches surrounded by LDs. 
This is, however, most likely a result of a BiFC overexpression artefact since ER does 
not reportedly form large blob-like structures surrounded by LDs. 
 
The treatment with the ORP2 high-affinity ligand, 22(R)OHC, reduced the BiFC 
complexes’ LD targeting in 76% of the cells, and promoted a diffuse ER localization 
of the BiFC, and also to a lesser extent localization at filament-like structures and the 
PM (I, Figure 1D). The filmentous ORP2–VAP-A structures most likely represent 
localization to ER sheets or tubules, as there was no co-localization observed with 
tubulin, actin, vimentin nor the Golgi, and VAP-A is predominantly attached to the 
ER. The low-affinity ligand 25OHC had a similar, but much weaker effect on the 
ORP2–VAP-A distribution as compared to 22(R)OHC. 
 
The 7KC treatment or the cellular cholesterol manipulations did not affect ORP2–
VAP-A BiFC localization compared to basal control (I, Figure 1D, 2D). The BiFC 
was, however, distributed more to ring-like structures surrounding the LDs and not 
vice versa, suggesting that the sterol manipulations reduce the formation of artefactual 
blob-like ER structures. 
 
Similar to the OSBP and the ORP4L analysis, the ligand-binding dependency of 
ORP2–VAP-A localization was studied by using the sterol binding deficient mutant 
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of ORP2. Importantly, the ORP2(ΔELSK)–VAP-A BiFC was targeted to LDs 
regardless of the 22(R)OHC or 25OHC treatments, indicating that the subcellular 
localization of ORP2–VAP-A is determined by the ORP2 oxysterol liganding. This is 
consistent with the earlier finding by Hynynen et al. (2009), which showed that the 
22(R)OHC treatment reduces the LD targeting of ORP2 and consistently, the sterol 
binding deficient mutant of ORP2 (I249W) displayed enhanced LD targeting. 
 
Our results indicate that the ORP2 high-affinity oxysterol ligand binding affects the 
LD targeting of ORP2 also in complex with VAP-A. ORP2 is intrinsically a cytosolic 
protein but the dispersed cytosolic-like distribution of the ORP2–VAP-A caused by 
22(R)OHC treatment indicated that ORP2 remains also under these conditions 
associated with the ER via VAP-A. Interestingly, the localization of ORP2–VAP-A 
BiFC to the PM indicates that ORP2 localizes to ER–PM MCSs as a result of ORP2 
ligand binding. The ligand binding most likely results in a conformational change that 
inhibits the exposure of an ORP2 LD targeting motif, albeit the precise mechanism of 
ORP2 LD targeting is yet unknown. 
 
 
5.2 ORP2-KO hepatocytes display altered expression of thousands of 
genes 
 
5.2.1 ORP2-KO dysregulates mRNAs involved in actin regulation (II) 
 
To extensively analyse the ORP2-related cellular functions, we established a stable 
ORP2 knock out (KO) cell line in HuH7 hepatocytes by employing CRISPR-Cas9 
mediated gene editing. Two different KO cells lines, derived from different gRNAs 
used in the genome manipulation, were used in the studies to minimize the possible 
off-target effects which may have occurred during the genome manipulation process. 
The viability of the KO cells importantly indicated that ORP2 is not a prerequisite for 
viability. The ORP2-KO cells, however, displayed an altered growth pattern upon 
culture, as the KO cells were forming ‘islet-like’ cell clusters instead of growing as an 
even monolayer like the maternal HuH7 cells (II, Figure 1C). 
 
To gain clues of the cellular effects of ORP2 depletion, mRNA levels of four parallel 
cultures of both ORP2-KO cell lines and controls were analysed using RNA 
sequencing. The RNA sequencing of the ORP2 depleted cells revealed altered 
expression of >2000 mRNAs, 579 of which had at least 2-fold expression changes. 
Importantly, the analysis showed that the ORP2 abrogation did not affect the mRNA 
levels of other ORP family members or VAPs (II, Supplemental Figure S2). 
 
The transcriptome of ORP2-KO cells was analysed using the Ingenuity pathway 
analysis (IPA) software, which predicted a number cellular functions and cell 
signalling pathways to be dysregulated in the ORP2-KO cells. These included several 
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pathways involving the actin cytoskeleton (II, Figure 1A; Table 2). Of note, IPA 
identified significant dysregulation in 12 mRNAs involved in the RhoA signalling 
pathway and 16 mRNAs of Rac1 signalling (II, Figure 4A; Supplementary Figure 
S5). These pathways are key components in the organization of F-actin into stress 
fibers and lamellipodia, respectively.  
 
The up-regulated RhoA signalling components were Rhotekin 1 and 2, 
phosphatidylinositol-4-phosphate 5-kinase (PI4P5K), DIAPH1 and actin related 
protein 2/3 (Arp2/3) complex subunits 1A and 5, while the down-regulated ones were 
lysophosphatidic acid receptor (LPAR), profilin 1 and 2, Rho-associated protein 
kinase 2 (ROCK), G-actin 1 and cofilin-2. From those PI4P5K, cofilin-2 and Arp2/3 
complex subunits are also subject to regulation by Rac1 signalling. Additional 
components up-regulated in the Rac1 signalling pathway were Abl interactor 2 
(ABI2), mitogen-activated protein kinase kinase kinase 1 (MEKK1), protein kinase C 
(PKC), NADPH oxidase 1 (Nox1), guanine nucleotide exchange factor (DBS) and 
cytoplasmic FMR1 interacting protein 1 (CYFIP1), and down-regulated were N-Ras, 
mitogen-activated protein kinase 8 (JNK1), mitogen-activated protein kinase kinase 1 
(MEK), mitogen-activated protein kinase 1 (ERK), nuclear factor κB subunit 1 (NF-
κB), par-3 family cell polarity regulator (PAR3) and phosphatidylinositol-4-phosphate 
3-kinase catalytic subunit type 2α (PI3K). 
 
Extensive disturbance in the genetic regulation of RhoA and Rac1 signalling 
associated genes suggests that ORP2 has a functional role in the actin cytoskeleton 
regulation. Interestingly, down-stream of RhoA signalling the DIAPH1 mRNA was 
found to be up-regulated which encodes a protein mDia1. mDia1 is in previous study 
indicated as an interaction partner of ORP2 (Li et al., 2013). mDia1 plays a role in the 
actin filament polymerization and provides and additional clue to a putative role of 
ORP2 in actin cytoskeleton regulation. 
 
 
5.2.2 ORP2-KO dysregulates TAG metabolic genes (III) 
 
In addition to genes involved in the cytoskeletal regulation, the ORP2 knock out cells 
displayed significant alterations in the expression of TAG metabolic enzymes. The 
up-regulated genes in TAG synthesis were GPAM, MBOAT1, AGPAT3 and 
LPGAT1, while the down-regulated ones were GPAT4 and lipin1–2. In addition, up-
regulated enzymes involved in TAG hydrolysis were PNPLA4, CES1 and NDST1, 
and down-regulated PNPLA3 and DAGLα (III, Figure 5F). 
 
Glycerol-phosphate acyltransferases (GPAM/GPATs) are implicated as rate limiting 
enzymes in the TAG synthesis through glycerol phosphate pathway, but genetic 
defects in other TAG biosynthetic enzymes have also been suggested to exert rate-
limiting regulation in later stages of the biosynthetic pathway (Lewin et al., 2008; 
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Wendel et al., 2009). GPAM/GPATs execute the initial step of TAG synthesis by 
esterifying long-chain fatty acids with glycerol-3-phosphate. 
 
The analysis of ORP2 knock out cells’ transcriptome showed 20% up-regulation of 
the mRNA for mitochondrial GPAM, and oppositely a 10% reduction in the 
expression of the the mRNA for GPAT4. GPAT4 is localized to ER membrane and 
was only later identified as an isoform of GPAT proteins (Nagle et al., 2008). The 
role of GPAT4 in TAG synthesis is not yet comprehensively characterized, but 
GPAT4-/- mice display 49% reduction in the liver GPAT activity and 45% diminished 
hepatic TAG content accompanied with resistance to diet-induced and genetic obesity 
(Nagle et al., 2008; Vergnes et al., 2006). 
 
In addition to GPATs, lipins are important in determining the rate of TAG synthesis. 
In the mRNA profile of ORP2-KO cells the expressions of lipin-1 and lipin-2 were 
significantly down-regulated, by 27% and 39%, respectively. Studies of lipin-1 
deficient mice point to reduced adipose tissue TAG storage (Phan et al., 2004; Reue 
et al., 2000), and in line, silencing of lipin-1 in hepatobastoma cells reduces cellular 
TAGs (Ishimoto et al., 2009). The role of lipin-2 is less studied, but the protein is 
enriched in the liver and silencing of lipin-2 correlates with reduced TAG synthesis 
(Donkor et al., 2007; Gropler et al., 2009). 
 
The ORP2 knock out cells also displayed small but significant reduction (-13%) in the 
expression of SREBP-1 (III, Figure 5E). SREBP-1 is expressed as an inactive 
membrane-bound precursor located in the ER, but during its activation, SREBP-1 
undergoes a proteolytic cleavage and re-localization into nucleus where it binds to 
SRE elements in the promoters of lipogenic genes (Brown and Goldstein, 1997). 
However, despite its proteolytic processing, the activity of SREBP-1c, which is the 
major SREBP-1 isoform responsible for the regulation of glucose and fatty acid 
metabolism, is suggested to be mainly regulated transcriptionally by insulin via the 
PI3K/Akt pathway (Azzout-Marniche et al., 2000; Fleischmann and Iynedjian, 2000; 
Foretz et al., 1999b; Kim et al., 1998; Porstmann et al., 2005; Ribaux and Iynedjian, 
2003). The ORP2-KO transcriptome also displayed significant alterations in the 
mRNA levels of 28 established SREBP-1 target genes (III, Figure 5E). Reduced 
expression of SREBP-1 in the ORP2 knock out cells implies defects in cellular fatty 
acid and TAG synthesis, as diminished SREBP-1 is associated with reduced 
expression of a range of lipogenic enzymes, including FAS and SCD1, the levels of 
which were reduced by 31% and 17%, respectively. In addition, silencing of SREBP-
1 in hepatoblastoma cells correlates with reduced Lipin-1 expression (Ishimoto et al., 
2009). 
 
The altered expression of TAG biosynthetic enzymes and SREBP-1 in ORP2 knock 
out cells implies effects on the cellular levels of TAGs, which are described in the 
section 5.3.3. However, transcriptional data cannot necessarily be used to explain 
physiological effects, as transcriptional regulation is only one mechanism among 
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others to regulate enzymatic reactions. In fact, several metabolic enzymes are 
regulated allosterically or by post-translational modifications, which permits more 
rapid adaptation to fluctuating availability of substrates (Jensen-Urstad and 
Semenkovich, 2012; Munday and Hemingway, 1999). In addition, the knowledge of 
the role of microRNA guided regulation of lipid metabolism is emerging. Several 
microRNAs are currently identified as important regulators of TAG metabolism by 
inhibiting the translation of their sequence-specific target genes in metabolic 
pathways (Horie et al., 2013; Shirasaki et al., 2013; Yang et al., 2015). Moreover, in 
the ORP2-KO transcriptome all enzymes in TAG synthesis or hydrolysis were not 
consistently up- or down-regulated, making it difficult to directly predict the 
consequence on the levels of TAGs. The non-systematic alteration in the mRNA 
expression levels of the enzymes suggests that some compensatory effects may have 
arisen to moderate the enzymatic defects at the cellular level.  
 
 
5.2.3 ORP2-KO reduces expression of glycolytic enzymes (III) 
 
The RNA sequencing of ORP2-KO cells also displayed down-regulation of enzymes 
involved in glycolysis. In fact, loss of ORP2 resulted in significant reduction of the 
transcripts of 12 glycolytic enzymes, which ultimately cover the whole glycolytic 
pathway. The enzymes affected were glucose-6-phosphate isomerase (GPI), 6-
phosphofructo-2-kinase/fructose-2,6-biphosphatase 3–4 (PFKFB3–4), fructose-
bisphosphate aldolase (ALDOA), triosephosphate isomerase 1 (TPI1), 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), phosphoglycerate kinase 1 
(PGK1), phosphoglycerate mutase 1 (PGAM1), enolase 1–3 (ENO1–3) and muscle 
pyruvate kinase (PKM) (III, Figure 4E). Most of the mRNAs were reduced only 
moderately (by 10–30%), but the gene expression of PFKFB4 was reduced by 65%. 
 
PFK-1 and L-PK are the rate limiting enzymes in the glycolytic pathway. PFK-1 is, 
however, not regulated at the transcriptional level, but by the cellular ATP/AMP ratio. 
In addition, fructose 2,6-bisphosphate is suggested to act as an allosteric activator of 
PFK-1 thus stimulating glycolysis (Rider et al., 2004). The formation of fructose 2,6-
bisphosphate from fructose-6-phosphate is catalysed by PFKFBs, from which the 
isoforms 3 and 4 were significantly down-regulated by the loss of ORP2, suggesting a 
decreased rate of glycolysis. In addition, the isoenzyme of L-PK, PKM, was found to 
be down-regulated in ORP2-KO cells. In total, the reduced expression of 12 
glycolytic enzymes indicates a diminished rate of glycolysis in ORP2-KO cells, 







5.3 ORP2 knock out reduces the availability of energetic substrates 
 
5.3.1 Membrane lipid and sterol content of ORP2-KO cells (III) 
 
In previous studies ORP2 was suggested to regulate cholesterol metabolism and 
silencing of ORP2 was shown to reduce the cellular levels of 22(R)OHC and 7KC, 
and increase cholesterol (Escajadillo et al., 2016; Hynynen et al., 2005; Laitinen et 
al., 2002). To comprehensively examine the possible effects of ORP2 depletion on the 
concentration of membrane lipids and sterols we exploited mass spectrometric 
lipidome analysis. The cellular lipid levels were measured from cells cultured under 
basal conditions, but analysis of free and esterified cholesterol levels were 
additionally performed after modulating the cellular cholesterol metabolism by 
lipoprotein starvation and by Mevastatin or LDL treatments prior to the 
measurements. The analysis covered different cellular lipid classes and the molecular 
species of following lipid classes: PCs, lyso-PCs, PEs, PE-plasmalogens, PIs, PSs and 
phosphatidylglycerols. In addition, ceramides, sphingomyelins and oxysterols 
(25OHC, 27OHC, 7αOHC, 7βOHC and 7KC) were analysed. Unexpectedly, the 
results showed no significant alterations in any of the above lipid classes or oxysterol 
species in the ORP2-KO cells compared to the controls (III, Supplementary Figure 
S3). The result indicates that either (i) in hepatocytes the ORP2 function is not 
directly connected to membrane lipid or sterol homeostasis or (ii) that the HuH7 cells 
chronically lacking ORP2 have developed compensatory adaptations. 
 
Furthermore, we cannot exclude the possibility that ORP2 executes functions in a cell 
type specific manner, and in some cell types ORP2 may have a tighter connection to 
sterol metabolism. This is implicated by the study by Escajadillo et al. (2016), which 
showed that the modulation of ORP2 expression affects the cellular levels of 
cholesterol and certain oxysterols in adrenocortical cells, which have an important 
role in steroid hormone biosynthesis. Cholesterol is the precursor for steroid hormone 
synthesis and also oxysterols are well established intermediates in steroid hormone 
production (Hanukoglu, 1992; Olkkonen et al., 2012), hence the ORP2 silencing 
effects on the adrenocortical sterol concentrations could reflect a specific 
steroidogenic function of ORP2 in certain tissues. 
 
 
5.3.2 ORP2-KO reduces glucose utilization (III) 
 
Inhibition in the expression of glycolytic enzymes in ORP2-KO cells suggests that 
ORP2 may have a role in cellular glucose homeostasis. The putative effects of ORP2 
depletion in the glucose processing were studied by measuring the rate of glucose 
uptake, glycolysis and glycogen synthesis in KO cells. Importantly, the study 
indicated that all of these cellular glucose handling processes were significantly 
impaired due to loss of ORP2. The uptake of [3H]-2-deoxy-D-glucose in a 15 min 
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period was reduced by 28–33% (III, Figure 4A), the glycolysis measured by 
extracellular acidification rate was decreased by 22–37% (III, Figure 4F,G) and the 
synthesis of [14C]glycogen from D-[U-14C]-glucose in a 1 h period was reduced by 
50–58% (III, Figure 4B). To further confirm the direct involvement of ORP2 in 
glucose handling, the glycogen synthesis was measured in ORP2-KO cells with ORP2 
reintroduced by overexpression. The ORP2 overexpression in the KO cells increased 
the glycogen synthesis by 37 % (III, Figure 4C). 
 
Moreover, the effects of two previously established ORP2 mutants, deficient in VAP- 
or PIP-binding, on the putative rescue of glycogen synthesis in the KO cells were 
analysed (III, Supplementary Figure S1B). Similar to the wild type, the VAP-binding 
deficient mutant rescued the KO phenotype, suggesting that the interaction with the 
ER or the VAPs are not a prerequisite for ORP2 to contribute the cellular glucose 
handling. The effects of the PIP-binding mutant varied between the experiments, thus 
the role of ORP2’s association with PIPs in the context of glucose metabolism could 
not be reliably determined.  
 
The reduced rate of glycolysis in ORP2-KO cells is consistent with the observed 
reduction of the mRNAs of glycolytic enzymes. The impaired synthesis of glycogen 
suggests impaired activity of GK, GYS or GSK-3. The GK provides substrates for 
glycogen synthesis by phosphorylating glucose to G-6-P, which also promotes 
glucose uptake via GLUT2 by maintaining a glucose concentration gradient. 
However, GK is transcriptionally regulated, and the ORP2-KO cells’ transcriptome 
did not indicate inhibition in the GK nor in the GLUT2 expression. GYS is principally 
regulated via phosphorylation by GSK-3, which is a down-stream target of PI3K/Akt 
signalling, as described in section 5.4.2. GLUT2 is the major PM glucose transporter 
of hepatocytes, but also GLUT1 is expressed in the liver (Karim et al., 2012). The 
expression of GLUT1 is also regulated by the PI3K/Akt signalling (Barthel et al., 
1999), and the ORP2-KO cells’ transcriptome displayed a 30% reduction in the 




5.3.3 ORP2-KO reduces TAG content and TAG synthesis (III) 
 
The involvement of ORP2 in TAG synthesis is suggested by earlier studies (Hynynen 
et al., 2009; Weber-Boyvat et al., 2015b), and the dysregulation of the TAG 
metabolic genes in the ORP2-KO cells’ transcriptome further supported an 
involvement of ORP2 in TAG metabolism. Thus, the TAG content of ORP2-KO cells 
was analysed. The analysis showed that, as compared to the normal ORP2 expressing 
cells, the ORP2-KO reduced the basal cellular TAG content by 21–28% (III, Figure 
5A). Moreover, analysis of the KO cells’ capacity to synthesize [3H]TAGs in a 3 h 
period from externally administered [3H]oleic acid also revealed diminished TAG 
synthesis by the KO cells (III, Figure 5B). Similar to glycogen synthesis, a direct 
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connection of ORP2 protein with the TAG synthesis was confirmed by an 
overexpression rescue study, which displayed a 31% increment in the TAG synthesis 
of the ORP2 overexpressing KO cells (III, Figure 5D). 
 
Additionally, no significant alteration was observed in the rescue effect between the 
wild type and VAP- or PIP-binding deficient mutants of ORP2 (III, Supplementary 
Figure S1C). This indicates that neither is the VAP- nor PIP-binding indispensable for 
ORP2 mediated enhancement in TAG synthesis. This is to some extent contrary to the 
previous indication by Weber-Boyvat et al. (2015b), who concluded that ORP2 
regulates TAG metabolism in complex with VAPs. The conclusion in the earlier study 
was result from a notion that triple-silencing of ORP2 together with VAP-A/-B had a 
greater impact on TAG synthesis and degradation than the double-silencing of ORP2 
with VAP-A or VAP-B. However, now taking into account our ORP2(mFFAT) 
rescue experiments in the ORP2-KO cells, it is possible that the knock-down of VAP-
A/-B in Weber-Boyvat et al. (2015b) affected the TAG synthesis via a different 
mechanism that is at least partially independent of their interaction with ORP2. 
 
One of the main functions of glycolysis is to provide carbons and energy to be used 
for fatty acid synthesis. Hence, it not surprising that the reduced glycolytic capacity of 
ORP2-KO cells also results in a reduced content of TAGs. It is, however, important to 
take into account that glycolysis also provides precursors for glycerophospholipid and 
cholesterol synthesis, the concentrations of which were not affected in the KO cells. 
Moreover, the TAG synthesis of ORP2-KO cells from externally added fatty acids 
was also significantly reduced, but the uptake of fatty acids to KO cells was shown 
not be affected (III, Figure 5C). This suggests that ORP2 affects the regulation of 
TAG synthesis also at a later stage independent of the availability of glycolytic 
substrates. However, it is possible that the impaired synthesis of TAGs correlates with 
the reduced release of glycolytic energy utilized for the de novo lipogenesis. 
Moreover, the observed reduction in the levels of basal TAGs and in the TAG 
synthesis could be a result of down-regulation in TAG synthesizing enzymes GPAT4 
and Lipin1–2 in the ORP2-KO cells. 
 
 
5.3.4 ORP2-KO and ER–lipid droplet contacts (III) 
 
ORP2 is previously suggested to enhance MCSs between LDs and ER when in 
complex with VAP-A (Weber-Boyvat et al., 2015b). We analysed the quantity of ER–
LD MCSs in ORP2-KO and control cells under basal conditions or after 3 h fatty acid 
loading by transmission electron microscopy. The analysis showed that the total LD 
area or the total length of the ER–LD contacts per cell were both increased in the 
ORP2-KO cells compared to the control cells. (III, Figure 6B,C). Moreover, after 
fatty acid loading, these parameters were significantly increased in the control cells, 
but remained unaltered in the KO cells, suggesting that the ER–LD contacts are not 
directly dependent on the LD area. Importantly, these results indicate that the ORP2–
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VAP complexes at ER–LD interfaces are not a requirement for MCS formation, but 
vice versa, under the basal culture conditions the quantity of the ER–LD contacts was 
greater in the KO cells than within the controls. 
 
These results do not support the earlier observation, which was also made in the 
HuH7 cell model (Weber-Boyvat et al., 2015b). It is however important to take into 
account that these studies were carried out by different methodological approaches. 
Here we used ORP2-KO cells and in the previous study the ER–LD contacts were 
measured after ORP2–VAP-A BiFC overexpression. The problem of the BiFC 
approach in the analysis of MCS is its irreversible nature (Kerppola, 2008; Kodama 
and Hu, 2012). MCSs are suggested as highly dynamic and temporal connections, but 
when using the BiFC approach with two interacting proteins which localize to the 
apposing membranes, the protein interaction formed between the two membranes is 
stabilized by the BiFC complex, which once formed can no longer dissociate 
(discussed in the section 5.1.1). Thus the MCSs containing BiFC protein complexes 
are transformed to stable contacts, and during 24 h overexpression carried out in the 
earlier study, the number of contacts presumably accumulates over the time. We 
speculate that the measurement of contacts sites in ORP2-KO cells provides a more 
accurate perspective to the intrinsic MCSs as compared to the BiFC overexpression. 
Considering this, the involvement of ORP2 in the ER–LD contact site formation is 
not sufficiently justified. 
 
 
5.4 Novel ORP2 interaction partners and cell signalling 
 
5.4.1 ORP2 interacts with Hsp90 and Cdc37 (III) 
 
In addition to gaining novel understanding on the intracellular role of ORP2 by 
analysing the ORP2-KO effects on the global mRNAs, the putative ORP2-related 
functions were studied by screening of novel ORP2 protein–protein interactions. The 
identification of ORP2 interaction partners was performed by transient expression of 
HA-ORP2 construct in HuH7 cells followed by HA co-immunoprecipitation and 
identification of eluted proteins by mass spectrometry proteomics. The interactome 
analysis identified 107 putative novel interaction partners for ORP2 (II: Supplemental 
data). 
 
Among the 107 identified proteins, one of the putative new partners of ORP2 was 
Cdc37. Cdc37 is a co-chaperone of heat shock protein 90 (Hsp90), which adapts 
client protein kinases to Hsp90 kinase activation system (Silverstein et al., 1998). To 
confirm the validity of the interaction we carried out pull-down experiments from 
HuH7 cell lysates using purified recombinant GST-ORP2 or plain GST as negative 
control. The experiments indicated a direct interaction between endogenous Cdc37 
and GST-ORP2. Interestingly, the pull-downs also showed an interaction of ORP2 
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with Hsp90 and Akt (III, Figure 2F). Akt is one of the Hsp90–Cdc37 chaperone 
clients, and disruption of Akt–Hsp90 interaction promotes Akt dephosphorylation and 
kinase inhibition via protein phosphatase 2A (Sato et al., 2000). Moreover, Akt and 
its phosphorylating kinase PDK1 are sensitive to Hsp90 inhibitors (Basso et al., 
2002). 
 
As Hsp90 and Cdc37 are found within cells as a binary complex and thus it is 
possible that Hsp90 was recognized in the pull-down sample due to its affinity for 
Cdc37. However, in the ORP2 pull-down sample compared to the starting lysate the 
band intensity was stronger for Hsp90, but with Cdc37 the band intensity was rather 
similar in both samples, suggesting that ORP2 may interact with Hsp90 directly and 
not via Cdc37. The interaction was further confirmed by treating the HuH7 cells with 
Withaferin A prior to the pull down – a drug which reportedly disrupts the Cdc37–
Hsp90 complex (Yu et al., 2010). The pull-down showed that the interaction of 
neither Hsp90 nor Cdc37 with ORP2 was abolished or reduced compared to the 
untreated cell control, indicating that both Cdc37 and Hsp90 interact directly with 
ORP2 (III, Figure 2G). 
 
No similar drug that would abolish the interaction between Hsp90 and Akt is known, 
complicating the identification of direct interaction of Akt with individual proteins in 
the Hsp90–Cdc37–ORP2 ternary complex. However, Akt was only barely visible in 
the ORP2 pull-down sample, which could indicate that ORP2 does not directly 
interact with Akt, but through Hsp90. The pull-down experiments also showed that 
the Withaferin A treatment promoted Akt dephosphorylation, detected initially by a 
band-shift and confirmed by lambda phosphatase treatment (III, Figure 2G,H). 
Importantly, in the GST-ORP2 pull-down sample only the hyperphosphorylated form 
of Akt was detected (III, Figure 2H). This finding strongly suggests that ORP2 does 
not interact with the inactive form of Akt but is physically involved in a complex in 
which Akt adopts its phosphorylated form, since dephosphorylated Akt was not 
detected in GST-ORP2 pull down. Hence it is possible that ORP2 is involved in the 
Akt activation process. 
 
 
5.4.2 ORP2-KO inhibits PI3K/Akt-signalling (III) 
 
To further analyse the role of ORP2 in the Akt activation, the Akt-signalling activity 
was assessed in ORP2 knock out cells with Akt(Ser473) and with its down-stream 
target GSK-3β(Ser9) antibodies in both basal and fatty acid starved conditions 
followed by insulin stimulations. Western blot analysis of KO cells showed a 
significant reduction in the phosphorylation of both Akt and GSK-3β in all conditions 
(III, Figure 1A,B,C,D), indicating suppression of Akt signalling in ORP2 depleted 
cells compared to controls. The knock out cells were, however, not completely 
immune to the insulin stimulus, as insulin was able to increase the protein 
phosphorylations in the KO cells. Furthermore, the ORP2-KO cells’ transcriptome 
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analysis showed dysregulation of 20 mRNAs of the PI3K/Akt signalling pathway (III, 
Figure 1A,B), IPA analysis of which indicated PI3K/Akt signalling as a significant 
ORP2-associated pathway and predicting it to be suppressed due to the loss of ORP2, 
consistent with the observed reduction in the Akt and GSK-3β phosphorylations. 
 
The analysis was expanded to non-cancerous cells, to avoid effects which could be 
caused by a point mutation in the p53 tumour suppressor gene of HuH7 cells. ORP2 
was knocked down with a lentivirus expressing ORP2-specific shRNA in primary 
human umbilical vein endothelial cells (HUVECs), followed by epidermal growth 
factor stimulation and analysis of Akt(Ser473) phosphorylation. Moreover, HUVECs 
were subjected to transduction using lentiviral vectors expressing wild type or two 
previously described ORP2 mutants, followed by the Akt(Ser473) quantification. 
Similar to HuH7 cells, depletion of OPR2 reduced the phosphorylation of Akt (-65%) 
in HUVECs (III, Figure 2E), and on the contrary, ORP2 overexpression increased the 
Akt phosphorylation by 18-fold (Supplemental Figure S1A). Importantly, similar to 
the TAG synthesis rescue in the ORP2-KO cells, both VAP- and PIP-binding 
deficient mutants were able to increase the Akt(Ser473) phosphorylation in HUVECs. 
The results imply that the role of ORP2 in the stimulation of Akt phosphorylation is 
not limited to immortalized cancer cells, and neither is the affinity of ORP2 for PIPs 
nor VAPs necessary for this function. 
 
The analysis of GSK-3β phosphorylation also provided a plausible explanation of the 
observed reduction of glycogenesis in the KO cells. Insulin/Akt signalling is 
designated as the main regulator of glycogenesis via GSK-3 phosphorylation at Ser9, 
which directly activates GYS. Impaired GSK-3 phosphorylation results in the 




5.4.3 ORP2 interacts with components of Rac1 and RhoA signalling pathways (II) 
 
As described previously, the ORP2-KO cells’ transcriptome analysis revealed 
dysregulation in dozens of components involved in the RhoA and the Rac1 signalling 
pathways. Consistently, analysis of the ORP2 interactome revealed 107 potential 
ORP2 protein interactions, of which the IPA analysis suggested ‘RhoA signalling’ as 
the most significant putative ORP2-associated pathway. The proteins identified in the 
ORP2 interactome and involved in RhoA signalling were Septin 9, ezrin, myosin light 
chain 12 (MLC12), Rho GTPase activating protein 12 (Arhgap12) and PI4Kα (II, 
Figure 4A). Furthermore, IQGAP1 of the Rac1 signalling was suggested as an 
interaction partner of ORP2 (II, Supplemental Figure S5). The interaction of ORP2 
with Septin 9, MLC12, Arhgap12 and IQGAP1 were validated by independent pull-
down or co-immunoprecipitation assays (II, Figure 4B,C; Supplemental Figure S5). 
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Septins are filament forming GTP-binding proteins, which are indicated as regulators 
of cytokinesis. Septin 9 localizes to the contractile ring of mitotic cells and disruption 
of septin 9 function is found to cause an arrest in cytokinesis (Chircop, 2014). 
Arhgap12 is a member of Rho GTPase activating proteins which negatively regulates 
the activity of Rho GTPases by promoting the hydrolysis of GTP and hence have an 
important role in cytoskeletal regulation (Moon and Zheng, 2003). Furthermore, 
myosins constitute a large family of actin binding proteins. MLC12 is one of 
regulatory light chains of the non-muscle myosins, the phosphorylation of which 
controls actin–myosin interaction and provides the contraction force for the cell. MLC 
phosphorylation is regulated by ROCK downs-stream of RhoA, and in non-muscle 
cells the acto-myosin bundles produce force for cell division through the contractile 
ring, and for cell migration in the form of stress fibers. Consistently, MLC12 knock 
down is shown to disrupt actin stress fiber formation (Park et al., 2011). Moreover, 
IQGAP1 is a protein scaffold down-stream of Rac1/Cdc42 and suggested as an 
important factor in the regulation of cadherin-mediated cell adhesions, cell 
polarization, lamellipodia formation and cell migration (Noritake et al., 2005; Owen 
et al., 2008). Interestingly, the scaffolding function of IQGAP1, which brings protein 
kinases in close proximity, was found to be important for regulation of Akt signalling. 
IQGAP1 was found to scaffold PI3K, PI4KIIIα and PIPKIα for efficient production of 
PI(3,4,5)P3 and secondly, to scaffold PDK1 and Akt to provide functional proximity 
for PI3K/Akt signalling activation (Choi et al., 2016). 
 
 
5.5 ORP2 and the actin cytoskeleton 
 
5.5.1 ORP2 impacts actin organization (II,III) 
 
IPA analysis of the  >500 gene transcripts with at least 2-fold expression changes in 
the ORP2-KO cells as compared to controls suggested a close link between the ORP2 
and a number of cellular functions involving actin cytoskeleton dynamics. Moreover, 
RhoA and Rac1 signalling, additionally connected to ORP2 by the identification of 
novel protein interactions, are important factors in the regulation of actin dynamics. 
To analyse the putative effects of ORP2 depletion on the actin organization, the KO 
cells were stimulated with insulin and the F-actin was visualized with fluorescent 
phalloidin. Interestingly, the fluorescence microscopy analysis showed that the cells 
lacking ORP2 had a significant defect in the formation of lamellipodia (II, Figure 2C). 
As HuH7 cells are not described as highly migrating cells, the fluorescence 
microscopy analysis was expanded to HUVECs. Consistent with the results in the 
ORP2-KO cells, the overexpression of ORP2 in HUVECs displayed a significant 
enhancement of lamellipodia formation compared to the controls (II, Supplemental 
Figure S4). The formation of lamellipodia requires active Rac1 (McCarty et al., 
2005), suggesting that ORP2 depletion interferes with Rac1 signalling. Presumably 
the dysregulated mRNAs of the Rac1 signalling components and/or the impeded 
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interaction of IQGAP1 with ORP2 results in unbalanced Rac1 signalling 
consequently disturbing lamellipodia formation in the ORP2 depleted cells. 
 
Moreover, the fluorescence microscopy analysis of F-actin showed a significant 
induction of cell surface blebs in the ORP2-KO cells, which were only seldom 
detectable in the control cells (II, Figure 2D). Knock down of ORP2 in the HUVECs 
resulted in the same phenotypic increment in bleb formation, suggesting that this 
ORP2 disruption phenotype is not limited to HuH7 cells. The bleb-based cell motility 
is associated with a high amount of active RhoA (Charras and Paluch, 2008). Some 
cells are found to switch to bleb-based motility under higher mechanical resistance of 
the substratum, which requires myosin II mediated actomyosin contractility (Ruprecht 
et al., 2015; Zatulovskiy et al., 2014), concomitant with increased RhoA activity. The 
interactome and transcriptome analyses strongly imply involvement of ORP2 in 
RhoA signalling, but further studies are required to confirm the putative enhancement 
in the RhoA signalling activity due to loss of ORP2. 
 
Moreover, the effect ORP2 overexpression to the F-actin organization in the KO cells 
was analysed accompanied with the VAP- or PIP-binding deficient mutants. 
Intriguingly, the overexpression of wild type ORP2 and the VAP-binding deficient 
mutant resulted in an enhancement in formation of filopodia-like cell surface 
protrusions (II, Figure 3A,B,D), suggesting increased actin polymerization. However, 
the F-actin of the KO cells transfected with the ORP2 mutant incapable of PIP-
binding did not differ from the untransfected KO cells (II, Figure 3C). This indicates 
that the ability of ORP2 to bind PIPs is important for its actin regulatory function. 
 
Further analysis of insulin stimulated HuH7 cells and HUVECs showed that GFP-
ORP2 localized in cortactin-positive lamellipodia, accompanied with phosphorylated 
Akt(Ser473) and Cdc37 (III, Fig 3A,B; Supplementary Figure S2). It is already 
previously suggested that PI3K and active Akt localize to the lamellipodia of 
migrating cells, and facilitate cell migration by inducing actin polymerization and 
actin reorganization into lamellipodia and filopodia (Qian et al., 2004; Ridley et al., 
2003; Xue and Hemmings, 2013). Furthermore, PI3K and Akt are found to activate 
Rac1 (Henderson et al., 2015; Scita et al., 2000). Hence, the suppression of PI3K/Akt 
signalling mediated by ORP2-KO is fully consistent with the dysregulation of 











5.5.2 ORP2-KO impairs cell adhesion and proliferation (II) 
 
The RNA sequencing and the IPA analysis uncovered, as a result of ORP2 depletion, 
dysregulation in 194 mRNAs encoding proteins involved in cell migration, 50 
mRNAs involved in cell adhesion and 223 mRNAs involved in cell proliferation 
processes, suggesting involvement of ORP2 protein in these cell physiological 
functions. 
 
The ORP2-KO effects on cell adhesion and proliferation were measured using the 
xCELLigence® Real-Time Cell Analysis system. During the 5 h measurement, cell 
adhesion to the substratum was decreased in ORP2-KO cells by 44–49% as compared 
to control (II, Figure 6B). Additionally, the slope of cell proliferation curve during the 
45 h measurement was reduced by 38–64% (II, Figure 6D). These results indicate that 
ORP2 is required for cell adhesion and proliferation, and the defects in these 
processes due to ORP2 depletion most likely result from disturbed expression of 
necessary genes and disrupted actin organization. Moreover, Septin9 is suggested to 
be important for cytokinesis and MLC phosphorylation in the contractile ring 
producing the force for the cell to divide, hence it is possible that ORP2 also 
participates in cell proliferation via its novel protein interactions. 
 
 
5.5.3 ORP2-KO mediated inhibition of cell migration (II) 
 
The migration of ORP2-KO cells was studied using a wound healing assay and 
xCELLigence® trans-filter migration application. Both analyses showed a significant 
defect in the migration of ORP2-KO cells as compared to ORP2 expressing control 
cells. The trans-filter migration analysis showed 65–77% reduction in the slopes of 
ORP2-KO cells’ migration curves (II, Figure 5E), and consistently, ORP2-KO cells’ 
wound closure was inhibited by 30–49% (II, Figure 5B). The impact of ORP2 on cell 
migration was further studied by overexpression analysis. Wild type ORP2 and 
mutants deficient in VAP- or PIP-binding were overexpressed in the ORP2-KO cells. 
Overexpression of the wild type ORP2 and the VAP-binding deficient mutant 
facilitated the wound closure by 74–130% compared to ORP2-KO cells, further 
supporting an important role for ORP2 in cell migration (II, Figure 5C). However, the 
ORP2 PIP-binding deficient mutant was unable to rescue the wound healing defect of 
the ORP2-KO cells (II, Figure 5C). This indicates an important role for ORP2 PIP 
liganding in the cell migration process, which is consistent with the observed defect 
of PIP-binding mutant to induce filopodia formation described above. Of note, it is 
possible that the phenotypic feature of ORP2-KO cells to grow as ‘islet-like’ cell 
clusters (described on page 53) is also a result of impaired migration of the cells, as 
one could postulate that the atypical clustering of cells upon culture is a consequence 
from proliferating cells’ inability to migrate apart after cell division. 
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The observed cell migration defect is consistent with the described defect of 
lamellipodia formation by the ORP2-KO cells, a process that is dependent on active 
Rac1. Altogether 194 mRNAs involved in cell migration and 16 mRNAs of Rac1 
signalling were found to be dysregulated in ORP2-KO cells, which possibly explains 
the defect in lamellipodia formation resulting in reduced cell locomotion. In addition, 
the inhibition of lamellipodia formation and cell migration can be a result of 
supressed PI3K/Akt signalling of the ORP2 KO cells. 
 
A number of studies connect PI3K/Akt signalling to the regulation of actin 
cytoskeleton organization and to cell migration. Both PI3K and Akt are found to 
induce actin filament reorganization and increase lamellipodia formation, as well as 
cell migration. On the contrary, drugs inhibiting PI3K and Akt are found to have the 
opposite effects. (Kim et al., 2001; Qian et al., 2004; Usatyuk et al., 2014; Zhao et al., 
2016) In fibroblasts the Akt mediated enhancement in cell motility is suggested occur 
via Rac/Cdc42 (Higuchi et al., 2001), and PI3K/Akt are suggested to activate Rac1 
(Henderson et al., 2015; Scita et al., 2000). Furthermore, Enomoto et al. (2005) 
showed that Akt phosphorylates an actin binding protein girdin, the phosphorylation 
of which increases migration of kidney epithelial cells. Furthermore, the study 
showed that Akt and phosphorylated girdin localizes to the lamellipodia of migrating 
cells, and in line, silencing of girdin disrupted the lamellipodia formation (Enomoto et 
al., 2005). Girdin also induces the migration of glioblastoma cells via PI3K/Akt (Gu 
et al., 2014; Ni et al., 2015). These studies indicate that the suppressed Akt signalling 
of ORP2-KO cells may be responsible for the inhibition of cell migration, and 
intriguingly, girdin was one of the putative ORP2 interaction partners identified in the 
interactome analysis. The interaction between ORP2 and girdin, however, is not yet 
confirmed. 
 
Hsp90 is also suggested to bind and crosslink actin filaments via the N-WASP and 
ARP2/3 complexes (Koyasu et al., 1986; Park et al., 2007), and Hsp90 is found to 
promote filopodia formation via N-WASP (Park et al., 2007). Furthermore, inhibition 
of Hsp90 is found to decrease actin polymerization and the formation of filopodia and 
lamellipodia, as well as to inhibit cell motility (Taiyab and Rao, 2011). Hence, it is 
possible that dysfunctional Rac1 signalling and supressed PI3K/Akt signalling 
together impair the lamellipodia formation and migration of the ORP2 depleted cells, 
which, on the other hand, can be a result of impeded ORP2 protein interactions. 
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6 SUMMARY AND CONCLUSIONS 
 
In my thesis, I examined the effects of ORPs’ high-affinity oxysterol ligands and 
modulation of the cellular cholesterol content on the intracellular localization and 
distribution of ORP–VAP-A BiFC complexes, to understand how the fluctuation in 
the intracellular sterol concentrations regulates the association of these complexes 
with distinct MCSs. In our investigations we did not observe alterations in the 
subcellular distributions of ORP1L–VAP-A or ORP9L–VAP-A upon sterol 
manipulations, suggesting that these complexes are not under the regulation of the 
cellular sterol content, or alternatively, these protein complexes are sensitive to 
regulation by sterol(s) not analysed in this study. 
 
The OSBP–VAP-A BiFC complexes were found to translocate to the trans-Golgi 
upon 25OHC loading or upon cellular cholesterol depletion, and the LDL treatment 
was found to have the opposite effect, resulting in a diffuse ER localization of OSBP–
VAP-A BiFC, consistent with earlier observations on the regulation of OSBP 
localization via sterols (Mesmin et al., 2013; Mesmin et al., 2017; Nhek et al., 2010; 
Ridgway et al., 1992; Storey et al., 1998). The effect of 25OHC on OSBP Golgi 
targeting was found to be dependent on the OSBP ligand-binding domain, suggesting 
that the ligand binding causes a conformational change in the OSBP that facilitates 
PI4P-targeting by the PH domain. In summary, our results provide strong evidence 
that the 25OHC or cholesterol depletion enhances the OSBP–VAP-A tethering at ER–
trans-Golgi MCSs. Importantly, Mesmin et al. (2013) indicated, that in the ER–Golgi 
interfaces, OSBP exchanges PI4P and cholesterol bi-directionally between these 
organelles. It is reasonable that upon low cellular cholesterol, enhanced de novo 
cholesterol synthesis at the ER promotes cholesterol transport to the trans-Golgi, but 
what could be the functional rationale of the effect of 25OHC on OSBP Golgi 
targeting? To continue, Mesmin et al. also indicated that the 25OHC binding inhibits 
the OSBP counter-transport activity, hence it is unlikely that the 25OHC mediated 
Golgi targeting of OSBP is important for the maintenance of the adequate Golgi 
cholesterol levels. It is possible, despite their similar impacts on OSBP Golgi 
targeting, that cholesterol depletion and 25OHC regulate distinct properties of OSBP. 
To support this, 25OHC was found to increase the association of CERT with trans-
Golgi via OSBP, required for the transport of ceramides from ER to the Golgi 
apparatus for SM synthesis (Banerji et al., 2010; Hanada et al., 2003; Perry and 
Ridgway, 2006). 
 
Similar to OSBP, ORP4L–VAP-A was found to be susceptible to regulation by 
25OHC or cellular cholesterol manipulations. In basal conditions the ORP4L–VAP-A 
complexes were found to localize to vimentin filaments and to the ER–PM MCSs, but 
the vimentin targeting was reduced upon all of the sterol treatments. The 25OHC 
treatment or the cellular cholesterol depletion were found to strengthen the ORP4L–
VAP-A association with the ER, and in turn, the LDL treatment caused enhanced PM 
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targeting of ORP4L–VAP-A. ORP4L is suggested to be important for cell 
proliferation, which is apparently independent of its property to localize to vimentin 
(Charman et al., 2014). Hence, it is possible that the PM localization of ORP4 is 
important for its function in the maintenance of cell proliferation, possibly for its 
involvement in signal transduction. 
 
Furthermore, we observed that the ORP2–VAP-A complexes exclusively localized to 
the interfaces of LDs and the ER, but the ER–LD targeting was severely 
compromised by the 22(R)OHC treatment, which caused the dispersal of the 
interaction along the ER network and also translocated ORP2–VAP-A complexes to 
ER–PM MCSs. The diverse localizations of ORP2 are consistent with our functional 
observations, that the cellular role of ORP2 is not limited to the TAG metabolism, but 
involves a wide spectrum of cell physiological functions the connections of which to 
LDs are unknown or even unlikely. 
 
The ubiquitous expression pattern of ORPs in eukaryotic tissues and their capacity to 
target MCSs of various different organelles in complex with VAPs provides an 
interesting hypothesis that these protein complexes could be important for the 
formation of new contacts. However, our investigations in the ORP2 knock out 
hepatocytes do not support a role for ORP2 in the formation of ER–LD MCSs, but it 
does not exclude that ORP2 could play a role in the inter-organelle communication at 
the ER–LD interfaces. This is not necessarily the case for all ORPs, since Mesmin et 
al. have indicated that OSBP does not only execute a lipid transfer function at the 
ER–Golgi interfaces but it is also involved in the formation of new contacts (Mesmin 
et al., 2013; Mesmin et al., 2017). 
 
In our analysis of the stable ORP2 knock out cells, we revealed new evidences of the 
metabolic functions of ORP2. We observed that the ORP2 depletion reduced the 
cellular TAG content and acute TAG synthesis, but the levels of membrane lipids and 
sterols remained unaffected, implicating a role of ORP2 in the maintenance of cellular 
energy reservoirs rather than in the homeostasis of membrane lipid compositions. 
This was further endorsed by the findings that the ORP2 depletion additionally 
reduced the uptake and the cellular processing of glucose, implicating a functional 
role of ORP2 in cellular anabolic processes. Importantly, our observations indicated 
that ORP2 depletion affects the TAG and glucose homeostasis by inhibiting the 
transcription of TAG and glucose metabolic enzymes as well as the transcription 
factor SREBP-1, and it also reduces the phosphorylation of GSK-3β – down-stream 
of PI3K/Akt signalling. 
 
The PI3K/Akt signalling route is an important regulator of cellular glucose and fatty 
acid metabolism, and intriguingly, we detected a novel connection of ORP2 with the 
PI3K/Akt signalling. We were able to show that ORP2 physically interacts with the 
Hsp90–Cdc37 chaperone complex, which promotes Akt phosphorylation and 
activation of the signalling cascade. Consistently, the ORP2 knock out resulted in 
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dysregulation of the mRNAs of various PI3K/Akt signalling components and reduced 
the activating phosphorylation of Akt at Ser473. 
 
Intriguingly, ORP2 was found to co-localize with phosphorylated Akt and Cdc37 at 
lamellipodia, and consistently, the formation of lamellipodia were severely 
compromised in the ORP2-KO cells, which also displayed a defect in migration. 
Furthermore, ORP2-KO was found to interact with components of the RhoA and the 
Rac1 signalling routes, and various mRNAs of the components of these signalling 
pathways were dysregulated as a result of ORP2-KO. In fact, the impaired 
lamellipodia formation and migration suggest compromised Rac1 signalling as a 
result of ORP2-KO, but most likely these phenotypic effects are also connected with 
the impaired Akt signalling. Various studies implicate to functional connections of 
PI3K and Akt with lamellipodia formation, cell migration or Rac1 regulation 
(Henderson et al., 2015; Kim et al., 2001; Qian et al., 2004; Ridley et al., 2003; Scita 
et al., 2000; Usatyuk et al., 2014; Xue and Hemmings, 2013; Zhao et al., 2016). On 
the other hand, ORP2 was also found to associate with the Rac1 effector IQGAP1, 
with an established role in the cell migration (Noritake et al., 2005), but which is also 
suggested to scaffold phosphoindositide kinases, PDK1 and Akt into functional 
proximity, by which it permits PI(3,4,5)P3 formation and Akt activation (Choi et al., 
2016). In relation to the previous, ORP2 is indicated to bind PI(3,4,5)P3 (Hynynen et 
al., 2005), and here we observed that the ORP2 mutant defective in PIP-binding was 
unable to rescue the ORP2 depletion effects on cell migration. This indicated that the 
PIP-binding property is important for the actin regulatory function of ORP2. For 
example, it is possible that due to its PI(3,4,5)P3 binding capacity, ORP2 is involved 
in the regulation of PI(3,4,5)P3 second messaging and consequently the abolishment 
of ORP2 results in disrupted down-stream signalling processes observed as actin-
based cell regulatory defects described here. The PIP-binding mutant of ORP2 was, 
despite this, able to increase the phosphorylation of Akt in HUVECs, suggesting that 
the mutation in the PIP-binding cleft may not prevent interaction of ORP2 with the 
Hsp90–Cdc37 chaperone complex. This hypothesis, however, requires future 
investigations. 
 
ORP2 depletion also interfered with the cell adhesion and proliferation, and 
furthermore, the KO cells displayed increased formation of cell surface blebs, which 
indicates an impaired association of F-actin with the plasma membrane (Charras et 
al., 2006). The increased blebbing implicates a high activity of RhoA (Aoki et al., 
2016; Charras and Paluch, 2008), and in addition to altered mRNA levels of RhoA 
signalling components, ORP2 was found to physically interact with several RhoA 
down-stream targets. Moreover, interaction of ORP2 with mDia1 is previously shown 
(Li et al., 2013). Together these observations suggests that via various protein 
interactions, ORP2 plays important roles in several cell signalling processes, and the 
abrogation of ORP2 results in severe defects in cell physiology, indicating that 
disturbed function of ORP2 may contribute to pathological conditions. In support of 
this notion, our bioinformatics analyses revealed a significant up-regulation in ORP2 
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Figure 5. A schematic model of novel ORP2 interaction partners and the putative role of ORP2 
interactions in different cellular processes. ORP2 was found to interact with Hsp90–Cdc37 complex, 
IQGAP1, Septin9, Arhgap12 and MYL12, molecular components of PI3K/Akt, Rac1 and RhoA 
signalling. ORP2 knock out was found to reduce the synthesis of glycogen and triglycerides, inhibit 
glucose uptake and glycolysis, and furthermore, impair lamellipodia formation, cell migration, 
adhesion and proliferation, suggesting a functional role of ORP2 in these cell physiological processes. 
 
Finally, the present observations of the novel connections of ORP2 with the actin 
cytoskeleton, and the previously reported causation of an autosomal dominant hearing 
loss as a result of a frameshift mutation in OSBPL2 encoding ORP2 (Thoenes et al., 
2015; Xing et al., 2015), strongly suggests that ORP2 plays an important role in the 
regulation of actin polymerization in hair cell stereocilia, which could depend on the 
observed interaction of ORP2 with mDia1 (Li et al., 2013), since mutations in 
DIAPH1 similarly result in an autosomal dominant non-syndromic hearing loss (Kang 
et al., 2017; Neuhaus et al., 2017; Stritt et al., 2016). 
 
To conclude, the present series of studies implicates a novel function of ORP2, which 
via PI3K/Akt signalling, acts as a regulatory link between cellular energy metabolism 
and cytoskeletal organization, and hence plays important roles in various cell 
physiological processes. Interestingly, a very recent study by Du et al. (2018) 
suggested that also ORP5 is involved in cell migration and proliferation, raising the 




The present series of studies was carried out during the years 2012–2018 at the 
Minerva Foundation Institute for Medical Research, which is thanked for providing 
excellent research facilities. The University of Helsinki Doctoral Programme in 
Biomedicine (DPBM) is thanked for the educational and financial support. 
 
I would warmly like to thank my supervisor Professor Vesa Olkkonen for giving me 
the opportunity to do my doctoral thesis in his research group and for giving me 
scientific guidance and support during these years. I appreciate how he always found 
time to help me through even the smallest problems encountered during the studies, 
and the freedom he gave me in designing and implementing my projects.  
 
I would like to express my appreciation to Docent Varpu Marjomäki for accepting the 
role of opponent, and Professor Matti Airaksinen for accepting the role of custos in 
the thesis dissertation. I would also like to thank my thesis reviewers Professor Neale 
Ridgway and Professor Pekka Lappalainen for giving me helpful comments on my 
thesis. The thesis committee members, Professor Elina Ikonen and Docent Honqxia 
Zhao, are thanked for giving me valuable advice and support during the meetings.  
 
I wish to acknowledge all the co-authors for their contribution and I am also equally 
grateful to all the people that I have worked with. Special gratitude belongs to Eeva 
Jääskeläinen, Liisa Arala and Riikka Kosonen for their great technical assistance. 
Without Eeva I wouldn’t have made it through, I have been very fortunate to be able 
to share this time with her. 
 
I am greatly indebted to my former colleague Docent You Zhou, whose help in my 
final two studies has been invaluable. Annika is thanked for her genuine interest 
towards my research and the great help she gave me which made it possible to finish 
my projects. For me it has been a great pleasure to work and spend time with her, I 
consider us to be a perfect team. Selina is thanked for her friendship and company 
both in and out of the lab. Nidhi is thanked for her support and advice for all these 
years. I feel very honoured how she has always believed in me and to my ability to 
conduct science. Raghu is thanked for his company in the meetings and for our 
countless laughs in the lab. I also want to thank the rest of the “Minerva girls”, Kata, 
Annukka, Enni, Johanna and Hanna, for our fun and loud nights out together. 
 
My deepest gratitude belongs to my beloved parents who have always supported me 
in all possible ways, and have made sure that I have the best possible premises to 
pursue my dreams. I also thank Mummi and Satu, and my siblings Samuel, Julkku 
and Rasse, and their families Aleksi, Maukka, Otava, Sanna-Maaret and Paavo. 
 
72
I also want to thank all my friends outside the lab, especially ‘the yam-yam cats’: 
Marikki, Hanni, Kari, Karo, Anna, Jesu, Emmi, Linda, Oona and Sanna for helping 
me to forget the work routines, their company gives so much joy, laughter, 
entertainment and compassion to my life. 
 
I would also like to thank the following organisations for their financial support of the 
work: the University of Helsinki Doctoral Programme in Biomedicine, the Finnish 
Concordia Fund, the Ida Montin Foundation sr, the Finnish-Norwegian Medical 
Foundation, the Aarne Koskelo Foundation, the Orion Research Foundation sr, the 
Päivikki and Sakari Sohlberg Foundation, the Aarne and Aili Turunen’s Foundation, 
the Eemil Aaltonen Foundation, The Niilo Helander Foundation, the Pulsus 
Foundation, the Finnish Atherosclerosis Society and the University of Helsinki 
Chancellors travel grant. 
 









Abercrombie, M., Heaysman, J. E. & Pegrum, S. M. 1972. Locomotion of fibroblasts 
in culture. V. Surface marking with concanavalin A. Experimental cell research 
73: 536-539.  
Abercrombie, M., Heaysman, J. E. & Pegrum, S. M. 1971. The locomotion of 
fibroblasts in culture. IV. Electron microscopy of the leading lamella. 
Experimental cell research 67: 359-367.  
Adeva-Andany, M. M., Gonzalez-Lucan, M., Donapetry-Garcia, C., Fernandez-
Fernandez, C. & Ameneiros-Rodriguez, E. 2016. Glycogen metabolism in 
humans. BBA clinical 5: 85-100.  
Agius, L. 2015. Role of glycogen phosphorylase in liver glycogen metabolism. 
Molecular aspects of medicine 46: 34-45.  
Agius, L. 2008. Glucokinase and molecular aspects of liver glycogen metabolism. The 
Biochemical journal 414: 1-18.  
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. 
B. & Cohen, P. 1997. Characterization of a 3-phosphoinositide-dependent protein 
kinase which phosphorylates and activates protein kinase Balpha. Current 
biology 7: 261-269.  
Alphey, L., Jimenez, J. & Glover, D. 1998. A Drosophila homologue of oxysterol 
binding protein (OSBP)--implications for the role of OSBP. Biochimica et 
biophysica acta 1395: 159-164.  
Alpy, F., Rousseau, A., Schwab, Y., Legueux, F., Stoll, I., Wendling, C., 
Spiegelhalter, C., Kessler, P., Mathelin, C., Rio, M. C., Levine, T. P. & 
Tomasetto, C. 2013. STARD3 or STARD3NL and VAP form a novel molecular 
tether between late endosomes and the ER. Journal of cell science 126: 5500-
5512.  
Alva, V. & Lupas, A. N. 2016. The TULIP superfamily of eukaryotic lipid-binding 
proteins as a mediator of lipid sensing and transport. Biochimica et biophysica 
acta 1861: 913-923.  
Anniss, A. M., Apostolopoulos, J., Dworkin, S., Purton, L. E. & Sparrow, R. L. 2002. 
An oxysterol-binding protein family identified in the mouse. DNA and cell 
biology 21: 571-580.  
Aoki, K., Maeda, F., Nagasako, T., Mochizuki, Y., Uchida, S. & Ikenouchi, J. 2016. 
A RhoA and Rnd3 cycle regulates actin reassembly during membrane blebbing. 
Proceedings of the National Academy of Sciences of the United States of America 
113: E1863-71.  
Azzout-Marniche, D., Becard, D., Guichard, C., Foretz, M., Ferre, P. & Foufelle, F. 
2000. Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) 
transcriptional activity in rat hepatocytes. The Biochemical journal 350: 389-393.  
Banerji, S., Ngo, M., Lane, C. F., Robinson, C. A., Minogue, S. & Ridgway, N. D. 
2010. Oxysterol binding protein-dependent activation of sphingomyelin synthesis 
74
in the golgi apparatus requires phosphatidylinositol 4-kinase IIalpha. Molecular 
biology of the cell 21: 4141-4150.  
Bannister, R. A. 2016. Bridging the myoplasmic gap II: more recent advances in 
skeletal muscle excitation-contraction coupling. The Journal of experimental 
biology 219: 175-182.  
Bannister, R. A. 2007. Bridging the myoplasmic gap: recent developments in skeletal 
muscle excitation-contraction coupling. Journal of muscle research and cell 
motility 28: 275-283.  
Barthel, A., Okino, S. T., Liao, J., Nakatani, K., Li, J., Whitlock, J. P.,Jr & Roth, R. 
A. 1999. Regulation of GLUT1 gene transcription by the serine/threonine kinase 
Akt1. The Journal of biological chemistry 274: 20281-20286.  
Barthel, A., Schmoll, D., Kruger, K. D., Bahrenberg, G., Walther, R., Roth, R. A. & 
Joost, H. G. 2001. Differential regulation of endogenous glucose-6-phosphatase 
and phosphoenolpyruvate carboxykinase gene expression by the forkhead 
transcription factor FKHR in H4IIE-hepatoma cells. Biochemical and biophysical 
research communications 285: 897-902.  
Basso, A. D., Solit, D. B., Chiosis, G., Giri, B., Tsichlis, P. & Rosen, N. 2002. Akt 
forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 
and is destabilized by inhibitors of Hsp90 function. The Journal of biological 
chemistry 277: 39858-39866.  
Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C. & Thompson, C. B. 2005. 
ATP citrate lyase is an important component of cell growth and transformation. 
Oncogene 24: 6314-6322.  
Beh, C. T., Cool, L., Phillips, J. & Rine, J. 2001. Overlapping functions of the yeast 
oxysterol-binding protein homologues. Genetics 157: 1117-1140.  
Bergert, M., Chandradoss, S. D., Desai, R. A. & Paluch, E. 2012. Cell mechanics 
control rapid transitions between blebs and lamellipodia during migration. 
Proceedings of the National Academy of Sciences of the United States of America 
109: 14434-14439.  
Berwick, D. C., Hers, I., Heesom, K. J., Moule, S. K. & Tavare, J. M. 2002. The 
identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in 
primary adipocytes. The Journal of biological chemistry 277: 33895-33900.  
Blake, W. L. & Clarke, S. D. 1990. Suppression of rat hepatic fatty acid synthase and 
S14 gene transcription by dietary polyunsaturated fat. The Journal of nutrition 
120: 1727-1729.  
Boureux, A., Vignal, E., Faure, S. & Fort, P. 2007. Evolution of the Rho family of 
ras-like GTPases in eukaryotes. Molecular biology and evolution 24: 203-216.  
Bray, D. & White, J. G. 1988. Cortical flow in animal cells. Science 239: 883-888.  
Briggs, M. W. & Sacks, D. B. 2003. IQGAP proteins are integral components of 
cytoskeletal regulation. EMBO reports 4: 571-574.  
Brouwers, M. C., Jacobs, C., Bast, A., Stehouwer, C. D. & Schaper, N. C. 2015. 
Modulation of Glucokinase Regulatory Protein: A Double-Edged Sword? Trends 
in molecular medicine 21: 583-594.  
75
Brown, M. S. & Goldstein, J. L. 1997. The SREBP pathway: regulation of cholesterol 
metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 
331-340.  
Burgardt, N. I., Gianotti, A. R., Ferreyra, R. G. & Ermacora, M. R. 2017. A structural 
appraisal of sterol carrier protein 2. Biochimica et biophysica acta 1865: 565-
577.  
Burgett, A. W., Poulsen, T. B., Wangkanont, K., Anderson, D. R., Kikuchi, C., 
Shimada, K., Okubo, S., Fortner, K. C., Mimaki, Y., Kuroda, M., Murphy, J. P., 
Schwalb, D. J., Petrella, E. C., Cornella-Taracido, I., Schirle, M., Tallarico, J. A. 
& Shair, M. D. 2011. Natural products reveal cancer cell dependence on 
oxysterol-binding proteins. Nature chemical biology 7: 639-647.  
Carlier, M. F., Laurent, V., Santolini, J., Melki, R., Didry, D., Xia, G. X., Hong, Y., 
Chua, N. H. & Pantaloni, D. 1997. Actin depolymerizing factor (ADF/cofilin) 
enhances the rate of filament turnover: implication in actin-based motility. The 
Journal of cell biology 136: 1307-1322.  
Carlier, M. F., Ressad, F. & Pantaloni, D. 1999. Control of actin dynamics in cell 
motility. Role of ADF/cofilin. The Journal of biological chemistry 274: 33827-
33830.  
Chang, C. L., Hsieh, T. S., Yang, T. T., Rothberg, K. G., Azizoglu, D. B., Volk, E., 
Liao, J. C. & Liou, J. 2013. Feedback regulation of receptor-induced Ca2+ 
signaling mediated by E-Syt1 and Nir2 at endoplasmic reticulum-plasma 
membrane junctions. Cell reports 5: 813-825.  
Chang, C. L. & Liou, J. 2015. Phosphatidylinositol 4,5-Bisphosphate Homeostasis 
Regulated by Nir2 and Nir3 Proteins at Endoplasmic Reticulum-Plasma 
Membrane Junctions. The Journal of biological chemistry 290: 14289-14301.  
Charman, M., Colbourne, T. R., Pietrangelo, A., Kreplak, L. & Ridgway, N. D. 2014. 
Oxysterol-binding protein (OSBP)-related protein 4 (ORP4) is essential for cell 
proliferation and survival. The Journal of biological chemistry 289: 15705-
15717.  
Charras, G. & Paluch, E. 2008. Blebs lead the way: how to migrate without 
lamellipodia. Nature reviews. Molecular cell biology 9: 730-736.  
Charras, G. T., Coughlin, M., Mitchison, T. J. & Mahadevan, L. 2008. Life and times 
of a cellular bleb. Biophysical journal 94: 1836-1853.  
Charras, G. T., Hu, C. K., Coughlin, M. & Mitchison, T. J. 2006. Reassembly of 
contractile actin cortex in cell blebs. The Journal of cell biology 175: 477-490.  
Charras, G. T., Yarrow, J. C., Horton, M. A., Mahadevan, L. & Mitchison, T. J. 2005. 
Non-equilibration of hydrostatic pressure in blebbing cells. Nature 435: 365-369.  
Chen, B., Chou, H. T., Brautigam, C. A., Xing, W., Yang, S., Henry, L., Doolittle, L. 
K., Walz, T. & Rosen, M. K. 2017. Rac1 GTPase activates the WAVE regulatory 
complex through two distinct binding sites. eLife 6: 10.7554/eLife.29795.  
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E. & Chan, D. C. 
2003. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and 
are essential for embryonic development. The Journal of cell biology 160: 189-
200.  
76
Chen, Z., Borek, D., Padrick, S. B., Gomez, T. S., Metlagel, Z., Ismail, A. M., 
Umetani, J., Billadeau, D. D., Otwinowski, Z. & Rosen, M. K. 2010. Structure 
and control of the actin regulatory WAVE complex. Nature 468: 533-538.  
Chircop, M. 2014. Rho GTPases as regulators of mitosis and cytokinesis in 
mammalian cells. Small GTPases 5: 10.4161/sgtp.29770.  
Choi, S., Hedman, A. C., Sayedyahossein, S., Thapa, N., Sacks, D. B. & Anderson, R. 
A. 2016. Agonist-stimulated phosphatidylinositol-3,4,5-trisphosphate generation 
by scaffolded phosphoinositide kinases. Nature cell biology 18: 1324-1335.  
Chu, B. B., Liao, Y. C., Qi, W., Xie, C., Du, X., Wang, J., Yang, H., Miao, H. H., Li, 
B. L. & Song, B. L. 2015. Cholesterol transport through lysosome-peroxisome 
membrane contacts. Cell 161: 291-306.  
Chung, J., Torta, F., Masai, K., Lucast, L., Czapla, H., Tanner, L. B., 
Narayanaswamy, P., Wenk, M. R., Nakatsu, F. & De Camilli, P. 2015. 
INTRACELLULAR TRANSPORT. PI4P/phosphatidylserine countertransport at 
ORP5- and ORP8-mediated ER-plasma membrane contacts. Science 349: 428-
432.  
Copeland, D. E. & Dalton, A. J. 1959. An association between mitochondria and the 
endoplasmic reticulum in cells of the pseudobranch gland of a teleost. The 
Journal of biophysical and biochemical cytology 5: 393-396.  
Cramer, L. P. & Mitchison, T. J. 1997. Investigation of the mechanism of retraction of 
the cell margin and rearward flow of nodules during mitotic cell rounding. 
Molecular biology of the cell 8: 109-119.  
Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. 1995. 
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. 
Nature 378: 785-789.  
Csordas, G., Varnai, P., Golenar, T., Roy, S., Purkins, G., Schneider, T. G., Balla, T. 
& Hajnoczky, G. 2010. Imaging interorganelle contacts and local calcium 
dynamics at the ER-mitochondrial interface. Molecular cell 39: 121-132.  
D'Angelo, G., Vicinanza, M. & De Matteis, M. A. 2008. Lipid-transfer proteins in 
biosynthetic pathways. Current opinion in cell biology 20: 360-370.  
Dao, V. T., Dupuy, A. G., Gavet, O., Caron, E. & de Gunzburg, J. 2009. Dynamic 
changes in Rap1 activity are required for cell retraction and spreading during 
mitosis. Journal of cell science 122: 2996-3004.  
Daum, G. & Vance, J. E. 1997. Import of lipids into mitochondria. Progress in lipid 
research 36: 103-130.  
Dawson, P. A., Ridgway, N. D., Slaughter, C. A., Brown, M. S. & Goldstein, J. L. 
1989. cDNA cloning and expression of oxysterol-binding protein, an oligomer 
with a potential leucine zipper. The Journal of biological chemistry 264: 16798-
16803.  
de Brito, O. M. & Scorrano, L. 2008. Mitofusin 2 tethers endoplasmic reticulum to 
mitochondria. Nature 456: 605-610.  
de Saint-Jean, M., Delfosse, V., Douguet, D., Chicanne, G., Payrastre, B., Bourguet, 
W., Antonny, B. & Drin, G. 2011. Osh4p exchanges sterols for 
77
phosphatidylinositol 4-phosphate between lipid bilayers. The Journal of cell 
biology 195: 965-978.  
De Stefani, D., Rizzuto, R. & Pozzan, T. 2016. Enjoy the Trip: Calcium in 
Mitochondria Back and Forth. Annual Review of Biochemistry 85: 161-192.  
De Vos, K. J., Morotz, G. M., Stoica, R., Tudor, E. L., Lau, K. F., Ackerley, S., 
Warley, A., Shaw, C. E. & Miller, C. C. 2012. VAPB interacts with the 
mitochondrial protein PTPIP51 to regulate calcium homeostasis. Human 
molecular genetics 21: 1299-1311.  
Denechaud, P. D., Bossard, P., Lobaccaro, J. M., Millatt, L., Staels, B., Girard, J. & 
Postic, C. 2008. ChREBP, but not LXRs, is required for the induction of glucose-
regulated genes in mouse liver. The Journal of clinical investigation 118: 956-
964.  
Dennis, E. A. & Kennedy, E. P. 1972. Intracellular sites of lipid synthesis and the 
biogenesis of mitochondria. Journal of lipid research 13: 263-267.  
Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R., Girard, 
J. & Postic, C. 2006. Liver-specific inhibition of ChREBP improves hepatic 
steatosis and insulin resistance in ob/ob mice. Diabetes 55: 2159-2170.  
Dentin, R., Girard, J. & Postic, C. 2005. Carbohydrate responsive element binding 
protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): 
two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 
87: 81-86.  
Dentin, R., Pegorier, J. P., Benhamed, F., Foufelle, F., Ferre, P., Fauveau, V., 
Magnuson, M. A., Girard, J. & Postic, C. 2004. Hepatic glucokinase is required 
for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic 
gene expression. The Journal of biological chemistry 279: 20314-20326.  
Dentin, R., Tomas-Cobos, L., Foufelle, F., Leopold, J., Girard, J., Postic, C. & Ferre, 
P. 2012. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for 
the activation of ChREBP in response to glucose in the liver. Journal of 
hepatology 56: 199-209.  
Denton, R. M. 2009. Regulation of mitochondrial dehydrogenases by calcium ions. 
Biochimica et biophysica acta 1787: 1309-1316.  
Deprez, J., Vertommen, D., Alessi, D. R., Hue, L. & Rider, M. H. 1997. 
Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein 
kinase B and other protein kinases of the insulin signaling cascades. The Journal 
of biological chemistry 272: 17269-17275.  
Dickson, E. J., Jensen, J. B., Vivas, O., Kruse, M., Traynor-Kaplan, A. E. & Hille, B. 
2016. Dynamic formation of ER-PM junctions presents a lipid phosphatase to 
regulate phosphoinositides. The Journal of cell biology 213: 33-48.  
Dimmer, K. S. & Rapaport, D. 2017. Mitochondrial contact sites as platforms for 
phospholipid exchange. Biochimica et biophysica acta 1862: 69-80.  
Disanza, A., Bisi, S., Winterhoff, M., Milanesi, F., Ushakov, D. S., Kast, D., 
Marighetti, P., Romet-Lemonne, G., Muller, H. M., Nickel, W., Linkner, J., 
Waterschoot, D., Ampe, C., Cortellino, S., Palamidessi, A., Dominguez, R., 
Carlier, M. F., Faix, J. & Scita, G. 2013. CDC42 switches IRSp53 from inhibition 
78
of actin growth to elongation by clustering of VASP. The EMBO journal 32: 
2735-2750.  
Donkor, J., Sariahmetoglu, M., Dewald, J., Brindley, D. N. & Reue, K. 2007. Three 
mammalian lipins act as phosphatidate phosphatases with distinct tissue 
expression patterns. The Journal of biological chemistry 282: 3450-3457.  
Du, X., Kumar, J., Ferguson, C., Schulz, T. A., Ong, Y. S., Hong, W., Prinz, W. A., 
Parton, R. G., Brown, A. J. & Yang, H. 2011. A role for oxysterol-binding 
protein-related protein 5 in endosomal cholesterol trafficking. The Journal of cell 
biology 192: 121-135.  
Du, X., Pham, Y. H. & Brown, A. J. 2004. Effects of 25-hydroxycholesterol on 
cholesterol esterification and sterol regulatory element-binding protein 
processing are dissociable: implications for cholesterol movement to the 
regulatory pool in the endoplasmic reticulum. The Journal of biological 
chemistry 279: 47010-47016.  
Du, X., Zadoorian, A., Lukmantara, I. E., Qi, Y., Brown, A. J. & Yang, H. 2018. 
Oxysterol-binding protein-related protein 5 (ORP5) promotes cell proliferation 
by activation of mTORC1 signaling. The Journal of biological chemistry 293: 
3806-3818 
Eden, E. R., Sanchez-Heras, E., Tsapara, A., Sobota, A., Levine, T. P. & Futter, C. E. 
2016. Annexin A1 Tethers Membrane Contact Sites that Mediate ER to 
Endosome Cholesterol Transport. Developmental cell 37: 473-483.  
Emoto, K., Kuge, O., Nishijima, M. & Umeda, M. 1999. Isolation of a Chinese 
hamster ovary cell mutant defective in intramitochondrial transport of 
phosphatidylserine. Proceedings of the National Academy of Sciences of the 
United States of America 96: 12400-12405.  
Enomoto, A., Murakami, H., Asai, N., Morone, N., Watanabe, T., Kawai, K., 
Murakumo, Y., Usukura, J., Kaibuchi, K. & Takahashi, M. 2005. Akt/PKB 
regulates actin organization and cell motility via Girdin/APE. Developmental cell 
9: 389-402.  
Escajadillo, T., Wang, H., Li, L., Li, D. & Sewer, M. B. 2016. Oxysterol-related-
binding-protein related Protein-2 (ORP2) regulates cortisol biosynthesis and 
cholesterol homeostasis. Molecular and cellular endocrinology 427: 73-85.  
Fairn, G. D. & McMaster, C. R. 2005a. Identification and assessment of the role of a 
nominal phospholipid binding region of ORP1S (oxysterol-binding-protein-
related protein 1 short) in the regulation of vesicular transport. The Biochemical 
journal 387: 889-896.  
Fairn, G. D. & McMaster, C. R. 2005b. The roles of the human lipid-binding proteins 
ORP9S and ORP10S in vesicular transport. Biochemistry and cell biology = 
Biochimie et biologie cellulaire 83: 631-636.  
Fehon, R. G., McClatchey, A. I. & Bretscher, A. 2010. Organizing the cell cortex: the 
role of ERM proteins. Nature reviews. Molecular cell biology 11: 276-287.  
Fleischmann, M. & Iynedjian, P. B. 2000. Regulation of sterol regulatory-element 
binding protein 1 gene expression in liver: role of insulin and protein kinase 
B/cAkt. The Biochemical journal 349: 13-17.  
79
Flis, V. V. & Daum, G. 2013. Lipid transport between the endoplasmic reticulum and 
mitochondria. Cold Spring Harbor perspectives in biology 5: 
10.1101/cshperspect.a013235.  
Follo, M. Y., Manzoli, L., Poli, A., McCubrey, J. A. & Cocco, L. 2015. PLC and 
PI3K/Akt/mTOR signalling in disease and cancer. Advances in biological 
regulation 57: 10-16.  
Foretz, M., Guichard, C., Ferre, P. & Foufelle, F. 1999a. Sterol regulatory element 
binding protein-1c is a major mediator of insulin action on the hepatic expression 
of glucokinase and lipogenesis-related genes. Proceedings of the National 
Academy of Sciences of the United States of America 96: 12737-12742.  
Foretz, M., Pacot, C., Dugail, I., Lemarchand, P., Guichard, C., Le Liepvre, X., 
Berthelier-Lubrano, C., Spiegelman, B., Kim, J. B., Ferre, P. & Foufelle, F. 
1999b. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene 
expression by glucose. Molecular and cellular biology 19: 3760-3768.  
Foufelle, F. & Ferre, P. 2002. New perspectives in the regulation of hepatic glycolytic 
and lipogenic genes by insulin and glucose: a role for the transcription factor 
sterol regulatory element binding protein-1c. The Biochemical journal 366: 377-
391.  
Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., 
Kaplan, D. R. & Tsichlis, P. N. 1995. The protein kinase encoded by the Akt 
proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. 
Cell 81: 727-736.  
Franzini-Armstrong, C., Pincon-Raymond, M. & Rieger, F. 1991. Muscle fibers from 
dysgenic mouse in vivo lack a surface component of peripheral couplings. 
Developmental biology 146: 364-376.  
Friedman, J. R., Dibenedetto, J. R., West, M., Rowland, A. A. & Voeltz, G. K. 2013. 
Endoplasmic reticulum-endosome contact increases as endosomes traffic and 
mature. Molecular biology of the cell 24: 1030-1040.  
Friedman, J. R., Lackner, L. L., West, M., DiBenedetto, J. R., Nunnari, J. & Voeltz, 
G. K. 2011. ER tubules mark sites of mitochondrial division. Science 334: 358-
362.  
Galmes, R., Houcine, A., van Vliet, A. R., Agostinis, P., Jackson, C. L. & Giordano, 
F. 2016. ORP5/ORP8 localize to endoplasmic reticulum-mitochondria contacts 
and are involved in mitochondrial function. EMBO reports 17: 800-810.  
Garbino, A., van Oort, R. J., Dixit, S. S., Landstrom, A. P., Ackerman, M. J. & 
Wehrens, X. H. 2009. Molecular evolution of the junctophilin gene family. 
Physiological genomics 37: 175-186.  
Geneste, O., Copeland, J. W. & Treisman, R. 2002. LIM kinase and Diaphanous 
cooperate to regulate serum response factor and actin dynamics. The Journal of 
cell biology 157: 831-838.  
Ghai, R., Du, X., Wang, H., Dong, J., Ferguson, C., Brown, A. J., Parton, R. G., Wu, 
J. W. & Yang, H. 2017. ORP5 and ORP8 bind phosphatidylinositol-4, 5-
biphosphate (PtdIns(4,5)P 2) and regulate its level at the plasma membrane. 
Nature communications 8: 757-017-00861-5.  
80
Giordano, F., Saheki, Y., Idevall-Hagren, O., Colombo, S. F., Pirruccello, M., 
Milosevic, I., Gracheva, E. O., Bagriantsev, S. N., Borgese, N. & De Camilli, P. 
2013. PI(4,5)P(2)-dependent and Ca(2+)-regulated ER-PM interactions mediated 
by the extended synaptotagmins. Cell 153: 1494-1509.  
Godi, A., Di Campli, A., Konstantakopoulos, A., Di Tullio, G., Alessi, D. R., Kular, 
G. S., Daniele, T., Marra, P., Lucocq, J. M. & De Matteis, M. A. 2004. FAPPs 
control Golgi-to-cell-surface membrane traffic by binding to ARF and 
PtdIns(4)P. Nature cell biology 6: 393-404.  
Goldschmidt-Clermont, P. J., Machesky, L. M., Doberstein, S. K. & Pollard, T. D. 
1991. Mechanism of the interaction of human platelet profilin with actin. The 
Journal of cell biology 113: 1081-1089.  
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B. & Hay, N. 2001. 
Inhibition of early apoptotic events by Akt/PKB is dependent on the first 
committed step of glycolysis and mitochondrial hexokinase. Genes & 
development 15: 1406-1418.  
Gropler, M. C., Harris, T. E., Hall, A. M., Wolins, N. E., Gross, R. W., Han, X., 
Chen, Z. & Finck, B. N. 2009. Lipin 2 is a liver-enriched phosphatidate 
phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in 
mice. The Journal of biological chemistry 284: 6763-6772.  
Gu, F., Wang, L., He, J., Liu, X., Zhang, H., Li, W., Fu, L. & Ma, Y. 2014. Girdin, an 
actin-binding protein, is critical for migration, adhesion, and invasion of human 
glioblastoma cells. Journal of neurochemistry 131: 457-469.  
Gupton, S. L. & Gertler, F. B. 2007. Filopodia: the fingers that do the walking. 
Science's STKE : signal transduction knowledge environment 2007: re5.  
Hall, A. 1994. Small GTP-binding proteins and the regulation of the actin 
cytoskeleton. Annual Review of Cell Biology 10: 31-54.  
Hamasaki, M., Furuta, N., Matsuda, A., Nezu, A., Yamamoto, A., Fujita, N., Oomori, 
H., Noda, T., Haraguchi, T., Hiraoka, Y., Amano, A. & Yoshimori, T. 2013. 
Autophagosomes form at ER-mitochondria contact sites. Nature 495: 389-393.  
Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M. & 
Nishijima, M. 2003. Molecular machinery for non-vesicular trafficking of 
ceramide. Nature 426: 803-809.  
Hanukoglu, I. 1992. Steroidogenic enzymes: structure, function, and role in regulation 
of steroid hormone biosynthesis. The Journal of steroid biochemistry and 
molecular biology 43: 779-804.  
Hao, J. J., Liu, Y., Kruhlak, M., Debell, K. E., Rellahan, B. L. & Shaw, S. 2009. 
Phospholipase C-mediated hydrolysis of PIP2 releases ERM proteins from 
lymphocyte membrane. The Journal of cell biology 184: 451-462.  
Harner, M., Korner, C., Walther, D., Mokranjac, D., Kaesmacher, J., Welsch, U., 
Griffith, J., Mann, M., Reggiori, F. & Neupert, W. 2011. The mitochondrial 
contact site complex, a determinant of mitochondrial architecture. The EMBO 
journal 30: 4356-4370.  
81
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K. & Puigserver, P. 2018. 
Insulin regulation of gluconeogenesis. Annals of the New York Academy of 
Sciences 1411: 21-35 
Helle, S. C., Kanfer, G., Kolar, K., Lang, A., Michel, A. H. & Kornmann, B. 2013. 
Organization and function of membrane contact sites. Biochimica et biophysica 
acta 1833: 2526-2541.  
Henderson, V., Smith, B., Burton, L. J., Randle, D., Morris, M. & Odero-Marah, V. 
A. 2015. Snail promotes cell migration through PI3K/AKT-dependent Rac1 
activation as well as PI3K/AKT-independent pathways during prostate cancer 
progression. Cell adhesion & migration 9: 255-264.  
Higgs, H. N. & Pollard, T. D. 1999. Regulation of actin polymerization by Arp2/3 
complex and WASp/Scar proteins. The Journal of biological chemistry 274: 
32531-32534.  
Higuchi, M., Masuyama, N., Fukui, Y., Suzuki, A. & Gotoh, Y. 2001. Akt mediates 
Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in 
invasive PTEN knockout cells. Current biology 11: 1958-1962.  
Hirata, Y., Brotto, M., Weisleder, N., Chu, Y., Lin, P., Zhao, X., Thornton, A., 
Komazaki, S., Takeshima, H., Ma, J. & Pan, Z. 2006. Uncoupling store-operated 
Ca2+ entry and altered Ca2+ release from sarcoplasmic reticulum through 
silencing of junctophilin genes. Biophysical journal 90: 4418-4427.  
Horie, T., Nishino, T., Baba, O., Kuwabara, Y., Nakao, T., Nishiga, M., Usami, S., 
Izuhara, M., Sowa, N., Yahagi, N., Shimano, H., Matsumura, S., Inoue, K., 
Marusawa, H., Nakamura, T., Hasegawa, K., Kume, N., Yokode, M., Kita, T., 
Kimura, T. & Ono, K. 2013. MicroRNA-33 regulates sterol regulatory element-
binding protein 1 expression in mice. Nature communications 4: 2883.  
Horton, J. D. 2002. Sterol regulatory element-binding proteins: transcriptional 
activators of lipid synthesis. Biochemical Society transactions 30: 1091-1095.  
Hsuan, J. & Cockcroft, S. 2001. The PITP family of phosphatidylinositol transfer 
proteins. Genome biology 2: REVIEWS3011.  
Hynynen, R., Laitinen, S., Kakela, R., Tanhuanpaa, K., Lusa, S., Ehnholm, C., 
Somerharju, P., Ikonen, E. & Olkkonen, V. M. 2005. Overexpression of OSBP-
related protein 2 (ORP2) induces changes in cellular cholesterol metabolism and 
enhances endocytosis. The Biochemical journal 390: 273-283.  
Hynynen, R., Suchanek, M., Spandl, J., Back, N., Thiele, C. & Olkkonen, V. M. 
2009. OSBP-related protein 2 is a sterol receptor on lipid droplets that regulates 
the metabolism of neutral lipids. Journal of lipid research 50: 1305-1315.  
Ichetovkin, I., Han, J., Pang, K. M., Knecht, D. A. & Condeelis, J. S. 2000. Actin 
filaments are severed by both native and recombinant dictyostelium cofilin but to 
different extents. Cell motility and the cytoskeleton 45: 293-306.  
Idevall-Hagren, O., Lu, A., Xie, B. & De Camilli, P. 2015. Triggered Ca2+ influx is 
required for extended synaptotagmin 1-induced ER-plasma membrane tethering. 
The EMBO journal 34: 2291-2305.  
Iizuka, K., Bruick, R. K., Liang, G., Horton, J. D. & Uyeda, K. 2004. Deficiency of 
carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as 
82
well as glycolysis. Proceedings of the National Academy of Sciences of the 
United States of America 101: 7281-7286.  
Ikemoto, T., Komazaki, S., Takeshima, H., Nishi, M., Noda, T., Iino, M. & Endo, M. 
1997. Functional and morphological features of skeletal muscle from mutant 
mice lacking both type 1 and type 3 ryanodine receptors. The Journal of 
physiology 501: 305-312.  
Im, Y. J., Raychaudhuri, S., Prinz, W. A. & Hurley, J. H. 2005. Structural mechanism 
for sterol sensing and transport by OSBP-related proteins. Nature 437: 154-158.  
Infante, R. E., Wang, M. L., Radhakrishnan, A., Kwon, H. J., Brown, M. S. & 
Goldstein, J. L. 2008. NPC2 facilitates bidirectional transfer of cholesterol 
between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. 
Proceedings of the National Academy of Sciences of the United States of America 
105: 15287-15292.  
Ishii, S., Iizuka, K., Miller, B. C. & Uyeda, K. 2004. Carbohydrate response element 
binding protein directly promotes lipogenic enzyme gene transcription. 
Proceedings of the National Academy of Sciences of the United States of America 
101: 15597-15602.  
Ishimoto, K., Nakamura, H., Tachibana, K., Yamasaki, D., Ota, A., Hirano, K., 
Tanaka, T., Hamakubo, T., Sakai, J., Kodama, T. & Doi, T. 2009. Sterol-
mediated regulation of human lipin 1 gene expression in hepatoblastoma cells. 
The Journal of biological chemistry 284: 22195-22205.  
Ismail, A. M., Padrick, S. B., Chen, B., Umetani, J. & Rosen, M. K. 2009. The 
WAVE regulatory complex is inhibited. Nature structural & molecular biology 
16: 561-563.  
Ito, K., Komazaki, S., Sasamoto, K., Yoshida, M., Nishi, M., Kitamura, K. & 
Takeshima, H. 2001. Deficiency of triad junction and contraction in mutant 
skeletal muscle lacking junctophilin type 1. The Journal of cell biology 154: 
1059-1067.  
Jagerstrom, S., Polesie, S., Wickstrom, Y., Johansson, B. R., Schroder, H. D., 
Hojlund, K. & Bostrom, P. 2009. Lipid droplets interact with mitochondria using 
SNAP23. Cell biology international 33: 934-940.  
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R. & Mangelsdorf, D. J. 1996. An 
oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. 
Nature 383: 728-731.  
Jansen, M., Ohsaki, Y., Rita Rega, L., Bittman, R., Olkkonen, V. M. & Ikonen, E. 
2011. Role of ORPs in sterol transport from plasma membrane to ER and lipid 
droplets in mammalian cells. Traffic 12: 218-231.  
Jaworski, C. J., Moreira, E., Li, A., Lee, R. & Rodriguez, I. R. 2001. A family of 12 
human genes containing oxysterol-binding domains. Genomics 78: 185-196.  
Jensen-Urstad, A. P. & Semenkovich, C. F. 2012. Fatty acid synthase and liver 
triglyceride metabolism: housekeeper or messenger? Biochimica et biophysica 
acta 1821: 747-753.  
83
Jha, S. K., Jha, N. K., Kar, R., Ambasta, R. K. & Kumar, P. 2015. p38 MAPK and 
PI3K/AKT Signalling Cascades inParkinson's Disease. International journal of 
molecular and cellular medicine 4: 67-86.  
Johansson, M., Lehto, M., Tanhuanpaa, K., Cover, T. L. & Olkkonen, V. M. 2005. 
The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters 
functional properties of late endocytic compartments. Molecular biology of the 
cell 16: 5480-5492.  
Johansson, M., Rocha, N., Zwart, W., Jordens, I., Janssen, L., Kuijl, C., Olkkonen, V. 
M. & Neefjes, J. 2007. Activation of endosomal dynein motors by stepwise 
assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor betalll spectrin. 
The Journal of cell biology 176: 459-471.  
Jousset, H., Frieden, M. & Demaurex, N. 2007. STIM1 knockdown reveals that store-
operated Ca2+ channels located close to sarco/endoplasmic Ca2+ ATPases 
(SERCA) pumps silently refill the endoplasmic reticulum. The Journal of 
biological chemistry 282: 11456-11464.  
Jurica, M. S., Mesecar, A., Heath, P. J., Shi, W., Nowak, T. & Stoddard, B. L. 1998. 
The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. 
Structure 6: 195-210.  
Kaiser, S. E., Brickner, J. H., Reilein, A. R., Fenn, T. D., Walter, P. & Brunger, A. T. 
2005. Structural basis of FFAT motif-mediated ER targeting. Structure 13: 1035-
1045.  
Kandutsch, A. A. & Chen, H. W. 1975. Regulation of sterol synthesis in cultured cells 
by oxygenated derivatives of cholesterol. Journal of cellular physiology 85: 415-
424.  
Kandutsch, A. A., Chen, H. W. & Shown, E. P. 1977. Binding of 25-
hydroxycholesterol and cholesterol to different cytoplasmic proteins. 
Proceedings of the National Academy of Sciences of the United States of America 
74: 2500-2503.  
Kandutsch, A. A. & Thompson, E. B. 1980. Cytosolic proteins that bind oxygenated 
sterols. Cellular distribution, specificity, and some properties. The Journal of 
biological chemistry 255: 10813-10821.  
Kang, T. H., Baek, J. I., Sagong, B., Park, H. J., Park, C. I., Lee, K. Y. & Kim, U. K. 
2017. A novel missense variant in the DIAPH1 gene in a Korean family with 
autosomal dominant nonsyndromic hearing loss. Genes & genetic systems 91: 
289-292.  
Karim, S., Adams, D. H. & Lalor, P. F. 2012. Hepatic expression and cellular 
distribution of the glucose transporter family. World journal of gastroenterology 
18: 6771-6781.  
Kawaguchi, T., Takenoshita, M., Kabashima, T. & Uyeda, K. 2001. Glucose and 
cAMP regulate the L-type pyruvate kinase gene by 
phosphorylation/dephosphorylation of the carbohydrate response element binding 
protein. Proceedings of the National Academy of Sciences of the United States of 
America 98: 13710-13715.  
84
Kawakami, Y., Nishimoto, H., Kitaura, J., Maeda-Yamamoto, M., Kato, R. M., 
Littman, D. R., Leitges, M., Rawlings, D. J. & Kawakami, T. 2004. Protein 
kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and 
stimulus-specific fashion. The Journal of biological chemistry 279: 47720-47725.  
Kerppola, T. K. 2008. Bimolecular fluorescence complementation (BiFC) analysis as 
a probe of protein interactions in living cells. Annual review of biophysics 37: 
465-487.  
Kersten, S. 2014. Integrated physiology and systems biology of PPARalpha. 
Molecular metabolism 3: 354-371.  
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B. & Wahli, W. 
1999. Peroxisome proliferator-activated receptor alpha mediates the adaptive 
response to fasting. The Journal of clinical investigation 103: 1489-1498.  
Kim, D., Kim, S., Koh, H., Yoon, S. O., Chung, A. S., Cho, K. S. & Chung, J. 2001. 
Akt/PKB promotes cancer cell invasion via increased motility and 
metalloproteinase production. FASEB journal : official publication of the 
Federation of American Societies for Experimental Biology 15: 1953-1962.  
Kim, J. B., Sarraf, P., Wright, M., Yao, K. M., Mueller, E., Solanes, G., Lowell, B. B. 
& Spiegelman, B. M. 1998. Nutritional and insulin regulation of fatty acid 
synthetase and leptin gene expression through ADD1/SREBP1. The Journal of 
clinical investigation 101: 1-9.  
Kim, S. Y., Kim, H. I., Kim, T. H., Im, S. S., Park, S. K., Lee, I. K., Kim, K. S. & 
Ahn, Y. H. 2004. SREBP-1c mediates the insulin-dependent hepatic glucokinase 
expression. The Journal of biological chemistry 279: 30823-30829.  
Kim, Y. J., Guzman-Hernandez, M. L., Wisniewski, E. & Balla, T. 2015. 
Phosphatidylinositol-Phosphatidic Acid Exchange by Nir2 at ER-PM Contact 
Sites Maintains Phosphoinositide Signaling Competence. Developmental cell 33: 
549-561.  
Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, 
B., Feng, J., Nakano, T., Okawa, K., Iwamatsu, A. & Kaibuchi, K. 1996. 
Regulation of myosin phosphatase by Rho and Rho-associated kinase. Science  
273: 245-248.  
Kodama, Y. & Hu, C. D. 2012. Bimolecular fluorescence complementation (BiFC): a 
5-year update and future perspectives. BioTechniques 53: 285-298.  
Kohn, A. D., Summers, S. A., Birnbaum, M. J. & Roth, R. A. 1996. Expression of a 
constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose 
uptake and glucose transporter 4 translocation. The Journal of biological 
chemistry 271: 31372-31378.  
Koldamova, R. P., Lefterov, I. M., Ikonomovic, M. D., Skoko, J., Lefterov, P. I., 
Isanski, B. A., DeKosky, S. T. & Lazo, J. S. 2003. 22R-hydroxycholesterol and 
9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and 
cholesterol efflux in brain cells and decrease amyloid beta secretion. The Journal 
of biological chemistry 278: 13244-13256.  
85
Kornmann, B., Currie, E., Collins, S. R., Schuldiner, M., Nunnari, J., Weissman, J. S. 
& Walter, P. 2009. An ER-mitochondria tethering complex revealed by a 
synthetic biology screen. Science 325: 477-481.  
Korzeniowski, M. K., Popovic, M. A., Szentpetery, Z., Varnai, P., Stojilkovic, S. S. & 
Balla, T. 2009. Dependence of STIM1/Orai1-mediated calcium entry on plasma 
membrane phosphoinositides. The Journal of biological chemistry 284: 21027-
21035.  
Koyasu, S., Nishida, E., Kadowaki, T., Matsuzaki, F., Iida, K., Harada, F., Kasuga, 
M., Sakai, H. & Yahara, I. 1986. Two mammalian heat shock proteins, HSP90 
and HSP100, are actin-binding proteins. Proceedings of the National Academy of 
Sciences of the United States of America 83: 8054-8058.  
Kwon, H. J., Abi-Mosleh, L., Wang, M. L., Deisenhofer, J., Goldstein, J. L., Brown, 
M. S. & Infante, R. E. 2009. Structure of N-terminal domain of NPC1 reveals 
distinct subdomains for binding and transfer of cholesterol. Cell 137: 1213-1224.  
Lacalle, R. A., Peregil, R. M., Albar, J. P., Merino, E., Martinez-A, C., Merida, I. & 
Manes, S. 2007. Type I phosphatidylinositol 4-phosphate 5-kinase controls 
neutrophil polarity and directional movement. The Journal of cell biology 179: 
1539-1553.  
Lagace, T. A., Byers, D. M., Cook, H. W. & Ridgway, N. D. 1997. Altered regulation 
of cholesterol and cholesteryl ester synthesis in Chinese-hamster ovary cells 
overexpressing the oxysterol-binding protein is dependent on the pleckstrin 
homology domain. The Biochemical journal 326: 205-213.  
Laitinen, S., Lehto, M., Lehtonen, S., Hyvarinen, K., Heino, S., Lehtonen, E., 
Ehnholm, C., Ikonen, E. & Olkkonen, V. M. 2002. ORP2, a homolog of 
oxysterol binding protein, regulates cellular cholesterol metabolism. Journal of 
lipid research 43: 245-255.  
Laitinen, S., Olkkonen, V. M., Ehnholm, C. & Ikonen, E. 1999. Family of human 
oxysterol binding protein (OSBP) homologues. A novel member implicated in 
brain sterol metabolism. Journal of lipid research 40: 2204-2211.  
Landschulz, K. T., Jump, D. B., MacDougald, O. A. & Lane, M. D. 1994. 
Transcriptional control of the stearoyl-CoA desaturase-1 gene by polyunsaturated 
fatty acids. Biochemical and biophysical research communications 200: 763-768.  
Lange, Y., Ye, J., Rigney, M. & Steck, T. L. 1999. Regulation of endoplasmic 
reticulum cholesterol by plasma membrane cholesterol. Journal of lipid research 
40: 2264-2270.  
Lappalainen, P., Kessels, M. M., Cope, M. J. & Drubin, D. G. 1998. The ADF 
homology (ADF-H) domain: a highly exploited actin-binding module. Molecular 
biology of the cell 9: 1951-1959.  
Lauffenburger, D. A. & Horwitz, A. F. 1996. Cell migration: a physically integrated 
molecular process. Cell 84: 359-369.  
Le Clainche, C., Schlaepfer, D., Ferrari, A., Klingauf, M., Grohmanova, K., 
Veligodskiy, A., Didry, D., Le, D., Egile, C., Carlier, M. F. & Kroschewski, R. 
2007. IQGAP1 stimulates actin assembly through the N-WASP-Arp2/3 pathway. 
The Journal of biological chemistry 282: 426-435.  
86
Lee, K. & Song, K. 2007. Actin dysfunction activates ERK1/2 and delays entry into 
mitosis in mammalian cells. Cell cycle 6: 1487-1495.  
Lee, S. H. & Dominguez, R. 2010. Regulation of actin cytoskeleton dynamics in cells. 
Molecules and cells 29: 311-325.  
Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, 
J. L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A. & 
Willson, T. M. 1997. Activation of the nuclear receptor LXR by oxysterols 
defines a new hormone response pathway. The Journal of biological chemistry 
272: 3137-3140.  
Lehto, M., Hynynen, R., Karjalainen, K., Kuismanen, E., Hyvarinen, K. & Olkkonen, 
V. M. 2005. Targeting of OSBP-related protein 3 (ORP3) to endoplasmic 
reticulum and plasma membrane is controlled by multiple determinants. 
Experimental cell research 310: 445-462.  
Lehto, M., Laitinen, S., Chinetti, G., Johansson, M., Ehnholm, C., Staels, B., Ikonen, 
E. & Olkkonen, V. M. 2001. The OSBP-related protein family in humans. 
Journal of lipid research 42: 1203-1213.  
Lehto, M., Mayranpaa, M. I., Pellinen, T., Ihalmo, P., Lehtonen, S., Kovanen, P. T., 
Groop, P. H., Ivaska, J. & Olkkonen, V. M. 2008. The R-Ras interaction partner 
ORP3 regulates cell adhesion. Journal of cell science 121: 695-705.  
Lessmann, E., Ngo, M., Leitges, M., Minguet, S., Ridgway, N. D. & Huber, M. 2007. 
Oxysterol-binding protein-related protein (ORP) 9 is a PDK-2 substrate and 
regulates Akt phosphorylation. Cellular signalling 19: 384-392.  
Lev, S. 2010. Non-vesicular lipid transport by lipid-transfer proteins and beyond. 
Nature reviews. Molecular cell biology 11: 739-750.  
Levanon, D., Hsieh, C. L., Francke, U., Dawson, P. A., Ridgway, N. D., Brown, M. S. 
& Goldstein, J. L. 1990. cDNA cloning of human oxysterol-binding protein and 
localization of the gene to human chromosome 11 and mouse chromosome 19. 
Genomics 7: 65-74.  
Levine, T. P. & Munro, S. 2002. Targeting of Golgi-specific pleckstrin homology 
domains involves both PtdIns 4-kinase-dependent and -independent components. 
Current biology 12: 695-704.  
Levine, T. P. & Munro, S. 1998. The pleckstrin homology domain of oxysterol-
binding protein recognises a determinant specific to Golgi membranes. Current 
biology 8: 729-739.  
Lewin, T. M., de Jong, H., Schwerbrock, N. J., Hammond, L. E., Watkins, S. M., 
Combs, T. P. & Coleman, R. A. 2008. Mice deficient in mitochondrial glycerol-
3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol 
accumulation during lipogenic diet and altered phospholipid fatty acid 
composition. Biochimica et biophysica acta 1781: 352-358.  
Li, D., Dammer, E. B., Lucki, N. C. & Sewer, M. B. 2013. cAMP-stimulated 
phosphorylation of diaphanous 1 regulates protein stability and interaction with 
binding partners in adrenocortical cells. Molecular biology of the cell 24: 848-
857.  
87
Li, X., Monks, B., Ge, Q. & Birnbaum, M. J. 2007. Akt/PKB regulates hepatic 
metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 
447: 1012-1016.  
Lietzke, S. E., Bose, S., Cronin, T., Klarlund, J., Chawla, A., Czech, M. P. & 
Lambright, D. G. 2000. Structural basis of 3-phosphoinositide recognition by 
pleckstrin homology domains. Molecular cell 6: 385-394.  
Liou, J., Fivaz, M., Inoue, T. & Meyer, T. 2007. Live-cell imaging reveals sequential 
oligomerization and local plasma membrane targeting of stromal interaction 
molecule 1 after Ca2+ store depletion. Proceedings of the National Academy of 
Sciences of the United States of America 104: 9301-9306.  
Liou, J., Kim, M. L., Heo, W. D., Jones, J. T., Myers, J. W., Ferrell, J. E.,Jr & Meyer, 
T. 2005. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered 
Ca2+ influx. Current biology 15: 1235-1241.  
Liu, X. & Ridgway, N. D. 2014. Characterization of the sterol and 
phosphatidylinositol 4-phosphate binding properties of Golgi-associated OSBP-
related protein 9 (ORP9). PloS one 9: e108368.  
Liu, Y., Boukhelifa, M., Tribble, E., Morin-Kensicki, E., Uetrecht, A., Bear, J. E. & 
Bankaitis, V. A. 2008. The Sac1 phosphoinositide phosphatase regulates Golgi 
membrane morphology and mitotic spindle organization in mammals. Molecular 
biology of the cell 19: 3080-3096.  
Loewen, C. J., Roy, A. & Levine, T. P. 2003. A conserved ER targeting motif in three 
families of lipid binding proteins and in Opi1p binds VAP. The EMBO journal 
22: 2025-2035.  
Lokuta, M. A., Senetar, M. A., Bennin, D. A., Nuzzi, P. A., Chan, K. T., Ott, V. L. & 
Huttenlocher, A. 2007. Type Igamma PIP kinase is a novel uropod component 
that regulates rear retraction during neutrophil chemotaxis. Molecular biology of 
the cell 18: 5069-5080.  
Longuet, C., Sinclair, E. M., Maida, A., Baggio, L. L., Maziarz, M., Charron, M. J. & 
Drucker, D. J. 2008. The glucagon receptor is required for the adaptive metabolic 
response to fasting. Cell metabolism 8: 359-371.  
Luik, R. M., Wang, B., Prakriya, M., Wu, M. M. & Lewis, R. S. 2008. 
Oligomerization of STIM1 couples ER calcium depletion to CRAC channel 
activation. Nature 454: 538-542.  
Ma, Z., Liu, Z. & Huang, X. 2010. OSBP- and FAN-mediated sterol requirement for 
spermatogenesis in Drosophila. Development 137: 3775-3784.  
Mabuchi, I. 1986. Biochemical aspects of cytokinesis. International review of 
cytology 101: 175-213.  
Machesky, L. M. & Gould, K. L. 1999. The Arp2/3 complex: a multifunctional actin 
organizer. Current opinion in cell biology 11: 117-121.  
Maeda, K., Anand, K., Chiapparino, A., Kumar, A., Poletto, M., Kaksonen, M. & 
Gavin, A. C. 2013. Interactome map uncovers phosphatidylserine transport by 
oxysterol-binding proteins. Nature 501: 257-261.  
Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N., Fujita, A., Iwamatsu, A., Obinata, 
T., Ohashi, K., Mizuno, K. & Narumiya, S. 1999. Signaling from Rho to the actin 
88
cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285: 895-
898.  
Magana, M. M. & Osborne, T. F. 1996. Two tandem binding sites for sterol 
regulatory element binding proteins are required for sterol regulation of fatty-acid 
synthase promoter. The Journal of biological chemistry 271: 32689-32694.  
Maleth, J., Choi, S., Muallem, S. & Ahuja, M. 2014. Translocation between 
PI(4,5)P2-poor and PI(4,5)P2-rich microdomains during store depletion 
determines STIM1 conformation and Orai1 gating. Nature communications 5: 
5843.  
Manford, A. G., Stefan, C. J., Yuan, H. L., Macgurn, J. A. & Emr, S. D. 2012. ER-to-
plasma membrane tethering proteins regulate cell signaling and ER morphology. 
Developmental cell 23: 1129-1140.  
Matsuda, S., Kobayashi, M. & Kitagishi, Y. 2013. Roles for PI3K/AKT/PTEN 
Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease. ISRN 
endocrinology 2013: 472432.  
Mattila, P. K. & Lappalainen, P. 2008. Filopodia: molecular architecture and cellular 
functions. Nature reviews. Molecular cell biology 9: 446-454.  
McCarty, O. J., Larson, M. K., Auger, J. M., Kalia, N., Atkinson, B. T., Pearce, A. C., 
Ruf, S., Henderson, R. B., Tybulewicz, V. L., Machesky, L. M. & Watson, S. P. 
2005. Rac1 is essential for platelet lamellipodia formation and aggregate stability 
under flow. The Journal of biological chemistry 280: 39474-39484.  
Medalia, O. & Geiger, B. 2010. Frontiers of microscopy-based research into cell-
matrix adhesions. Current opinion in cell biology 22: 659-668.  
Mesmin, B., Bigay, J., Moser von Filseck, J., Lacas-Gervais, S., Drin, G. & Antonny, 
B. 2013. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P 
exchange by the ER-Golgi tether OSBP. Cell 155: 830-843.  
Mesmin, B., Bigay, J., Polidori, J., Jamecna, D., Lacas-Gervais, S. & Antonny, B. 
2017. Sterol transfer, PI4P consumption, and control of membrane lipid order by 
endogenous OSBP. The EMBO journal 36: 3156-3174 
Miki, H., Suetsugu, S. & Takenawa, T. 1998. WAVE, a novel WASP-family protein 
involved in actin reorganization induced by Rac. The EMBO journal 17: 6932-
6941.  
Min, S. W., Chang, W. P. & Sudhof, T. C. 2007. E-Syts, a family of membranous 
Ca2+-sensor proteins with multiple C2 domains. Proceedings of the National 
Academy of Sciences of the United States of America 104: 3823-3828.  
Mitchison, T. J. & Cramer, L. P. 1996. Actin-based cell motility and cell locomotion. 
Cell 84: 371-379.  
Mohammadi, A., Perry, R. J., Storey, M. K., Cook, H. W., Byers, D. M. & Ridgway, 
N. D. 2001. Golgi localization and phosphorylation of oxysterol binding protein 
in Niemann-Pick C and U18666A-treated cells. Journal of lipid research 42: 
1062-1071.  
Moon, S. Y. & Zheng, Y. 2003. Rho GTPase-activating proteins in cell regulation. 
Trends in cell biology 13: 13-22.  
89
Moser von Filseck, J., Vanni, S., Mesmin, B., Antonny, B. & Drin, G. 2015. A 
phosphatidylinositol-4-phosphate powered exchange mechanism to create a lipid 
gradient between membranes. Nature communications 6: 6671.  
Munday, M. R. & Hemingway, C. J. 1999. The regulation of acetyl-CoA carboxylase-
-a potential target for the action of hypolipidemic agents. Advances in Enzyme 
Regulation 39: 205-234.  
Murley, A., Lackner, L. L., Osman, C., West, M., Voeltz, G. K., Walter, P. & 
Nunnari, J. 2013. ER-associated mitochondrial division links the distribution of 
mitochondria and mitochondrial DNA in yeast. eLife 2: e00422.  
Musacchio, A., Gibson, T., Rice, P., Thompson, J. & Saraste, M. 1993. The PH 
domain: a common piece in the structural patchwork of signalling proteins. 
Trends in biochemical sciences 18: 343-348.  
Nagle, C. A., Vergnes, L., Dejong, H., Wang, S., Lewin, T. M., Reue, K. & Coleman, 
R. A. 2008. Identification of a novel sn-glycerol-3-phosphate acyltransferase 
isoform, GPAT4, as the enzyme deficient in Agpat6-/- mice. Journal of lipid 
research 49: 823-831.  
Nakae, J., Kitamura, T., Silver, D. L. & Accili, D. 2001. The forkhead transcription 
factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase 
expression. The Journal of clinical investigation 108: 1359-1367.  
Nakano, K., Takaishi, K., Kodama, A., Mammoto, A., Shiozaki, H., Monden, M. & 
Takai, Y. 1999. Distinct actions and cooperative roles of ROCK and mDia in Rho 
small G protein-induced reorganization of the actin cytoskeleton in Madin-Darby 
canine kidney cells. Molecular biology of the cell 10: 2481-2491.  
Narumiya, S., Tanji, M. & Ishizaki, T. 2009. Rho signaling, ROCK and mDia1, in 
transformation, metastasis and invasion. Cancer metastasis reviews 28: 65-76.  
Neuhaus, C., Lang-Roth, R., Zimmermann, U., Heller, R., Eisenberger, T., Weikert, 
M., Markus, S., Knipper, M. & Bolz, H. J. 2017. Extension of the clinical and 
molecular phenotype of DIAPH1-associated autosomal dominant hearing loss 
(DFNA1). Clinical genetics 91: 892-901.  
Ngo, M. & Ridgway, N. D. 2009. Oxysterol binding protein-related Protein 9 (ORP9) 
is a cholesterol transfer protein that regulates Golgi structure and function. 
Molecular biology of the cell 20: 1388-1399.  
Nhek, S., Ngo, M., Yang, X., Ng, M. M., Field, S. J., Asara, J. M., Ridgway, N. D. & 
Toker, A. 2010. Regulation of oxysterol-binding protein Golgi localization 
through protein kinase D-mediated phosphorylation. Molecular biology of the 
cell 21: 2327-2337.  
Ni, W., Fang, Y., Tong, L., Tong, Z., Yi, F., Qiu, J., Wang, R. & Tong, X. 2015. 
Girdin regulates the migration and invasion of glioma cells via the PI3K-Akt 
signaling pathway. Molecular medicine reports 12: 5086-5092.  
Niggli, V. & Rossy, J. 2008. Ezrin/radixin/moesin: versatile controllers of signaling 
molecules and of the cortical cytoskeleton. The international journal of 
biochemistry & cell biology 40: 344-349.  
Nishita, M., Tomizawa, C., Yamamoto, M., Horita, Y., Ohashi, K. & Mizuno, K. 
2005. Spatial and temporal regulation of cofilin activity by LIM kinase and 
90
Slingshot is critical for directional cell migration. The Journal of cell biology 
171: 349-359.  
Nissila, E., Ohsaki, Y., Weber-Boyvat, M., Perttila, J., Ikonen, E. & Olkkonen, V. M. 
2012. ORP10, a cholesterol binding protein associated with microtubules, 
regulates apolipoprotein B-100 secretion. Biochimica et biophysica acta 1821: 
1472-1484.  
Nordlie, R. C., Foster, J. D. & Lange, A. J. 1999. Regulation of glucose production by 
the liver. Annual Review of Nutrition 19: 379-406.  
Noritake, J., Watanabe, T., Sato, K., Wang, S. & Kaibuchi, K. 2005. IQGAP1: a key 
regulator of adhesion and migration. Journal of cell science 118: 2085-2092.  
Oh, K. J., Han, H. S., Kim, M. J. & Koo, S. H. 2013. CREB and FoxO1: two 
transcription factors for the regulation of hepatic gluconeogenesis. BMB reports 
46: 567-574.  
Olkkonen, V. M. 2013. OSBP-related proteins: liganding by glycerophospholipids 
opens new insight into their function. Molecules 18: 13666-13679.  
Olkkonen, V. M., Beaslas, O. & Nissila, E. 2012. Oxysterols and their cellular 
effectors. Biomolecules 2: 76-103.  
Osman, C., Voelker, D. R. & Langer, T. 2011. Making heads or tails of phospholipids 
in mitochondria. The Journal of cell biology 192: 7-16.  
Owen, D., Campbell, L. J., Littlefield, K., Evetts, K. A., Li, Z., Sacks, D. B., Lowe, P. 
N. & Mott, H. R. 2008. The IQGAP1-Rac1 and IQGAP1-Cdc42 interactions: 
interfaces differ between the complexes. The Journal of biological chemistry 
283: 1692-1704.  
Palazzo, A. F., Cook, T. A., Alberts, A. S. & Gundersen, G. G. 2001. mDia mediates 
Rho-regulated formation and orientation of stable microtubules. Nature cell 
biology 3: 723-729.  
Palecek, S. P., Huttenlocher, A., Horwitz, A. F. & Lauffenburger, D. A. 1998. 
Physical and biochemical regulation of integrin release during rear detachment of 
migrating cells. Journal of cell science 111: 929-940.  
Park, C. Y., Hoover, P. J., Mullins, F. M., Bachhawat, P., Covington, E. D., Raunser, 
S., Walz, T., Garcia, K. C., Dolmetsch, R. E. & Lewis, R. S. 2009. STIM1 
clusters and activates CRAC channels via direct binding of a cytosolic domain to 
Orai1. Cell 136: 876-890.  
Park, I., Han, C., Jin, S., Lee, B., Choi, H., Kwon, J. T., Kim, D., Kim, J., Lifirsu, E., 
Park, W. J., Park, Z. Y., Kim, D. H. & Cho, C. 2011. Myosin regulatory light 
chains are required to maintain the stability of myosin II and cellular integrity. 
The Biochemical journal 434: 171-180.  
Park, S. J., Suetsugu, S., Sagara, H. & Takenawa, T. 2007. HSP90 cross-links 
branched actin filaments induced by N-WASP and the Arp2/3 complex. Genes to 
cells : devoted to molecular & cellular mechanisms 12: 611-622.  
Patel, R. K. & Mohan, C. 2005. PI3K/AKT signaling and systemic autoimmunity. 
Immunologic research 31: 47-55.  
91
Peng, J., Wallar, B. J., Flanders, A., Swiatek, P. J. & Alberts, A. S. 2003. Disruption 
of the Diaphanous-related formin Drf1 gene encoding mDia1 reveals a role for 
Drf3 as an effector for Cdc42. Current biology 13: 534-545.  
Peretti, D., Dahan, N., Shimoni, E., Hirschberg, K. & Lev, S. 2008. Coordinated lipid 
transfer between the endoplasmic reticulum and the Golgi complex requires the 
VAP proteins and is essential for Golgi-mediated transport. Molecular biology of 
the cell 19: 3871-3884.  
Perry, R. J. & Ridgway, N. D. 2006. Oxysterol-binding protein and vesicle-associated 
membrane protein-associated protein are required for sterol-dependent activation 
of the ceramide transport protein. Molecular biology of the cell 17: 2604-2616.  
Phan, J., Peterfy, M. & Reue, K. 2004. Lipin expression preceding peroxisome 
proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in 
vitro. The Journal of biological chemistry 279: 29558-29564.  
Pollard, T. D. 2007. Regulation of actin filament assembly by Arp2/3 complex and 
formins. Annual Review of Biophysics and Biomolecular Structure 36: 451-477.  
Pollard, T. D., Blanchoin, L. & Mullins, R. D. 2000. Molecular mechanisms 
controlling actin filament dynamics in nonmuscle cells. Annual Review of 
Biophysics and Biomolecular Structure 29: 545-576.  
Pollard, T. D. & Borisy, G. G. 2003. Cellular motility driven by assembly and 
disassembly of actin filaments. Cell 112: 453-465.  
Porstmann, T., Griffiths, B., Chung, Y. L., Delpuech, O., Griffiths, J. R., Downward, 
J. & Schulze, A. 2005. PKB/Akt induces transcription of enzymes involved in 
cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24: 
6465-6481.  
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, 
J. R., Chung, Y. L. & Schulze, A. 2008. SREBP activity is regulated by 
mTORC1 and contributes to Akt-dependent cell growth. Cell metabolism 8: 224-
236.  
Porter, K. R. & Palade, G. E. 1957. Studies on the endoplasmic reticulum. III. Its 
form and distribution in striated muscle cells. The Journal of biophysical and 
biochemical cytology 3: 269-300.  
Prinz, W. A. 2014. Bridging the gap: membrane contact sites in signaling, 
metabolism, and organelle dynamics. The Journal of cell biology 205: 759-769.  
Qian, Y., Corum, L., Meng, Q., Blenis, J., Zheng, J. Z., Shi, X., Flynn, D. C. & Jiang, 
B. H. 2004. PI3K induced actin filament remodeling through Akt and p70S6K1: 
implication of essential role in cell migration. American journal of physiology. 
Cell physiology 286: C153-63.  
Raiborg, C., Wenzel, E. M., Pedersen, N. M., Olsvik, H., Schink, K. O., Schultz, S. 
W., Vietri, M., Nisi, V., Bucci, C., Brech, A., Johansen, T. & Stenmark, H. 2015. 
Repeated ER-endosome contacts promote endosome translocation and neurite 
outgrowth. Nature 520: 234-238.  
Rathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M. & 
Thompson, C. B. 2003. Akt-directed glucose metabolism can prevent Bax 
92
conformation change and promote growth factor-independent survival. Molecular 
and cellular biology 23: 7315-7328.  
Rebbeck, R. T., Karunasekara, Y., Gallant, E. M., Board, P. G., Beard, N. A., 
Casarotto, M. G. & Dulhunty, A. F. 2011. The beta(1a) subunit of the skeletal 
DHPR binds to skeletal RyR1 and activates the channel via its 35-residue C-
terminal tail. Biophysical journal 100: 922-930.  
Reue, K., Xu, P., Wang, X. P. & Slavin, B. G. 2000. Adipose tissue deficiency, 
glucose intolerance, and increased atherosclerosis result from mutation in the 
mouse fatty liver dystrophy (fld) gene. Journal of lipid research 41: 1067-1076.  
Ribaux, P. G. & Iynedjian, P. B. 2003. Analysis of the role of protein kinase B 
(cAKT) in insulin-dependent induction of glucokinase and sterol regulatory 
element-binding protein 1 (SREBP1) mRNAs in hepatocytes. The Biochemical 
journal 376: 697-705.  
Rider, M. H., Bertrand, L., Vertommen, D., Michels, P. A., Rousseau, G. G. & Hue, 
L. 2004. 6-Phosphofructo-2-Kinase/fructose-2,6-Bisphosphatase: Head-To-Head 
with a Bifunctional Enzyme that Controls Glycolysis. The Biochemical journal 
381: 561-579.  
Ridgway, N. D., Dawson, P. A., Ho, Y. K., Brown, M. S. & Goldstein, J. L. 1992. 
Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand 
binding. The Journal of cell biology 116: 307-319.  
Ridgway, N. D., Lagace, T. A., Cook, H. W. & Byers, D. M. 1998. Differential 
effects of sphingomyelin hydrolysis and cholesterol transport on oxysterol-
binding protein phosphorylation and Golgi localization. The Journal of biological 
chemistry 273: 31621-31628.  
Ridley, A. J. 2001. Rho family proteins: coordinating cell responses. Trends in cell 
biology 11: 471-477.  
Ridley, A. J. & Hall, A. 1992. The small GTP-binding protein rho regulates the 
assembly of focal adhesions and actin stress fibers in response to growth factors. 
Cell 70: 389-399.  
Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, 
G., Parsons, J. T. & Horwitz, A. R. 2003. Cell migration: integrating signals from 
front to back. Science 302: 1704-1709.  
Rizzuto, R. & Pozzan, T. 2006. Microdomains of intracellular Ca2+: molecular 
determinants and functional consequences. Physiological Reviews 86: 369-408.  
Robertson, J. D. 1960. The molecular structure and contact relationships of cell 
membranes. Progress in biophysics and molecular biology 10: 343-418.  
Rocha, N., Kuijl, C., van der Kant, R., Janssen, L., Houben, D., Janssen, H., Zwart, 
W. & Neefjes, J. 2009. Cholesterol sensor ORP1L contacts the ER protein VAP 
to control Rab7-RILP-p150 Glued and late endosome positioning. The Journal of 
cell biology 185: 1209-1225.  
Rohatgi, R., Ma, L., Miki, H., Lopez, M., Kirchhausen, T., Takenawa, T. & 
Kirschner, M. W. 1999. The interaction between N-WASP and the Arp2/3 
complex links Cdc42-dependent signals to actin assembly. Cell 97: 221-231.  
93
Romeo, G. R. & Kazlauskas, A. 2008. Oxysterol and diabetes activate STAT3 and 
control endothelial expression of profilin-1 via OSBP1. The Journal of biological 
chemistry 283: 9595-9605.  
Rosivatz, E. & Woscholski, R. 2011. Removal or masking of 
phosphatidylinositol(4,5)bisphosphate from the outer mitochondrial membrane 
causes mitochondrial fragmentation. Cellular signalling 23: 478-486.  
Rossman, K. L., Der, C. J. & Sondek, J. 2005. GEF means go: turning on RHO 
GTPases with guanine nucleotide-exchange factors. Nature reviews. Molecular 
cell biology 6: 167-180.  
Rowland, A. A., Chitwood, P. J., Phillips, M. J. & Voeltz, G. K. 2014. ER contact 
sites define the position and timing of endosome fission. Cell 159: 1027-1041.  
Rui, L. 2014. Energy metabolism in the liver. Comprehensive Physiology 4: 177-197.  
Ruprecht, V., Wieser, S., Callan-Jones, A., Smutny, M., Morita, H., Sako, K., Barone, 
V., Ritsch-Marte, M., Sixt, M., Voituriez, R. & Heisenberg, C. P. 2015. Cortical 
contractility triggers a stochastic switch to fast amoeboid cell motility. Cell 160: 
673-685.  
Rusinol, A. E., Cui, Z., Chen, M. H. & Vance, J. E. 1994. A unique mitochondria-
associated membrane fraction from rat liver has a high capacity for lipid 
synthesis and contains pre-Golgi secretory proteins including nascent 
lipoproteins. The Journal of biological chemistry 269: 27494-27502.  
Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. 2005. Phosphorylation 
and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-
1101.  
Sato, S., Fujita, N. & Tsuruo, T. 2000. Modulation of Akt kinase activity by binding 
to Hsp90. Proceedings of the National Academy of Sciences of the United States 
of America 97: 10832-10837.  
Schorr, S. & van der Laan, M. 2018. Integrative functions of the mitochondrial 
contact site and cristae organizing system. Seminars in cell & developmental 
biology 76: 191-200 
Schroepfer, G. J.,Jr. 2000. Oxysterols: modulators of cholesterol metabolism and 
other processes. Physiological Reviews 80: 361-554.  
Scita, G., Tenca, P., Frittoli, E., Tocchetti, A., Innocenti, M., Giardina, G. & Di Fiore, 
P. P. 2000. Signaling from Ras to Rac and beyond: not just a matter of GEFs. The 
EMBO journal 19: 2393-2398.  
Sechi, A. S. & Wehland, J. 2004. ENA/VASP proteins: multifunctional regulators of 
actin cytoskeleton dynamics. Frontiers in bioscience : a journal and virtual 
library 9: 1294-1310.  
Semenza, G. L., Jiang, B. H., Leung, S. W., Passantino, R., Concordet, J. P., Maire, P. 
& Giallongo, A. 1996. Hypoxia response elements in the aldolase A, enolase 1, 
and lactate dehydrogenase A gene promoters contain essential binding sites for 
hypoxia-inducible factor 1. The Journal of biological chemistry 271: 32529-
32537.  
Shirasaki, T., Honda, M., Shimakami, T., Horii, R., Yamashita, T., Sakai, Y., Sakai, 
A., Okada, H., Watanabe, R., Murakami, S., Yi, M., Lemon, S. M. & Kaneko, S. 
94
2013. MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus 
replication in human hepatoma cells. Journal of virology 87: 5270-5286.  
Shyu, Y. J. & Hu, C. D. 2008. Fluorescence complementation: an emerging tool for 
biological research. Trends in biotechnology 26: 622-630.  
Sidossis, L. S. & Wolfe, R. R. 1996. Glucose and insulin-induced inhibition of fatty 
acid oxidation: the glucose-fatty acid cycle reversed. The American Journal of 
Physiology 270: E733-8.  
Silverstein, A. M., Grammatikakis, N., Cochran, B. H., Chinkers, M. & Pratt, W. B. 
1998. p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site 
on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. 
The Journal of biological chemistry 273: 20090-20095.  
Skirpan, A. L., Dowd, P. E., Sijacic, P., Jaworski, C. J., Gilroy, S. & Kao, T. H. 2006. 
Identification and characterization of PiORP1, a Petunia oxysterol-binding-
protein related protein involved in receptor-kinase mediated signaling in pollen, 
and analysis of the ORP gene family in Arabidopsis. Plant Molecular Biology 
61: 553-565.  
Stanyon, C. A. & Bernard, O. 1999. LIM-kinase1. The international journal of 
biochemistry & cell biology 31: 389-394.  
Stathopulos, P. B., Zheng, L., Li, G. Y., Plevin, M. J. & Ikura, M. 2008. Structural 
and mechanistic insights into STIM1-mediated initiation of store-operated 
calcium entry. Cell 135: 110-122.  
Storey, M. K., Byers, D. M., Cook, H. W. & Ridgway, N. D. 1998. Cholesterol 
regulates oxysterol binding protein (OSBP) phosphorylation and Golgi 
localization in Chinese hamster ovary cells: correlation with stimulation of 
sphingomyelin synthesis by 25-hydroxycholesterol. The Biochemical journal 
336: 247-256.  
Stritt, S., Nurden, P., Turro, E., Greene, D., Jansen, S. B., Westbury, S. K., Petersen, 
R., Astle, W. J., Marlin, S., Bariana, T. K., Kostadima, M., Lentaigne, C., 
Maiwald, S., Papadia, S., Kelly, A. M., Stephens, J. C., Penkett, C. J., Ashford, 
S., Tuna, S., Austin, S., Bakchoul, T., Collins, P., Favier, R., Lambert, M. P., 
Mathias, M., Millar, C. M., Mapeta, R., Perry, D. J., Schulman, S., Simeoni, I., 
Thys, C., BRIDGE-BPD Consortium, Gomez, K., Erber, W. N., Stirrups, K., 
Rendon, A., Bradley, J. R., van Geet, C., Raymond, F. L., Laffan, M. A., Nurden, 
A. T., Nieswandt, B., Richardson, S., Freson, K., Ouwehand, W. H. & Mumford, 
A. D. 2016. A gain-of-function variant in DIAPH1 causes dominant 
macrothrombocytopenia and hearing loss. Blood 127: 2903-2914.  
Suchanek, M., Hynynen, R., Wohlfahrt, G., Lehto, M., Johansson, M., Saarinen, H., 
Radzikowska, A., Thiele, C. & Olkkonen, V. M. 2007. The mammalian 
oxysterol-binding protein-related proteins (ORPs) bind 25-hydroxycholesterol in 
an evolutionarily conserved pocket. The Biochemical journal 405: 473-480.  
Sugawara, K., Morita, K., Ueno, N. & Shibuya, H. 2001. BIP, a BRAM-interacting 
protein involved in TGF-beta signalling, regulates body length in Caenorhabditis 
elegans. Genes to cells : devoted to molecular & cellular mechanisms 6: 599-
606.  
95
Suraneni, P., Rubinstein, B., Unruh, J. R., Durnin, M., Hanein, D. & Li, R. 2012. The 
Arp2/3 complex is required for lamellipodia extension and directional fibroblast 
cell migration. The Journal of cell biology 197: 239-251.  
Sutherland, C., O'Brien, R. M. & Granner, D. K. 1996. New connections in the 
regulation of PEPCK gene expression by insulin. Philosophical transactions of 
the Royal Society of London.Series B, Biological sciences 351: 191-199.  
Svitkina, T. 2018. The Actin Cytoskeleton and Actin-Based Motility. Cold Spring 
Harbor perspectives in biology 10: 10.1101/cshperspect.a018267.  
Symons, M., Derry, J. M., Karlak, B., Jiang, S., Lemahieu, V., Mccormick, F., 
Francke, U. & Abo, A. 1996. Wiskott-Aldrich syndrome protein, a novel effector 
for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84: 723-
734.  
Szabadkai, G., Bianchi, K., Varnai, P., De Stefani, D., Wieckowski, M. R., Cavagna, 
D., Nagy, A. I., Balla, T. & Rizzuto, R. 2006. Chaperone-mediated coupling of 
endoplasmic reticulum and mitochondrial Ca2+ channels. The Journal of cell 
biology 175: 901-911.  
Taiyab, A. & Rao, C. 2011. HSP90 modulates actin dynamics: inhibition of HSP90 
leads to decreased cell motility and impairs invasion. Biochimica et biophysica 
acta 1813: 213-221.  
Takekura, H., Nishi, M., Noda, T., Takeshima, H. & Franzini-Armstrong, C. 1995a. 
Abnormal junctions between surface membrane and sarcoplasmic reticulum in 
skeletal muscle with a mutation targeted to the ryanodine receptor. Proceedings 
of the National Academy of Sciences of the United States of America 92: 3381-
3385.  
Takekura, H., Takeshima, H., Nishimura, S., Takahashi, M., Tanabe, T., Flockerzi, 
V., Hofmann, F. & Franzini-Armstrong, C. 1995b. Co-expression in CHO cells 
of two muscle proteins involved in excitation-contraction coupling. Journal of 
muscle research and cell motility 16: 465-480.  
Takeshima, H., Komazaki, S., Nishi, M., Iino, M. & Kangawa, K. 2000. 
Junctophilins: a novel family of junctional membrane complex proteins. 
Molecular cell 6: 11-22.  
Taylor, F. R., Saucier, S. E., Shown, E. P., Parish, E. J. & Kandutsch, A. A. 1984. 
Correlation between oxysterol binding to a cytosolic binding protein and potency 
in the repression of hydroxymethylglutaryl coenzyme A reductase. The Journal 
of biological chemistry 259: 12382-12387.  
Thoenes, M., Zimmermann, U., Ebermann, I., Ptok, M., Lewis, M. A., Thiele, H., 
Morlot, S., Hess, M. M., Gal, A., Eisenberger, T., Bergmann, C., Nurnberg, G., 
Nurnberg, P., Steel, K. P., Knipper, M. & Bolz, H. J. 2015. OSBPL2 encodes a 
protein of inner and outer hair cell stereocilia and is mutated in autosomal 
dominant hearing loss (DFNA67). Orphanet journal of rare diseases 10: 15-015-
0238-5.  
Tong, J., Yang, H., Yang, H., Eom, S. H. & Im, Y. J. 2013. Structure of Osh3 reveals 
a conserved mode of phosphoinositide binding in oxysterol-binding proteins. 
Structure  21: 1203-1213.  
96
Usatyuk, P. V., Fu, P., Mohan, V., Epshtein, Y., Jacobson, J. R., Gomez-Cambronero, 
J., Wary, K. K., Bindokas, V., Dudek, S. M., Salgia, R., Garcia, J. G. & 
Natarajan, V. 2014. Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt 
signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, 
reactive oxygen species (ROS) generation, and motility of lung endothelial cells. 
The Journal of biological chemistry 289: 13476-13491.  
Uzbekov, R., Kireyev, I. & Prigent, C. 2002. Centrosome separation: respective role 
of microtubules and actin filaments. Biology of the cell 94: 275-288.  
van der Kant, R., Fish, A., Janssen, L., Janssen, H., Krom, S., Ho, N., Brummelkamp, 
T., Carette, J., Rocha, N. & Neefjes, J. 2013. Late endosomal transport and 
tethering are coupled processes controlled by RILP and the cholesterol sensor 
ORP1L. Journal of cell science 126: 3462-3474.  
Vance, J. E. 2014. MAM (mitochondria-associated membranes) in mammalian cells: 
lipids and beyond. Biochimica et biophysica acta 1841: 595-609.  
Vance, J. E. 1990. Phospholipid synthesis in a membrane fraction associated with 
mitochondria. The Journal of biological chemistry 265: 7248-7256.  
Vaulont, S., Munnich, A., Marie, J., Reach, G., Pichard, A. L., Simon, M. P., 
Besmond, C., Barbry, P. & Kahn, A. 1984. Cyclic AMP as a transcriptional 
inhibitor of upper eukaryotic gene transcription. Biochemical and biophysical 
research communications 125: 135-141.  
Vergnes, L., Beigneux, A. P., Davis, R., Watkins, S. M., Young, S. G. & Reue, K. 
2006. Agpat6 deficiency causes subdermal lipodystrophy and resistance to 
obesity. Journal of lipid research 47: 745-754.  
Vihervaara, T., Jansen, M., Uronen, R. L., Ohsaki, Y., Ikonen, E. & Olkkonen, V. M. 
2011a. Cytoplasmic oxysterol-binding proteins: sterol sensors or transporters? 
Chemistry and physics of lipids 164: 443-450.  
Vihervaara, T., Uronen, R. L., Wohlfahrt, G., Bjorkhem, I., Ikonen, E. & Olkkonen, 
V. M. 2011b. Sterol binding by OSBP-related protein 1L regulates late endosome 
motility and function. Cellular and molecular life sciences 68: 537-551.  
Voelker, D. R. 1989. Reconstitution of phosphatidylserine import into rat liver 
mitochondria. The Journal of biological chemistry 264: 8019-8025.  
Walsh, C. M., Chvanov, M., Haynes, L. P., Petersen, O. H., Tepikin, A. V. & 
Burgoyne, R. D. 2009. Role of phosphoinositides in STIM1 dynamics and store-
operated calcium entry. The Biochemical journal 425: 159-168.  
Wang, C., JeBailey, L. & Ridgway, N. D. 2002. Oxysterol-binding-protein (OSBP)-
related protein 4 binds 25-hydroxycholesterol and interacts with vimentin 
intermediate filaments. The Biochemical journal 361: 461-472.  
Wang, P. Y., Weng, J. & Anderson, R. G. 2005. OSBP is a cholesterol-regulated 
scaffolding protein in control of ERK 1/2 activation. Science 307: 1472-1476.  
Wang, P. Y., Weng, J., Lee, S. & Anderson, R. G. 2008a. The N terminus controls 
sterol binding while the C terminus regulates the scaffolding function of OSBP. 
The Journal of biological chemistry 283: 8034-8045.  
Wang, W., Chen, L., Ding, Y., Jin, J. & Liao, K. 2008b. Centrosome separation 
driven by actin-microfilaments during mitosis is mediated by centrosome-
97
associated tyrosine-phosphorylated cortactin. Journal of cell science 121: 1334-
1343.  
Wang, Y., Deng, X., Zhou, Y., Hendron, E., Mancarella, S., Ritchie, M. F., Tang, X. 
D., Baba, Y., Kurosaki, T., Mori, Y., Soboloff, J. & Gill, D. L. 2009. STIM 
protein coupling in the activation of Orai channels. Proceedings of the National 
Academy of Sciences of the United States of America 106: 7391-7396.  
Wang, Y., Litvinov, R. I., Chen, X., Bach, T. L., Lian, L., Petrich, B. G., Monkley, S. 
J., Kanaho, Y., Critchley, D. R., Sasaki, T., Birnbaum, M. J., Weisel, J. W., 
Hartwig, J. & Abrams, C. S. 2008a. Loss of PIP5KIgamma, unlike other PIP5KI 
isoforms, impairs the integrity of the membrane cytoskeleton in murine 
megakaryocytes. The Journal of clinical investigation 118: 812-819.  
Wang, Y., Rogers, P. M., Su, C., Varga, G., Stayrook, K. R. & Burris, T. P. 2008b. 
Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. The 
Journal of biological chemistry 283: 26332-26339.  
Watanabe, N., Kato, T., Fujita, A., Ishizaki, T. & Narumiya, S. 1999. Cooperation 
between mDia1 and ROCK in Rho-induced actin reorganization. Nature cell 
biology 1: 136-143.  
Watson, R. T., Kanzaki, M. & Pessin, J. E. 2004. Regulated membrane trafficking of 
the insulin-responsive glucose transporter 4 in adipocytes. Endocrine reviews 25: 
177-204.  
Weber-Boyvat, M., Kentala, H., Lilja, J., Vihervaara, T., Hanninen, R., Zhou, Y., 
Peranen, J., Nyman, T. A., Ivaska, J. & Olkkonen, V. M. 2015a. OSBP-related 
protein 3 (ORP3) coupling with VAMP-associated protein A regulates R-Ras 
activity. Experimental cell research 331: 278-291.  
Weber-Boyvat, M., Kentala, H., Peranen, J. & Olkkonen, V. M. 2015b. Ligand-
dependent localization and function of ORP-VAP complexes at membrane 
contact sites. Cellular and molecular life sciences 72: 1967-1987.  
Wegner, A. 1976. Head to tail polymerization of actin. Journal of Molecular Biology 
108: 139-150.  
Wendel, A. A., Lewin, T. M. & Coleman, R. A. 2009. Glycerol-3-phosphate 
acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis. 
Biochimica et biophysica acta 1791: 501-506.  
Wilhelm, L. P., Wendling, C., Vedie, B., Kobayashi, T., Chenard, M. P., Tomasetto, 
C., Drin, G. & Alpy, F. 2017. STARD3 mediates endoplasmic reticulum-to-
endosome cholesterol transport at membrane contact sites. The EMBO journal 
36: 1412-1433.  
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., 
Strongin, A. Y., Brocker, E. B. & Friedl, P. 2003. Compensation mechanism in 
tumor cell migration: mesenchymal-amoeboid transition after blocking of 
pericellular proteolysis. The Journal of cell biology 160: 267-277.  
Wollweber, F., von der Malsburg, K. & van der Laan, M. 2017. Mitochondrial contact 
site and cristae organizing system: A central player in membrane shaping and 
crosstalk. Biochimica et biophysica acta 1864: 1481-1489.  
98
Wong, L. H., Copic, A. & Levine, T. P. 2017. Advances on the Transfer of Lipids by 
Lipid Transfer Proteins. Trends in biochemical sciences 42: 516-530.  
Wu, C., Asokan, S. B., Berginski, M. E., Haynes, E. M., Sharpless, N. E., Griffith, J. 
D., Gomez, S. M. & Bear, J. E. 2012. Arp2/3 is critical for lamellipodia and 
response to extracellular matrix cues but is dispensable for chemotaxis. Cell 148: 
973-987.  
Wu, M. M., Buchanan, J., Luik, R. M. & Lewis, R. S. 2006. Ca2+ store depletion 
causes STIM1 to accumulate in ER regions closely associated with the plasma 
membrane. The Journal of cell biology 174: 803-813.  
Wu, W. I. & Voelker, D. R. 2004. Reconstitution of phosphatidylserine transport from 
chemically defined donor membranes to phosphatidylserine decarboxylase 2 
implicates specific lipid domains in the process. The Journal of biological 
chemistry 279: 6635-6642.  
Wyles, J. P., Perry, R. J. & Ridgway, N. D. 2007. Characterization of the sterol-
binding domain of oxysterol-binding protein (OSBP)-related protein 4 reveals a 
novel role in vimentin organization. Experimental cell research 313: 1426-1437.  
Xiang, Y. & Wang, Y. 2010. GRASP55 and GRASP65 play complementary and 
essential roles in Golgi cisternal stacking. The Journal of cell biology 188: 237-
251.  
Xing, G., Yao, J., Wu, B., Liu, T., Wei, Q., Liu, C., Lu, Y., Chen, Z., Zheng, H., 
Yang, X. & Cao, X. 2015. Identification of OSBPL2 as a novel candidate gene 
for progressive nonsyndromic hearing loss by whole-exome sequencing. Genetics 
in medicine : official journal of the American College of Medical Genetics 17: 
210-218.  
Xu, Y., Liu, Y., Ridgway, N. D. & McMaster, C. R. 2001. Novel members of the 
human oxysterol-binding protein family bind phospholipids and regulate vesicle 
transport. The Journal of biological chemistry 276: 18407-18414.  
Xue, G. & Hemmings, B. A. 2013. PKB/Akt-dependent regulation of cell motility. 
Journal of the National Cancer Institute 105: 393-404.  
Yamashita, H., Takenoshita, M., Sakurai, M., Bruick, R. K., Henzel, W. J., 
Shillinglaw, W., Arnot, D. & Uyeda, K. 2001. A glucose-responsive transcription 
factor that regulates carbohydrate metabolism in the liver. Proceedings of the 
National Academy of Sciences of the United States of America 98: 9116-9121.  
Yamazaki, M., Miyazaki, H., Watanabe, H., Sasaki, T., Maehama, T., Frohman, M. 
A. & Kanaho, Y. 2002. Phosphatidylinositol 4-phosphate 5-kinase is essential for 
ROCK-mediated neurite remodeling. The Journal of biological chemistry 277: 
17226-17230.  
Yan, D., Jauhiainen, M., Hildebrand, R. B., Willems van Dijk, K., Van Berkel, T. J., 
Ehnholm, C., Van Eck, M. & Olkkonen, V. M. 2007. Expression of human 
OSBP-related protein 1L in macrophages enhances atherosclerotic lesion 
development in LDL receptor-deficient mice. Arteriosclerosis, Thrombosis, and 
Vascular Biology 27: 1618-1624.  
Yan, D., Mayranpaa, M. I., Wong, J., Perttila, J., Lehto, M., Jauhiainen, M., Kovanen, 
P. T., Ehnholm, C., Brown, A. J. & Olkkonen, V. M. 2008. OSBP-related protein 
99
8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from 
macrophages. The Journal of biological chemistry 283: 332-340.  
Yang, Z., Cappello, T. & Wang, L. 2015. Emerging role of microRNAs in lipid 
metabolism. Acta pharmaceutica Sinica.B 5: 145-150.  
Yecies, J. L., Zhang, H. H., Menon, S., Liu, S., Yecies, D., Lipovsky, A. I., Gorgun, 
C., Kwiatkowski, D. J., Hotamisligil, G. S., Lee, C. H. & Manning, B. D. 2011. 
Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-
dependent and independent pathways. Cell metabolism 14: 21-32.  
Yu, Y., Hamza, A., Zhang, T., Gu, M., Zou, P., Newman, B., Li, Y., Gunatilaka, A. 
A., Zhan, C. G. & Sun, D. 2010. Withaferin A targets heat shock protein 90 in 
pancreatic cancer cells. Biochemical pharmacology 79: 542-551.  
Zatulovskiy, E., Tyson, R., Bretschneider, T. & Kay, R. R. 2014. Bleb-driven 
chemotaxis of Dictyostelium cells. The Journal of cell biology 204: 1027-1044.  
Zechner, R., Kienesberger, P. C., Haemmerle, G., Zimmermann, R. & Lass, A. 2009. 
Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. 
Journal of lipid research 50: 3-21.  
Zhao, H. F., Wang, J., Jiang, H. R., Chen, Z. P. & To, S. S. 2016. PI3K p110beta 
isoform synergizes with JNK in the regulation of glioblastoma cell proliferation 
and migration through Akt and FAK inhibition. Journal of experimental & 
clinical cancer research  35: 78-016-0356-5.  
Zhao, K. & Ridgway, N. D. 2017. Oxysterol-Binding Protein-Related Protein 1L 
Regulates Cholesterol Egress from the Endo-Lysosomal System. Cell reports 19: 
1807-1818.  
Zhong, W., Yi, Q., Xu, B., Li, S., Wang, T., Liu, F., Zhu, B., Hoffmann, P. R., Ji, G., 
Lei, P., Li, G., Li, J., Li, J., Olkkonen, V. M. & Yan, D. 2016. ORP4L is essential 
for T-cell acute lymphoblastic leukemia cell survival. Nature communications 7: 
12702.  
Zhou, T., Li, S., Zhong, W., Vihervaara, T., Beaslas, O., Perttila, J., Luo, W., Jiang, 
Y., Lehto, M., Olkkonen, V. M. & Yan, D. 2011. OSBP-related protein 8 (ORP8) 
regulates plasma and liver tissue lipid levels and interacts with the nucleoporin 
Nup62. PloS one 6: e21078.  
Zhou, Y., Wohlfahrt, G., Paavola, J. & Olkkonen, V. M. 2014. A vertebrate model for 
the study of lipid binding/transfer protein function: conservation of OSBP-related 
proteins between zebrafish and human. Biochemical and biophysical research 
communications 446: 675-680.  
 
